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The thymus is a heterogeneous mix of hematopoietic and stromal cells that function 
to generate a functional, self-tolerant T-cell pool. Although many of these populations 
are well studied, the role of non-epithelial stroma remains unclear.  
 
Thymic mesenchyme has been identified as an important regulator of T-cell egress. 
Studies of lymphotoxin beta-receptor (LTβR) have revealed its critical role in T-cell 
egress as well as the development and function of lymph node mesenchyme. We 
hypothesized that LTβR regulation of thymic mesenchyme is critical for T-cell egress. 
To test this we generated Wnt-1creLtbrflox mice to delete LTβR on thymic 
mesenchyme and revealed this to be non-essential for T-cell egress. Moreover, we 
generated Foxn-1creLtbrflox mice to delete LTβR on thymic epithelial cell (TEC). 
Despite the critical role of LTβR in medullary TEC development, T-cell egress was 
normal. However, deleting LTβR on thymic endothelium using Flk-1creLtbrflox mice 
revealed an essential role of LTβR regulation of endothelium to control T-cell egress. 
Our analysis also revealed that T-cell entry into the perivascular space during T-cell 
egress occurs stochastically. Collectively our findings highlight a novel role for LTβR 
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1.1 THYMUS AND THYMOCYTE DEVELOPMENT 
1.1.1 Overview Of The Thymus 
The thymus is one of two primary lymphoid organs whose function is to support the 
development of lymphocytes that are essential for the host’s adaptive immune 
protection. The bone marrow is the other primary lymphoid tissue and it functions to 
support the development of B-cells as well as the generation of T-cell precursors, 
which migrate to the thymus where they undergo a tightly regulated programme of 
development. T-cells play a vital role in defending the host against foreign and 
harmful cells all the while remaining tolerant to the host’s own cells thereby 
preventing autoimmune disease. T-cells can only achieve this by undergoing a highly 
selective and rigorous developmental program during their development within the 
thymus.  
 
The importance of the thymus and the role that it plays within the immune system 
was first discovered in 1961 in a study which revealed that surgical removal of the 
thymus (thymectomy) resulted in the absence of peripheral T-cells (1). Since this 
initial observation thymus research has covered many aspects of thymic biology, 
including the developmental regulation of the organ, the different cell populations that 
make it up, how it regulates the development of thymocytes (developing T-cells) and 
how it regulates and achieves a highly effective immune regulatory role whilst 
ensuring tolerance to self. Together this research has collectively emphasized the 
essential role that the thymus plays in the development of the T-cell repertoire and its 




The thymus regulates the development of T-cells through its unique 
microenvironment that contains specific cell types, whose organization and function 
is specialized to educate and screen different thymocyte subsets through their 
various stages of development. The thymus generates two main types of T-cells 
differing by their T-cell receptor (TCR); γδ and αβ T-cells.  
 
αβ T-cells are the primary T-cell population generated by the thymus and can be 
separated into functionally distinct helper T-cells and cytotoxic T-cells based on their 
expression of the co-receptor CD4 or CD8, respectively. The expression of the co-
receptor aids the binding of the TCR to major histocompatibility complex (MHC)–
peptide complex by stabilizing the interaction. CD4+ T-cells recognize peptides 
presented in the context of MHC Class II molecules, while CD8+ T-cells recognize 
MHC Class I associated peptides and this specificity is important both during the 
development of the T-cells as well as their function within the periphery. Thymocytes 
undergo a number of regulated developmental processes during their development 
within the thymus. Subsequent to cortical thymic epithelial cell (cTEC)-mediated 
positive selection, T-cell receptor (TCR) bearing CD4+ thymocytes interact with 
medullary thymic epithelial cells (mTEC) that present self-peptide-MHC class II 
complexes. Depending on the strength of TCR signaling during this interaction the 
developing CD4+ T-cell can either continue it’s development as a CD4+ T-cell, be 
selected to differentiate into a regulatory T-cell or be selected for cell death (negative 
selection) (more detail of this process in Section 1.1.5). Once CD4+ T-cells complete 
this intrathymic development and enter the periphery the naïve T-cell can become 
activated by antigenic stimulation as a result of specific TCR interactions with 
 
4 
peptide-MHC complexes presented by antigen presenting cells (APC) coupled with 
CD3 activation (2). CD4+ T-cells have multiple potential lineages and their 
differentiation into a specific lineage is dependent on the specific cytokine signaling 
and transcription factors. Subsets of CD4+ T-cells include: T-helper 1 (Th1), Th2, 
Th9, Th17, follicular helper T-cells (Tfh) and induced Tregs (iTreg) (2). The signals 
instructing the differentiation of each lineage are specific and each subset has a 
particular function within peripheral T-cell immunity. As their name suggests, the 
main function of CD4+ T-cells is to “help” other cells to kill target cells through their 
production of various mediators such as cytokines. For example activated Th1 and 
Th2 cells produce cytokines that stimulate clonal expansion and antibody production 
by B-cells or both can also activate CD8+ cytotoxic T-cells to kill infected cells (3,4). 
An exception to this helper role are regulatory T-cells, which are a subclass of CD4+ 
T-cells which are rescued during negative selection and act in an 
immunosuppressive manner to curtail immune response. 
 
CD8+ T-cells also undergo intrathymic development similar to CD4+ T-cells but 
instead interact with self-peptide MHC Class I complexes and are selected for 
survival or cell death depending on the strength of TCR signaling during this 
interaction. Once CD8+ cytotoxic T-cells have entered the periphery they are 
activated by antigenic stimulation of their TCR by cognate endogenous peptides 
presented by MHC Class I on virally infected cells. Cytotoxic T-cells kill target cells 
through at least three distinct pathways. Cytotoxic T-cells can produce tumor 
necrosis factor α which triggers target-cell apoptosis and interferon γ which triggers 
increased MHC Class I presentation pathway and Fas expression in the target cells 
enhancing cytotoxic T-cell killing (5,6). Cytotoxic T-cells can also kill target cells 
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through direct cell-cell contact, either binding Fas on the target cell triggering 
apoptosis or releasing highly cytotoxic perforins and granzymes directly into the 
target cell causing apoptosis (7–9).  
 
γδ T-cells are thought to arise during the earliest stages of T-cell development and 
represent a much smaller fraction of the periphery T-cell pool compared to αβ T-cells. 
In contrast to αβ T-cells, much less is known of the function and development of γδ 
T-cells.  
 
These two cell types can be further subdivided into many different subtypes based on 
their developmental stages and function. The following sections will cover the 
different cells types and development stages of the αβ T-cell lineage. 
1.1.2 Thymic Colonization And Early T-Cell Progenitors 
Unlike the bone marrow, which is the site of the generation of B-cell precursors and 
their development, the thymus is not able to produce its own hematopoietic stem 
cells to generate T-cell precursors from. Therefore, T-cell development is dependent 
on the colonization of the thymus by blood-borne progenitor cells (10). The origin of 
the hemogenic progenitor cell and how it colonizes the thymus differs during different 
stages of development. At day 12 of gestation (E12), progenitor cell entry occurs 
prior to vascularization of the thymus, therefore progenitor cells migrate into the 
thymus via adjacent blood vessels and must migrate through the surrounding 
mesenchymal layer of the early thymic rudiment to enter the epithelial compartment 
of the early thymus (11,12). At this early stage the progenitor cells are sourced 
mainly from the fetal liver (13). However at the post-natal and adult stage the T-cell 
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progenitor arises from the bone marrow and the developed vasculature of the thymus 
supports the direct entry of the progenitors into the thymus via blood vessels at the 
junction between the cortex and the medulla, a region termed the corticomedullary 
junction (CMJ) (14). Progenitor entry occurs in waves during both embryogenesis 
and adulthood, during embryogenesis the progenitor cells mainly give rise to γδ T-
cells, however at the late stages of embryogenesis and the subsequent post-natal 
and adult thymus, thymocyte development has largely switched to the αβ T-cell 
lineage (15,16). As this thesis focuses on aspects of αβ T-cells, the following 
sections will center on the development of αβ T-cells and their precursors during 
post-natal and adult stages. 
 
The phenotypic characterization of the hematopoietic progenitor cells that colonize 
the thymus is poorly understood, in part due to the very small number of these cells 
that exist within the adult thymus. It is also difficult due to the capacity of multiple 
different bone marrow borne progenitors such as hematopoietic stem cell (HSCs), 
multipotent progenitor cells (MPP) and common lymphoid progenitors (CLPs) to give 
rise to thymus settling progenitors and undergo subsequent T-cell development (17). 
However more is known about the progenitor cells downstream of the thymus 
colonizing cells. Commonly referred to as early T-cell progenitors (ETPs), these cells 
are the earliest progenitor population that has been relatively well defined within the 
thymus and represent the starting point of intrathymic T-cell development. ETP are 
found within the DN1 thymocyte population, which are identified as being negative for 
the co-receptors CD4 and CD8, CD25- and CD44+. However the DN1 population 
contains a mixture of other cell types including those of non-T-cell lineage such as B-
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cell progenitors. Therefore ETP are defined as Lineagelow (a cocktail of markers 
including those associated with non-T-cell lineages such as B220 which identifies B-
cells) as well as CD25-KIT+Sca-1+ (18,19). ETP have multilineage potential, being 
able to give rise to B-cells as well as T-cells as T lineage commitment does not occur 
until progeny downstream of the ETP (18). 
 
Colonization of the thymus by these progenitor cells upstream of ETP has been 
shown to be regulated, at least in part, by adhesive interactions between P-selectin 
expressed by the thymic endothelial cells and P-selectin glycoprotein ligand 1 
(PSGL1) expressed by the progenitor cells (20). Rossi et. al showed that mice 
deficient for PSGL1 had reduced numbers of ETP within the thymus as a 
consequence of disrupted progenitor cell entry (20). This same study by Rossi et. al 
revealed that the number of thymic progenitors within the thymus regulates the 
expression of P-selectin, acting as a feedback loop to regulate endothelial-mediated 
progenitor entry into the thymus (20). This is in accordance with an initial study which 
observed that the thymus is receptive to progenitor cell entry for a period of ~1 week 
and refractive for ~3 weeks which allows for the progressive emptying of the 
microenvironmental niche for the next wave (15). Together these two studies 
highlight a role of self-regulation of thymocyte progenitor entry into the thymus. 
 
The chemokine receptors C-C chemokine receptor type 7 (CCR7) and 9 (CCR9) both 
play a role in regulating T-cell progenitor entry into the thymus. Whilst CCR9 
regulates progenitor entry, there may be a degree of redundancy in the requirement 
for this chemokine receptor, as absence of CCR9 when CCR7 is still expressed does 
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not impact progenitor entry due to CCR7 fully supporting progenitor entry (21). 
However absence of both CCR9 and CCR7 resulted in a severe reduction of ETP 
within the double-deficient mouse thymus suggesting a clear role of CCR9 and CCR7 
working together to regulate progenitor entry (21). 
 
It has also been shown that lymphotoxin beta receptor (LTβR) can regulate 
progenitor entry into the thymus, as mice deficient for LTβR have a significant 
reduction of ETP (22). It is thought that this reduction in T-cell progenitor entry in 
LTβR-deficient mice is a result of reduced expression of the intracellular adhesion 
molecule 1 (ICAM-1) and vascular adhesion molecule 1 (VCAM-1) which are both 
reduced as shown by PCR of thymic mesenchyme and endothelium (22). 
Interestingly this LTβR-dependent regulation of thymocyte entry was not due to 
altered P-selectin expression which appeared normal on LTβR-deficient endothelium 
(22). Consistent with these findings, mAb inhibition of ICAM-1 or VCAM-1, or 
inhibition of the integrins that these adhesion molecules bind to, impaired the homing 
of progenitors to the thymus (23). This essential role of LTβR requires interaction 
between LTβR-expressing stroma and LTβR-ligand-bearing thymocytes providing 
evidence that thymocytes play a role in regulating T-cell progenitor entry via 
interactions with thymic endothelium (22,24). Consistent with the thymic endothelial 
cells’ role in regulating progenitor entry via P-selectin, it has been recently shown that 
LTβR regulates a specific type of endothelial cell, termed thymic portal endothelium, 
which is significantly reduced in LTβR-deficient mice and therefore these portal 




Upon development from the thymus colonizing T-cell progenitor, ETP undergo further 
developmental progression that eventually gives rise to T-cell lineage restricted 
immature DN3 thymocytes which then in turn give rise to CD4+CD8+ αβ TCR-
expressing DP thymocytes that undergo positive selection. The following section will 
cover how these developmental stages occur as well as how each is regulated in 
detail. The key stages of the T-cell development programme are summarized within 
Figure 1.1. 
1.1.3 Early Thymocyte Development And T-Cell Lineage Commitment 
ETP within the thymus are not yet lineage restricted and still have the capacity to 
give rise to many non-T-cell lineages such as B-cells, DCs and NK cells (25). T-cell 
lineage commitment does not occur as a single event; instead commitment occurs 
over a number of developmental stages between ETP and the T-cell lineage 
committed DN3 thymocyte population, summarized in Figure 1.1 (26). 
 
The developmental progression begins with ETP defined as CD4-CD8-CD25-
CD44+CD117+ (18,19). ETP develop into DN2 thymocytes, which are CD4-CD8-
CD25+CD44+CD117+ and have lost B-cell potential but still have NK-cell, DC and T-
cell lineage potential (27). The DN2 population can be split into two distinct 
populations termed DN2a and DN2b (28). Using a pLCK-GFP reporter model which 
reports Lck signaling within the developing thymocyte, Masuda et. al were able to 
show that DN2 cells can be separated by the expression of the pLCK-GFP. GFP- 
DN2a cells differentiate and give rise to GFP+ DN2b which have lost DC lineage 










Figure 1.1. T-Cell Development 
T-cell progenitors enter the thymus at the cortico-medullary junction (CMJ) via blood 
vessels, which are surrounded by pericytes, and develop into CD25-CD44+CD117+ 
early T-cell progenitors (ETP). ETP migrate to the inner cortex and develop into 
CD25+CD44+ DN2 cells under the regulation of cortical thymic epithelial cells (cTEC). 
DN2 thymocytes migrate further into the outer cortex, migrating along a cellular 
matrix comprised of VCAM-1-expressing cTEC and develop into CD25+CD44- DN3. 
Development of DN2 into DN3 thymocytes marks T-cell lineage commitment and 
DN3 express the T-cell receptor (TCR) β chain and a pre-TCRα chain. DN3 cells 
then develop into pre-DP thymocytes, which begin TCRα chain rearrangement but do 
not yet express CD4 or CD8 co-receptors. Generation of TCRα and it’s pairing with 
TCRβ forms an αβ TCR which is accompanied with an upregulation of CD4 and CD8 
and develop into DP (CD4+CD8+) thymocytes. DP thymocytes interact with self-
peptide-self-MHC complex-bearing cTEC and undergo positive selection, where 
successful low affinity interactions between DP TCR and self-peptide MHC on cTEC 
select the DP cell for survival. Successful positive selection results in commitment 
and differentiation of CD4+CD8- SP4 and CD4-CD8+ SP8 thymocytes, which migrate 
to the medulla. These SP thymocytes then interact with medullary TEC and undergo 
negative selection, where SP thymocytes expressing TCRs that bind self-peptide-
self-MHC complexes with low affinity survive and SP thymocytes with TCR that bind 
with high affinity are selected for cell death. These immature SP thymocytes then 
undergo intrathymic maturation during which they acquire egress-competence and 
then exit the thymus via blood vessels at the CMJ.  
  
Pericyte 




































           High affinity       
      interaction 
(Negative  
Selection) 





















The developmental transition from ETP to DN2 is regulated by signals from the 
microenvironment in which the ETP inhabit. ETP are abundant in the perimedullary 
cortex, a region of the cortex near the CMJ where the thymus colonizing cells enter 
the thymus (14). These early progenitors spend a long time within the perimedullary 
cortex, with one study revealing that these cells spend approximately 10 days in this 
region, during which these cells undergo roughly 1000-fold expansion (29). ETP are 
in constant contact with stromal cells within the cortex, mainly cortical thymic 
epithelial cells (cTECs), which support ETP and their development to DN2. ETP/DN2 
migrate to the inner cortex under the guidance of the CXC chemokine ligand 12 
(CXCL12) expressed by cTEC which binds to its receptor CXC chemokine receptor 4 
(CXCR4) expressed by early thymocytes (30). Failure of this signaling results in 
failure to migrate into the inner cortex and a developmental block at the ETP/DN1 
stage, highlighting the requirement of specialized areas within the cortex for the 
development of different developmental stages of DN thymocytes (30). Kit ligand 
(KitL) regulates the proliferation and differentiation of DN thymocytes and it has been 
shown that the membrane bound form of KitL (mKitL) (ligand for Kit, CD117) is 
produced by cTEC as well as vascular endothelial cells near the CMJ (31,32). ETP 
are dependent on mKitL produced by cortex-specific vascular endothelial cells for 
their proliferation and differentiation into DN2 thymocytes (31,33). ETP proliferation 
and differentiation is also regulated by Notch signaling, notably from delta like ligand 
4 (DLL4) produced by cTEC binding to Notch receptors on the ETP, as well as 
signaling through the interleukin-7 receptor (IL-7R) and IL-7 produced by cTEC (33–
35). Constant interaction with cTEC is therefore essential for the development of the 
ETP-DN2 transition as well as their migration into the inner cortex. 
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DN2 thymocytes are found throughout the cortex as they make their way from the 
inner cortex to the outer cortex via chemokine gradient driven migration (14). DN2 
cells migrate to the outer cortex using a cellular matrix, rather than an extracellular 
matrix, comprised of VCAM-1-expressing cTEC which allows the DN2 to remain in 
contact with cTEC and receive signals from the cTEC as they migrate (36). Similarly 
to ETP, Kit-KitL interactions regulate proliferation and differentiation of the DN2 cells, 
however DN2 cells interact with mKitL-expressing cTEC instead of endothelial cells 
(31,33,34). Notch ligands expressed by cTEC also play a role in regulating 
proliferation and differentiation of DN2 cells (34). Following a period of proliferation, 
DN2b develop into DN3 cells which is characterized by a downregulation of CD44 
and CD117 expression resulting in a CD4-CD8-CD25+CD44- phenotype (26,28). 
 
Importantly the developmental transition into DN3 thymocytes marks the stage that 
developing thymocyte precursors commit to the T-cell lineage and become unipotent 
(26). DN3 thymocytes greatly increase T-cell receptor (TCR) rearrangement, which is 
initiated at DN2, and generate a fully rearranged TCRβ chain (37). In the context of 
αβ T-cell development, TCR rearrangement refers to the process of generating a 
TCR β chain by recombination of segments of Variable, Diversity and Joining, V(D)J, 
genes occurring at the β loci (38). This occurs through the activity of nucleases and 
ligases that randomly cut and join, respectively, gene fractions together under the 
control of recombination-activating gene 1 and 2 (RAG-1 and RAG-2) which are 
essential for V(D)J rearrangement (39,40). This results in the joining of a random 
segment from each of the V(D)J regions to generate a combination that encode 
proteins that form a functional β chain. Mombaerts et. al showed in addition to the 
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essential requirement for either RAG-1 or RAG-2 for V(D)J recombination and 
subsequent T-cell development, introduction of a single fully rearranged TCRβ gene 
can convert DN cells to DP, highlighting an essential role of TCRβ expression in DN 
thymocyte development (39–41). 
 
Only DN3 thymocytes that have successfully generated a TCRβ chain become 
activated by TCR-dependent selection; identifying heterogeneity within the DN3 
compartment (42). DN3 thymocytes that have yet to be selected are CD27lo and 
termed DN3a, whereas DN3 thymocytes that have undergone TCR-dependent 
selection upregulate CD27 expression and are termed DN3b (42). For αβ T-cell 
development, DN3b thymocytes that have successfully generated the TCRβ chain 
undergo a process termed β selection. This is a process that requires a functional 
TCRβ chain forming a pre-TCR with an invariant pre-TCRα (pTα) chain, the presence 
of both TCRβ and pTα is essential for T-cell development (41,43,44). This pre-TCR 
must be functional for the cells to interact with TCR signaling proteins otherwise cells 
that fail to produce a pre-TCR die by apoptosis (45). Pre-TCR signals cooperate with 
Notch signals (Notch/DLL1 interactions), as well as signaling from CXCR4-CXCL12 
interactions, to promote cell survival, proliferation and differentiation of the DN3b 
cells to the DP cell stage (46–48). Following β selection, the DN3b cells undergo 
extensive proliferation and rapidly downregulate CD25, becoming pre-DP thymocytes 
(26,49). These pre-DP thymocytes are an intermediary population between DN3b 
and CD4+CD8+ DP thymocytes and begin TCRα chain rearrangement as well as 
migrate back towards the CMJ. Generation of the TCRα chain and its subsequent 
pairing with the TCRβ chain forms a mature TCR which is accompanied by 
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upregulation of CD4 and CD8 expression triggering the rapid progression to DP cells, 
the development of which will be discussed in further detail in the following section. 
 
1.1.4 Positive Selection 
Once DP thymocytes have generated a TCRα chain, it pairs with the TCRβ chain to 
form an αβ T-cell receptor expressed on the surface of the cell. DP thymocytes that 
express a functional αβ TCR are selected to continue their development via a 
process termed positive selection. Positive selection is a crucial step in thymocyte 
development as it screens the DP thymocyte population to ensure that cells 
progressing to the next stage of development have a functional T-cell receptor, which 
is critical to the T-cells overall functions. The importance of this process is highlighted 
by the fact that only 5-10% of DP thymocytes express low affinity TCR specificities 
and are therefore selected for cell survival (50,51). During this process, the αβ TCR 
expressed by the developing DP thymocyte binds to self-peptide self-MHC 
complexes presented by cTEC and this ability to induce a normal program of positive 
selection is distinct to cTEC (52). DP thymocytes are programmed for cell death by 
default but the successful recognition and binding of their TCR to self-peptide MHC 
complexes induces TCR signaling which promotes their survival (53). Such pro-
survival regulators include the retinoic acid receptor-related orphan nuclear hormone 
regulator γ (RORγ) and trans-acting T-cell factor-1 (TCF-1), with it’s co-activator β-
catenin, are required for the expression of the anti-apoptotic factor Bcl-xL (54,55). 
Absence of either RORγ or TCF-1 results in loss of Bcl-xL and leads to accelerated 
spontaneous cell death of the DP thymocytes (54,55). Therefore DP thymocytes are 
programmed for apoptosis but these transcription factors promote their survival to 
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maximize the time frame in which DP thymocytes can undergo positive selection 
(54,55).  
 
It is suggested that the strength of TCR binding to self-peptide MHC complexes 
determines the cells fate. DP thymocytes with low affinity are selected for survival 
and continuation of the developmental program. Gene rearrangement occurs during 
the generation of both the β and α chain to increase the maximum number of random 
self-peptide TCR specificities. TCRα rearrangement continues even after pairing of 
the α chain and the β chain to maximize the chances of successful positive selection, 
until either the cell is selected on having a functional αβ TCR or the cells do not 
receive a survival signal within the survival timeframe of DP thymocytes 
(approximately 3-4 days) and die by neglect via programmed cell death (56,57). 
Upon positive selection, RAG-1 and RAG-2 are downregulated to cease further gene 
rearrangement (56,57).  
 
Ultimately successful positive selection of DP thymocytes results in the commitment 
and differentiation into either CD4+CD8- SP4 or CD4-CD8+ SP8 thymocytes. SP4 
thymocytes recognize MHC Class II whereas SP8 thymocytes recognize MHC Class 
I (58). Multiple models have been proposed to explain how DP thymocytes commit to 
either of these two lineages. The two previously prevailing models suggested either 
an instructional or stochastic program of lineage commitment. The instructional 
model proposes that the recognition and engagement of a specific class of MHC by 
the TCR specifically terminates the expression of the mismatched co-receptor 
molecule and therefore directs the lineage commitment to either SP4 or SP8. This 
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would suggest that a TCR recognizing MHC Class I promotes the commitment to 
SP8 by signaling to switch off CD4 expression, whereas a TCR that recognizes MHC 
Class II promotes the commitment to SP4 by signaling to switch off CD8 expression 
(58). Whilst initial studies suggested that co-receptors delivered different instructional 
signals to commit to the appropriate linage, further studies suggested that the 
strength of the TCR signal determined lineage commitment, with strong TCR signals 
leading to SP4 commitment and weak signals leading to SP8 lineage commitment 
(59,60). The stochastic model suggests early lineage commitment to SP4 or SP8 
occurs independently of the TCR specificity. Binding of TCR and self-peptide MHC 
complex provokes down-modulation of the mismatched co-receptor and partial 
differentiation towards the MHC matched lineage, which a second TCR engagement 
with a self-peptide MHC complex finalizes this commitment (61,62). However some 
experimental observations seemed to contradict some of the key principles of these 
two models leading to an alternative model termed the kinetic signaling model 
(63,64). The kinetic signaling model proposes that SP4/SP8 lineage commitment is 
determined by the duration of the TCR signal which is determined by common 
cytokine receptor γ chains (γC) family members, such as IL-7, promoting specific 
lineage commitment (63). DP thymocytes that have received a TCR signal initially 
terminate CD8 transcription becoming CD4+CD8low intermediate thymocytes that, 
importantly, are not lineage committed (63). If, upon CD8 downregulation, TCR 
signaling is maintained then the CD4+CD8low thymocyte will commit to the CD4+CD8- 
SP4 lineage as the TCR interaction must be MHC Class II restricted for continued 
signaling to occur (63). However if TCR signaling has stopped due to the CD4 
expressing cell’s TCR interacting with MHC Class I, then the cell becomes 
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responsive to IL-7 which signals the thymocyte to undergo “co-receptor reversal” 
(63). This is a process where CD4 transcription is terminated and CD8 transcription 
is reinstated, leading to a CD4lowCD8+ thymocytes which then begins to receive TCR 
signaling and commits to CD4-CD8+SP8 lineage (63). 
 
Additional transcription factors have been shown to play a role in lineage 
commitment for example Runt-related transcription factor 3 (Runx3) and the zinc 
finger transcription factor T-helper inducing POZ-KruppelV like factor (ThPOK). 
Runx3 binds and activates CD4 silencers to repress CD4 transcription, directing 
lineage commitment to SP8 fate (65). Opposing this regulatory role, ThPOK is 
activated upon MHC Class II engagement and is essential for lineage commitment to 
SP4 (66,67). ThPOK directly binds CD4 gene silencers, antagonizing their repressive 
functions to activate the CD4 gene (68). Interestingly this process acts as a positive 
feedback loop, as ThPOK activation of the CD4 gene results in increased surface 
expression of CD4, which prolongs TCR engagement with the MHC Class II leading 
to further ThPOK activation (68).  
 
As well as undergoing positive selection through interactions with self-peptide MHC 
complexes expressed by cTEC, DP thymocytes upregulate their expression of C-C 
chemokine receptor 7 (CCR7) following TCR engagement (69–72). The CCR7-
ligands CCL19 and CCL21 are expressed by medullary TEC (mTEC) and this drives 
the migration of DP and newly selected SP thymocytes from the cortex towards the 
medulla where they undergo the next stage of development (69–71). This 
requirement of CCR7 is essential for the delocalization of the developing thymocyte 
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from the cortex to the medulla, however in the absence of CCR7-mediate migration 
thymocyte development is not impaired, instead thymocytes leave the thymus 
functionally mature however they have not undergone central tolerance (69–71). This 
is explained by recent research which has shown that the development of 
conventional SP4 thymocytes can occur in the absence of the thymic medulla, as 
seen in mice deficient in RelB-dependent mTEC (72). In addition to CCR7-dependent 
migration, CCR4 and CCR9 have been suggested to play a role in this cortex to 
medulla migration. It has been shown that activated DP cells, identified as transiently 
expressing the activation marker CD69 following TCR stimulation, and SP 
thymocytes express CCR9 which facilitates migration towards it’s ligand CCL25 
expressed by cTEC, but importantly PlexinD1 blocks CCL25-mediated migration in 
these cells allowing the migration against the CCL25 gradient and towards CCR7-
ligands in the medulla (73). Similarly CCR4 is reported to be upregulated upon 
positive selection however analysis of CCR4-deficient mice, CCR7-dificient mice and 
CCR4;CCR7 double-deficient mice does not support a role for CCR4 in cortex to 
medulla migration (74). Although this suggests that CCR4 does not have an essential 
role positive selection findings from Hu et. al  indicate that CCR4 is required for 
medullary dependent tolerance potentially through regulating mTEC:dendritic cell 
interactions (75).  
 
Once DP thymocytes have undergone positive selection, progressed to the next 
development stage of either SP4 or SP8 lineage commitment and migrated to the 




1.1.5 Central Tolerance 
Whilst positive selection is a fundamental process in ensuring thymocytes express 
functional TCRs capable of binding self-peptide MHC complexes, it does not check 
whether the TCR specificity of each thymocyte could be harmful to self. The random 
nature of generating a TCR creates a massive range of diversity amongst the TCR 
specificities and whilst that is good for the diversity of the T-cell repertoire, it also 
means that within these different TCR specificities there will exist TCRs that will 
recognize self-peptides and determine the peptide-bearing cell a target. This is the 
basis of autoimmunity, when the hosts own immune cells recognize the body’s 
tissues and organs as a target. To prevent autoimmunity an additional selection 
process occurs termed negative selection. Negative selection is key in establishing 
central tolerance; for T-cells, central tolerance induction is a process that occurs 
within the thymus to prevent the generation of self-reactive T-cells. Central tolerance 
includes clonal deletion of autoreactive T-cells by negative selection as well as the 
generation of regulatory T-cells which act to suppress any self-reactive T-cells that 
escape into the periphery.  
 
Negative selection occurs through apoptosis of thymocytes bearing high affinity 
TCRs for self and therefore bind strongly to self-peptide MHC complexes triggering 
strong TCR signals. Within the apoptosis pathway, BH3-only proteins have been 
highlighted as playing an essential role in clonal deletion of self-reactive thymocytes. 
BH3-only proteins are a pro-apoptotic group of the BCL-2 family, a family which 
includes both pro- and anti-apoptotic members (76). It has been shown that 
specifically Bim and Puma work in co-operation to regulate the deletion of auto-
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reactive thymocytes (77). For example Bim has been shown to be upregulated upon 
high affinity binding of self-Ags which increases the binding to the pro-survival factor 
BCL-XL, inhibiting its functions, leading to apoptosis (76,78).  
 
Interestingly, negative selection occurs both in the cortex and the medulla and 
therefore occurs at multiple stages of thymocyte development such as early DP 
development when the cell has just begun to express the TCR within the cortex, 
through to later stages of SP development within the medulla (53,79,80). Through the 
use of Bim-deficient mice crossed with a Nur77GFP reporter, a reporter that correlates 
GFP expression with TCR signal strength, Stritesky et. al were able to show that 75% 
of thymocytes undergoing negative selection are at the DP stage of thymocyte 
development in the cortex compared to 25% undergoing negative selection at the SP 
stage in the medulla (81). However the negative selection that occurs within the 
cortex occurs due to the involvement of rare dendritic cells within the cortex rather 
than interactions with cTEC (79). On the other hand, negative selection occurring in 
the medulla is further dependent on mTEC as these stromal cells are specialized for 
ectopic expression of tissue restricted antigens (TRAs), which are self-peptides that 
are usually restricted to specific cells within the host’s body but mTEC are able to 
generate these peptides and present them to the developing thymocytes. Antigen 
presentation can occur either directly by the mTEC or by “antigen hand-over” and 
presentation by neighboring antigen-presenting cells (APCs) within the medulla such 
as DCs. The mechanisms that mTEC employ, as well as what makes them 
specialized for negative selection, are covered in more detail in section 1.2.3.2. In 
short, the mTEC population as a whole is able to express almost all peripheral 
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transcripts, presenting these peptides either directly or via APCs within the medulla 
and therefore can check the TCR specificities of the developing SP thymocytes to 
eliminate any with specificity to the TRAs. The importance of the medulla for negative 
selection is highlighted in mice that either lack the ability to migrate to the medulla 
(CCR7-deficient mice) or mice that lack the medulla all together (such as RelB-
deficient mice), both of which result in autoimmunity (69,71,82). 
 
Positive and negative selection are not sequential events where cells must undergo 
positive selection first before moving on and undergoing negative selection, such an 
order would suggest that the TCR signal be different during the two processes. 
Instead a cell can undergo negative selection before it undergoes positive selection, 
consistent with the fact that negative selection can occur in the cortex (80,83). What 
decides the difference between positive selection and negative selection is the 
affinity of the TCR, a high affinity towards self-peptide MHC complexes triggers 
negative selection whilst low affinity signals positive selection. The intracellular 
mediator extracellular-signal-regulated kinase (ERK) is a member of the mitogen-
activated protein kinase (MAPK) cascade and is involved in both positive and 
negative selection (84,85). It has been shown that high affinity binding induces high 
intensity ERK activation, which is associated with cell death indicating its role in 
negative selection, whereas positive selection stimulates a lower intensity and brief 
activation of ERK which declines but then gradually increases and is sustained (86). 
Thus depending on the TCR stimulation of either low or high affinity, the induced 
activation of ERK differs and the subsequent outcome of positive or negative 
selection is determined. Similar studies of the MAPK signaling pathway have 
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highlighted the narrow gap between positive and negative selection in terms of ligand 
affinity and signaling threshold (87). 
 
High affinity TCR binding does not necessarily mean the thymocyte will undergo 
negative selection. Instead thymocytes with a high affinity may be directed down an 
alternative developmental pathways giving rise to non-conventional T-cell subsets 
such as nTregs or invariant natural killer T-cells (iNKTs) (88). Within the medulla, a 
small fraction of MHC Class II-restricted thymocytes that receive TCR stimulation 
from a high affinity TCR self-peptide MHC interaction can be rescued from clonal 
deletion and develop into natural Treg (nTreg) (88,89). nTreg are a regulatory 
subtype of SP4 thymocyte that suppress autoreactive T-cells in the periphery and are 
essential to central tolerance. Upon TCR stimulation within an affinity range between 
positive and negative selection, thymocytes upregulate CD25 becoming 
CD25+Foxp3- pre-Treg and then go on to upregulate Forkhead box p3 (Foxp3) to 
develop into CD25+Foxp3+ Treg (90). Foxp3 is essential to the suppressive function 
of the Treg, for example IL-10 is essential for the function of Treg that suppress 
inflammatory response toward intestinal antigens and IL-10 has been shown to be a 
downstream effector mechanism induced by Foxp3 (89–91). The thymic medulla is 
essential for the development of Treg as shown in RelB-deficient mice which lack a 
thymic medulla due to perturbed mTEC development, have absent Treg and severe 
autoimmune defects (72,92,93). Interestingly a recent study found that whilst the 
thymic medulla is essential for the development of Treg, conventional SP4 
thymocytes were present at normal frequencies and appeared phenotypically mature, 
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as shown by using a system of grafting RelB-deficient thymic lobes into a wildtype 
(WT) host (72).   
 
Therefore as well as playing a vital role in negative selection of SP thymocytes, 
mTEC also play an essential role in the development of a regulatory subset of SP4 
thymocytes which enforce tolerance within the periphery. 
 
1.1.6 Thymocyte Egress 
It has been estimated that developing SP thymocytes stay within the medulla for a 
period of 4-5 days following development from DP to SP thymocytes (94). During this 
intramedullary residency, the developing SP thymocytes are exposed to negative 
selection and Treg specification, as discussed previously, however they also undergo 
functional and phenotypic maturation prior to their egress from the thymus. The 
maturation status of the SP thymocyte can be determined by its cell surface 
expression of a number of maturation markers such as CD69, CD62L, HSA and 
MHC Class I. Immature SP thymocytes can be identified as CD69+CD62L-HSA+ 
whereas mature SP thymocytes downregulate CD69 and HSA and upregulate 
CD62L to become CD69-CD62L+HSA- (95). Changes in maturational status of the SP 
thymocytes is important for its survival and marks the end of negative selection as 
HSAhi thymocytes are susceptible to tolerance induction whereas HSAlow are strongly 
resistant (96). Additionally, maturation of the SP thymocyte is linked to acquiring key 
functions such as becoming proliferation-competent and egress-competent (95,97). 
Xing et. al were able to show that the expression profile of CD69 and MHC Class I 
was able to reveal three populations within SP4 and SP8 thymocytes that were 
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distinct in their proliferative and egress capabilities (97). CD69+MHC Class I- SP 
thymocytes were the least mature and termed SM, CD69+MHC Class I+ SP 
thymocytes were termed M1 and are proliferation-competent and CD69-MHC Class I+ 
were termed M2 and are both proliferation- and egress-competent (97). In this study 
and similar studies of thymocyte egress, a mature cell is deemed egress-competent if 
it expresses the sphingosine-1-phosphate receptor 1 (S1PR1) (95,97,98). S1PR1 is 
a G protein-coupled receptor which mediates migration towards a gradient of its 
ligand, the lipid signaling molecule sphingosine-1-phosphate (S1P) (98). Forkhead 
box protein O1 (Foxo1) and Krüpple-like factor 2 (Klf2) are transcriptional regulators 
of S1PR1 expression and are upregulated during thymocyte maturation (99–101). SP 
thymocyte maturation status was defined on the basis of CD69 and CD62L 
expression prior to the discovery of S1P-S1PR1 expression, however the definition of 
immature as CD69+CD62L- and mature as CD69loCD62L+ does coincide with the 
expression of S1PR1 and the S1PR1 regulating transcription factors. CD62L and 
S1PR1 are both downstream targets of Klf2 and S1PR1/CD69 expression is linked, 
therefore as the thymocyte matures, it increases Foxo1 and Klf2 expression which 
upregulates CD62L as well as S1PR1 expression and concomitantly downregulates 
CD69 (99–103).  
 
Disruption of the S1P-S1PR1 axis has significant consequences on thymocyte 
egress as doing so results in reduced thymic output resulting in both reduced T-cells 
in the periphery and an intrathymic accumulation of mature thymocytes (98). Initial 
studies revealed the importance of this pathway through the use of the 
immunomodulator FTY720 which revealed reduced T-cell egress from the thymus 
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and secondary lymphoid organs due to FTY720 being a potent agonist of S1PR1 
which prevents the migration response to the S1P gradient as well as inducing 
downregulation of the S1PR1 on the SP thymocyte cell surface (104–109). S1P-
dependent egress has been shown to require an S1P gradient that is high at the 
point of exit, both at the vessel that the cell will leave the thymus by and in the blood, 
which is where the egressing cells will move into when leaving the thymus, whilst 
remaining low within the rest of the thymic parenchyma (110,111).  
 
Several mouse models have revealed that, within the thymus, the S1P-S1PR1 axis is 
regulated by multiple cell types and these cells act to maintain the S1P gradient 
within the thymus. The mechanisms that regulate the S1P gradient mainly fall under 
two categories; maintaining high levels of S1P by production of S1P at the site of exit 
or maintaining low levels by degrading or dephosphorylating S1P within the rest of 
the thymic microenvironment.  
 
S1P production is regulated by two enzymes, sphingosine kinase 1 (SPHK1) and 
SPHK2 which catalyze the ATP-dependent phosphorylation of sphingosine to 
generate S1P and both are expressed by thymic pericytes which is consistent with 
pericytes ensheathing blood vessels at the point of egress (111). Deleting SPHK 
specifically on thymic pericytes resulted in intrathymic accumulation of mature 
thymocytes and peripheral T-cell lymphopenia, both of which are indicative of 
disrupted thymocyte egress and thus highlights the crucial role of thymic 




Thymic epithelial cells have been shown to sustain the intrathymic S1P gradient 
though the production of lipid phosphate phosphatase 3 (LPP3), a dephosphorylating 
enzyme which inactivates S1P to maintain low intrathymic S1P levels promoting 
thymocyte egress (112). Deletion of Ppa2b, the gene that encodes LPP3, specifically 
on TEC results in an intrathymic accumulation of mature thymocytes and interestingly 
deletion of Ppa2b specifically on thymic endothelial cells also results in altered 
egress (112). Therefore both TEC and endothelium regulate SIP-dependent 
thymocyte egress through production of LPP3. Furthermore thymic endothelium has 
also been implicated in regulating S1P-dependent thymocyte egress through the 
expression of the S1P transporter spinster homolog 2 (Spns2). Spns2 is required for 
S1P release from endothelial cells, with deletion of Spns2 resulting in intrathymic 
accumulation of mature thymocytes consistent with an egress defect (113).   
 
In addition to stromal cells, thymocytes and thymic DCs have also been shown to 
play a role in regulating thymocyte egress, with Zamora-Pineda et. al finding that 
deletion of S1P lyase (SGPL) in bone marrow-derived cells resulted in reduced 
thymocyte egress and a concomitant intrathymic accumulation of mature SP 
thymocytes (114). However despite expression of SGPL by radioresistant cells, 
deletion of Sgpl on TEC or endothelium did not alter thymocyte egress (114). 
 
The S1P-S1PR1 axis is regarded as the primary mechanism regulating thymocyte 
egress however there are additional mechanisms that have been shown to play a 
role in egress. It was recently shown that IL-4 receptor α (IL-4Rα), which forms part 
of the type-2 IL-4R complex, is expressed by thymic stromal cells and is essential for 
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normal S1P-S1PR1-independent thymocyte egress (115). This role of IL-4Rα is 
dependent on provision of the IL-4R ligands IL-4 and IL-13 by iNKT cells to trigger IL-
4R signaling (115). The absence of IL-4R signaling results in an intrathymic 
accumulation of mature thymocytes, which can be found within the perivascular 
space, as well as a reduction in recent thymic emigrants (RTE) in the periphery 
(115). Therefore in addition to the S1P-S1PR1 pathway, type-2 cytokines are an 
important regulator of T-cell egress suggesting a multifaceted mechanism regulating 
T-cell egress both at the molecular and cellular level. 
 
The chemokine receptor CCR7 and its ligand CCL19 are essential for T-cell egress 
within neonates, however this pathway is not required for T-cell egress within adult 
mice suggesting differing egress mechanisms may exist at different stages of 
development (69,116). A possible explanation for this difference could be that during 
development from neonate to adult there is a shift from CCR7-dependent egress 
mechanisms to mechanisms that are dominant in the adult such as the S1P-S1PR1 
pathway and the IL-4Rα pathway. A recent study found that Aire-deficient neonatal 
mice, which have reduced CCR7-ligand expression, have impaired thymocyte egress 
but this egress defect is alleviated in adult Aire-deficient mice (117). This study 
revealed that the S1P-S1PR1 pathway is functional at the neonatal stage but it is not 
sufficient to correct for the CCR7-dependent egress defect (117). However in Aire-
deficient beyond 3 weeks of age, S1PR1 was significantly upregulated on mature 
thymocytes and this alleviated the T-cell egress defect seen in the younger neonatal 
Aire-deficient mouse and thus S1PR1-dependent egress becomes the dominant 
pathway regulating T-cell egress (117).  
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Another chemokine found within the thymus, CXCR4, was thought to be involved in 
regulating thymocyte egress. Until recently it was not clear whether CXCR4 was a 
positive or negative regulator of releasing mature thymocytes from the thymus as 
there was evidence supporting both as well as these studies being complicated by 
the embryonic lethality of CXCR4-deficient mice (118–121). However a recent study 
using CD4creCXCR4flox mice, which circumvents this embryonic lethality, found no 
abnormalities in SP thymocyte development or egress, suggesting that CXCR4 is 
dispensable for thymocyte egress (122). 
 
Whilst these studies provide evidence for the involvement of multiple pathways and 
cell types in regulating T-cell egress, the precise regulation of this critical process 
remain relatively unclear and we aim to explore this topic in Chapter 4. 
 
1.2 THYMIC STROMAL MICROENVIRONMENTS 
1.2.1 Stromal Populations Of The Thymus 
The thymic microenvironment is heterogeneous and essential to the function of the 
thymus. The primary stromal populations of the thymus are thymic epithelial cells, 
which include cortical TEC and medullary TEC that are vital to the process of positive 
and negative selection, respectively, as discussed in previous sections. Due to the 
importance of the role of TEC a great deal of research has been carried out 
investigating their development and function, as well as defining the heterogeneity 
within the cTEC and mTEC compartments based on their expression patterns of 




However the non-epithelial compartment of thymic stroma remains less well 
characterized and studied. Non-epithelial cells comprise of endothelial cells, which 
vascularize the thymus and regulate ETP entry into the thymus. Thymic 
mesenchyme is the other main non-epithelial population and comprises of cells that 
contribute to the capsule, trabeculae and septae of the thymus structure as well as 
fibroblasts, which have been shown to regulate the development of thymic epithelium 
and thymocytes. Additionally thymic mesenchyme includes thymic pericytes, which 
support the vasculature as well as thymocyte egress. Further discussion of thymic 
mesenchyme and their function can be found in section 1.2.5. 
 
1.2.2 The Development And Regulation Of Thymic Epithelial Cells 
The most abundant population of thymic stroma are the thymic epithelial cells, which 
can be separated into cortical thymic epithelial cells (cTEC) and medullary thymic 
epithelial cells (mTEC) based on their location and function within the thymus. cTEC 
are restricted to the cortex where they support thymocyte development and screen 
thymocytes for a functional TCR whereas mTEC are restricted to the medulla and 
ensure the removal of self-reactive T-cells as well as support the selection of 
regulatory T-cells. As discussed in previous sections these distinct regions of the 
thymus are vital for thymocyte development.  
 
1.2.2.1 The regulation of early stages of epithelial cell development 
During the earliest stages of thymus development (around E10-E11) the thymus 
consists of an endodermal-derived epithelial rudiment, which arises from the third 
pharyngeal pouch (3PP), which is surrounded by neural crest-derived mesenchyme 
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(123,124). As thymus organogenesis progresses, hematopoietic progenitors migrate 
through the surrounding NC-derived mesenchyme and colonize the developing 
thymus (123,125). This early stage colonization initiates the formation of a complex 
three-dimensional epithelial network, which is characteristic of the thymic epithelial 
compartment. One of the key transcription factors of thymic epithelial cells, Foxn-1 is 
expressed by essentially all EpCAM-1+ embryonic TEC and plays an important role in 
the developing thymus. Absence of Foxn-1 in nude mice (nu/nu), which carry a 
naturally occurring mutation of the Foxn-1 gene, results in athymia (126). Whilst it 
has been shown that the initial endodermal-to-epithelial transition occurs 
independently of Foxn-1 signaling, Foxn-1 has been shown to play a key role in 
multiple aspects of TECs, including differentiation, proliferation and formation of the 
three-dimensional TEC network (11,127,128). Additionally Foxn-1 has been shown to 
regulate genes associated with T-cell progenitor recruitment, such as CXCL12 and 
CCL21 and T-cell progenitor lineage specification, such as delta-like ligand 4 (DLL4) 
(11,128).  
 
The subsequent lineage specification of the thymic epithelium towards the cTEC and 
mTEC lineages is a complex process, our understanding of which has greatly 
benefited from a number of studies in recent years. Adult cTEC and mTEC are 
clearly distinguishable due to their differential expression of chemokines, cytokines, 
cell positioning and transcription factors, however embryonic TEC are comparatively 
less well defined. Clonal assays have shown that a single TEC progenitor taken from 
an E12 enhanced yellow fluorescent protein (eYFP) reporter mouse thymus and 
reintroduced into a WT E12 thymus can give rise to cTEC and mTEC, directly 
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showing that within the embryonic thymus, both cTEC and mTEC arise from a Foxn-
1-dependent bipotent TEC progenitor cell (129). A similar study used an in vivo 
approach by creating a null allele of Foxn-1 which was revertible specifically within 
thymic epithelial cell precursors, with the assumption that the Foxn-1-deficient thymic 
rudiment still contains thymic epithelial cell precursors (130). Using this inducible 
model, Bleul et. al were able to show that both cTEC and mTEC arise from an 
upstream bipotent progenitor (130).  
 
The developmental progression of epithelial cells downstream of the bipotent 
progenitor and the lineage relationship of cTEC and mTEC have been of interest in 
recent TEC progenitor studies. Baik et. al were able to show that the majority of the 
embryonic TEC population expressed the cTEC marker CD205 but did not express 
the mTEC-associated marker CD40 (CD205+CD40-) and thus are said to have a 
cTEC-like phenotype (131). This population of CD205+CD40- can then progress 
through to a CD205+CD40+ developmental stage and then to a CD205-CD40+ stage 
suggesting that TEC progenitors serially acquire cTEC and then mTEC lineages 
(131). In vivo analysis of the development capacity of the CD205+CD40- TEC 
progenitor revealed that these cells can give rise to both cTEC and mTEC lineages, 
including AIRE+ mTEC cells (131). This study showed that TEC progenitors that give 
rise to both cTEC and mTEC have hallmarks of both the cTEC lineage (CD205 
expression) and the mTEC lineage (CD40 expression, as well as RANK expression) 
(131). A similar observation was found by Ohigashi et. al who, using a β5tcre x loxP-
dependent GFP reporter mouse model, were able to show that almost all mTEC 
came from a TEC progenitor expressing β5t, supporting the model that the TEC 
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progenitor has a cTEC-like phenotype or potential pre-commitment to the cTEC 
lineage (132). These analyses support what is referred to as a “serial progression” 
model of TEC development, wherein TEC progenitors first acquire cTEC lineage 
markers, followed by acquisition of mTEC lineage markers and then lineage 
commitment to mTEC (133). A study by Ribeiro et. al revealed that whilst mTEC can 
be derived from IL-7+ TEC which are enriched within the cTEC compartment, mTEC 
can also arise from IL-7- compartment suggesting an alternative mTEC 
developmental pathway also exists (134). Whilst these studies provide important 
insight into the lineage relationship of cortical and medullary epithelia, it still remains 
to be seen how these populations and their development into lineage committed TEC 
is regulated. 
 
Downstream of the bipotent TEC progenitor, mTEC stem cells (mTECSCs) have 
been identified within the embryonic thymus. Identified as Claudin (Cld) 3,4hiSSEA-1+ 
TEC, these mTECSCs were shown to posses self-renewal capacity as well as the 
ability to sustain long-term generation of mTEC and functionally contribute to 
sustained self-tolerance (135). These mTECSCs are unipotent, only giving rise to 
mTEC cells and therefore are downstream of the bipotent TEC progenitor (135). 
Further analysis of this population was recently carried out which showed that the 
expression of the tumor necrosis factor receptor super family (TNFRSF) member, 
receptor activator of nuclear factor-κB (RANK), a hallmark characteristic of mTEC, is 
not expressed within the Cld3,4hiSSEA-1+ mTECSC population and instead RANK 
expression is restricted to the SSEA-1- fraction of Cld3,4hi mTEC progenitors 
(136,137). Interestingly the induction of RANK expression coincides with 
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downregulation of the cTEC marker CD205 and upregulation of MHC Class II 
suggesting that these Cld3,4hiRANK+ TEC are mTEC committed progenitor cells that 
are downstream of the Cld3,4hiSSEA-1+ mTECSC (136). Additionally, the findings of 
Baik et. al also revealed that Foxn-1 may play a role in regulating the pool size of the 
mTECSCs, but neither Foxn-1 or RelB signaling are required for the emergence of 
the mTECSCs (136). Interestingly RelB is required for the generation of the RANK+ 
mTEC progenitor which is downstream of the mTECSC which reveals a key 
regulatory step in the development of the mTEC lineage (136). A precursor 
population has also been identified which gives rise to Aire+ mTECS termed pMECs 
(138). These pMECs express RANK and cTEC molecules and their development into 
Aire+ mTECs has been shown to be dependent on activation of the classical NF-κB 
signaling pathway via TRAF6-dependedent RANK signaling (138). Akiyama et. al 
showed that the development of the pMECs from their precursors (pro-pMECS) was 
dependent on non-classical NF-κB activation by RANK and lymphotoxin β receptor 
(LTβR) signaling (138). Whether these populations of mTECSCs and pro-
pMECs/pMECs are directly related has not yet been resolved. 
 
Due to the cTEC-like phenotype of the bipotent progenitor it has been difficult to 
further separate the developmental stages of the mature cTEC population and 
therefore knowledge of the development of this TEC subset is less well known. cTEC 
maturation can be identified through the expression of CD40 and MHC Class II 
(139).Early CD205+ β5t-expressing cTEC progenitors lack expression of CD40 and 
MHC Class II and the development of these cells are Foxn-1-dependent suggesting 
they are downstream of the bipotent progenitor (139). The developmental 
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progression of these cells to mature CD205+CD40hiMHC Class IIhi cTEC is 
dependent on the presence of DN1-3 thymocytes however the development of the 
CD205+ progenitor can occur in the absence of these signals (139). Compared to 
this, the regulation of mTEC development has been much more extensively research 
and will be the focus of the following section. 
1.2.2.2 The regulation of mTEC development  
The development of lineage committed, mature mTECs is highly regulated and is 
dependent on reciprocal interaction with developing thymocytes that reside in the 
medulla. These reciprocal thymocyte:epithelial interactions are required for both the 
development of the thymocytes but also for the development of the mTEC and this 
interaction is often referred to as ‘cross-talk’ (140).  
 
αβ T-cells have been shown to play a vita role for mTEC development. Research 
using Tcrα-/- mice which cannot generate a functional αβ TCR and therefore lack 
post-positive selection αβ T-cells have a significant loss of medullary TEC, however 
the cTEC compartment is normal in these mice (141,142). Loss of SP4 thymocytes 
has been shown to be essential for the development of a normal medulla. Mice 
deficient for MHC Class II have a loss of SP4 thymocytes and altered medullary 
architecture (143). Administration of an anti-TCR mAb into MHC Class II-deficient 
mice restores SP4 thymocyte development and rescues the medullary phenotype 
(143,144). Additionally it has been shown that SP4 thymocytes are needed for mTEC 
proliferation (145). It has even been shown that signals from non-conventional T-cells 
such as invariant natural killer T-cells (iNKTs) are essential for the development of 




Understanding how these T-cell populations regulate TEC development requires an 
understanding of the specific signaling pathways involved in thymocyte:epithelial 
cross-talk and this has been the focus of TEC developmental research for some time. 
A large focus of this research has revolved around TNFRSF members. This group of 
receptors has been of major interest due to the important role of many of its 
members in regulating TEC development. TNFRSF members mediate nuclear factor 
(NF)κB transcription factors and signaling pathways that have been shown to be 
highly important in regulating mTEC and medullary organization such as TRAF6, 
which regulates signaling by TNFRSF members RANK and CD40 which activate the 
classical NFκB pathway (138,147). Additionally RANK, CD40 and LTβR activate 
RelB, mediated by NFκB inducing kinase (NIK), and deletion of either RelB or NIK 
results in defects in medullary organization and mTEC development (92,148).  
 
The LTβR signaling pathway has been shown to play an essential role in the 
development of peripheral lymphoid organs as well as the maturation of stromal cells 
within these organs (149,150). With regards to TEC development, Boehm et. al were 
the first to show the requirement for LTβR signaling within the thymus, showing that 
the LTβR-deficient mouse thymus has a severe medullary disorganization and 
reduction in UEA-1+ mTEC (151). Within the reduced mTEC compartment of Ltbr-/- 
there is a loss of CCL21 and CCL19 expression, reduced numbers of the CCL21-
expressing mTEClo subset and although LTβR does not directly regulate the 
expression of Aire on mTEC, LTβR-deficient mice do have a reduction in the number 




LTβR has three known ligands, the homotrimer lymphotoxin α (LTα3), heterodimer 
lymphotoxin α1β2 (LTα1β2) and LIGHT (158). The LTβR ligand LTα is expressed on 
DP, SP4, SP8 as well as lymphoid tissue inducers (LTi) within the thymus and 
therefore LTβR:LTβR-ligand signaling is an important process in regulating the 
development of thymic medullary environment via cross-talk (159). Although LTβR 
has been shown to not regulate Aire expression by mTEC, it was proposed that 
LTβR regulates the expression of Fezf2 where it directly induces the expression of 
Fezf2-dependent TRAs important for negative selection (160). However our recent 
study showed that the breakdown in tolerance seen in LTβR-deficient mice is in fact 
due to disrupted regulation of DC frequency and the make up of the DC pool and 
mTEC continue to express both Aire and Fezf2 in the absence of LTβR (157). As 
stated above LTβR, along with RANK, is also required for the development of pMECs 
from their pro-pMEC precursors (138).  
 
Another key regulator of mTEC development is the receptor activator of NFκB 
(RANK) and its ligand RANKL expressed by lymphocytes. RANKL is expressed by a 
number of different thymocyte populations within the thymus and RANK:RANKL 
signaling occurring through cross-talk is highly important in TEC development. RANK 
signaling was first identified as a key regulator of mTEC development by Rossi et. al 
who’s findings revealed that Rank-/- mice had a significant reduction of Aire+ mTEC, 
highlighting the essential role of RANK signaling in the development of Aire+ mTEC 
within the embryonic thymus (152). This study also revealed that RANKL provision 
from CD4+CD3- lymphoid tissue inducer (LTi) cells was playing a role in regulating 
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the Aire+ mTEC in the embryonic thymus (152). However a similar study published 
shortly after revealed that RANK-dependent development of Aire+ mTEC in the adult 
thymus was primarily regulated by RANKL provision by positively selected 
thymocytes rather than other intrathymic sources of RANKL including LTi suggesting 
different mechanisms of RANKL provision at different stages of development (161). 
Additionally Hikosaka et. al were also able to show a role for osteoprotegerin (OPG) 
which is a decoy receptor for RANKL and acts as a negative regulator of mTEC, with 
mice deficient for OPG having large medullary areas and an increase in Aire+ mTEC 
(137,161). This is consistent with reports that RANKL is expressed on DP, SP8 and 
SP4 thymocytes, enriched on the immature CD69+ fraction of SP4 thymocytes, as 
well as Foxp3+ Treg (159,162). It has also been shown that RANKL is expressed by 
iNKT cells within the thymus and absence of RANKL+ iNKT cells results in reduced 
mTEC and Aire+ mTEC and therefore highlighting iNKT cells as a source of RANKL 
capable of supporting RANK-dependent mTEC development (146). 
 
CD40-deficient mice do not have any overt medullary disorganization or reduction in 
mTEC or Aire+ mTEC numbers (161). Whilst this observation was shown to be true 
for CD40-deficient mice, CD40 does play a role in regulating postnatal mTEC 
development and medullary distribution in cooperation with RANK signaling 
(162,163). It was also shown that RANK signaling is required for the upregulation of 
CD40 on mTEC and that CD40 may also regulate mTEC proliferation (162). 
Highlighting a role for CD40:CD40L interactions and CD40L is expressed by SP 




Interestingly, studies have shown that CD80loMHC Class IIlo mTEC (mTEClo) develop 
into Aire expressing CD80hiMHC Class IIhi mTEC (mTEChi) (152). However the 
mTEClo population has been identified as a mature population itself and therefore is a 
heterogeneous population that consists of both mature mTECs and immature mTECs 
that can give rise to mTEChi cells (152,156). Together these signaling pathways 
reveal a strict program of thymocyte driven regulation of mTEC development 
including both Aire+ mTEChi and CCL21+ mTEClo. 
1.2.3 The Function Of Thymic Epithelial Cells 
As discussed in previous sections, thymic epithelium is vital to the function of the 
thymus. Through the expression of a range of molecules such as chemokines, 
cytokines and transcription factors, cTEC and mTEC are able to regulate multiple 
stages of thymocyte development. The functions and how the cTECs and mTECs are 
able to carry them out are covered in the following sections 1.2.3.1 and 1.2.3.2. 
 
1.2.3.1 The function of cortical thymic epithelial cells 
cTEC, termed for their location within the cortex of the thymus, are a specialized 
subset of TEC which are commonly identified as Cytokeratin8+CD205+Ly51+ TEC. 
The primary role of cTEC is to regulate the early stages of thymocyte development 
ranging from ETP to CD4+CD8+ (DP) thymocytes and this is evidenced by the 
specialized genes expressed by cTEC. 
 
A key role of cTEC is during the process of positive selection. As discussed in more 
detail in section 1.1.4, positive selection is the process where αβ TCR-expressing DP 
thymocytes are screened to ensure their TCR is functional and able to recognize self-
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MHC-peptide complexes with low affinity TCR engagement. Expression of peptides 
by MHC Class I and II is not limited to cTEC or mTEC, as expression of these 
molecules within the thymus is vital to both positive and negative selection. However 
cTEC have the ability to facilitate and regulate the positive selection of developing 
thymocytes through unique machinery that degrade proteins to provide these self-
peptides self-MHC complexes that optimize the process of positive selection.  
 
One of the major molecules associated with this machinery is the thymoproteasome 
which is a cTEC-specific form of proteasome, other forms include the constitutive 
proteasome and the immunoproteasome (164). The thymoproteasome is unique in 
that the β5 (PSMB5) subunit of the constitutive proteasome is replaced by the β5t 
(PSMB11) subunit (164,165). This incorporation of the β5t subunit is important as the 
peptides that the β5t-containing thymoproteasome generates have unique cleavage 
motifs and have low affinity for MHC Class I clefts (165,166). Therefore the 
thymoproteasome within cTEC facilitates optimum positive selection as only SP8 
thymocytes that receive a signal with low-affinity TCR engagement with peptide-MHC 
Class I complexes are selected for cell survival during positive selection (165). β5t is 
critical for this function of positive selection of SP8 thymocytes as β5t-deficient mice 
exhibit significantly impaired CD8 T-cell development characterized by reduced CD8 
T-cell numbers, altered TCR repertoire, restricted functional capacity and increased 
incidence of self-reactive T-cells (165,167,168). Takada et. al showed that not only 
does the low affinity peptides generated by the thymoproteasome facilitate positive 
selection of SP8 thymocytes but it also fine-tunes the antigen responsiveness of the 
subsequent mature CD8+ T-cell within the periphery (169). Therefore the cTEC 
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specific thymoproteasome is highly important in MHC Class I-mediated development 
of CD8+ T-cells. 
 
cTEC also have machinery specialized for MHC Class II restricted positive selection 
of SP4 thymocytes. cTEC have been found to express both cathepsin L and thymus 
specific serine protease (TSSP). Cathepsin L is a lysosomal cysteinal protease which 
has been previously shown to play a role in MHC Class II αβ heterodimer assembly 
(170,171). However cathepsin L has also been shown to play a direct role in positive 
selection of SP4 thymocytes by generating MHC Class II peptide ligands presented 
by cTEC during positive selection and in line with this role, mice deficient for 
cathepsin L have impaired SP4 selection (170,171).  TSSP is a protease found in 
cTEC and first proposed by Bowlus et. al to have a role in MHC Class II antigen 
processing (172). More recent analysis showed that TSSP-deficient mice produced 
normal CD4+ T-cell numbers despite a reduction in the frequency of cTEC expressing 
high levels of surface MHC Class II (173). However through the use of MHC Class II-
restricted TCR transgenic Marilyn or OT-II mice it was shown that TSSP-deficiency 
impairs the selection of Marilyn and OT-II CD4+ T-cells (173). In a polyclonal setting it 
was also shown that TSSP-deficiency impaired positive selection of CD4+ T-cells that 
expressed specific TCRs but was not necessary for the selection of the majority of 
CD4+ T-cells (174). Thus TSSP is necessary for the selection of some CD4+ T-cell 
specificities and contributes to the diversification of the CD4+ T-cell repertoire 
(173,174). TSSP is not required for the selection of SP8 thymocytes consistent with 
its role in MHC Class II restricted peptides (173). Additionally a process of 
macroautophagy, the process responsible for the degradation of the majority of 
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intracellular proteins, occurs within the cTEC which enables MHC Class II peptide 
loading, which is essential for the selection of specific CD4+ T-cell specificities (175). 
Autophagy is a process of protein degradation, which occurs during the starvation 
response as an energy source within the cell however within the thymus 
macroautophagy can occur in a starvation-independent manner (176). It has been 
shown that impairment of macroautophagy specifically within TECs disrupts normal 
selection of MHC Class II-restricted CD4+ T-cells (175).  
 
As well as directly regulating positive selection, cTEC can also regulate positive 
selection in a slightly different manner. Within the cortex, specialized 
structures/complexes form between developing DP thymocytes and a single cTEC 
that engulfs the DP thymocytes. These complexes were first identified by Wekerle et. 
al and were termed ‘thymic nurse cells’ (TNCs) due to their apparent ability to 
facilitate lymphocyte survival and differentiation (177). It was later revealed that the 
primary function of TNCs was to aid DP thymocytes through positive selection by 
providing an environment for the DP thymocyte cell to undergo a second TCRα 
rearrangement and thus increasing the odds of positive selection (178). Despite this 
role, the same study showed that TNCs are not essential for positive selection and 
therefore their role is more involved in optimizing the process of positive selection 
than supporting it (178). Together these studies highlight the multiple functional roles 
cTEC posses to regulate positive selection. 
 
cTEC have also been shown to be involved in early stages of thymocyte 
development prior to positive selection. One of the main characteristic molecules of 
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cTEC is the notch signaling ligand delta-like ligand 4 (DLL4), which is abundant in 
cTEC, and Notch1-DLL4 interactions are essential for driving T-cell lineage 
commitment of thymocyte progenitors (179,180). The importance of DLL4 is evident 
when it is deleted specifically on TEC, such as with the Foxn-1creDll4flox mouse 
model, which results in a complete block of T-cell development and loss of T-cell 
progenitors (180,181). Interestingly there is a role of these thymocyte-cTEC 
interactions in regulating the expression of DLL4 by cTEC, as these interactions 
induce downregulation of DLL4 and therefore suggests a mechanism of feedback of 
DP thymocytes regulating thymopoiesis (179). cTEC produce the cytokines 
interleukin-7 (IL-7) and kit-ligand (also referred to as stem cell factor) which have 
both been shown to promote early thymocyte survival, differentiation and proliferation 
within the cortex (31,33,34,134). Downstream of early T-cell progenitors, cTEC 
regulate DP thymocyte development through production of transforming growth factor 
β (TGFβ), which regulates the cell cycle progression and differentiation of DP 
thymocytes from their CD4-CD8lo precursors (182). 
 
cTEC also express a number of chemokines which are involved in regulating the 
early stages of thymocyte development. cTEC have been shown to express CCL25 
(CCR9-ligand) which regulates thymus colonization by lymphoid progenitors both at 
the pre-vascularization stage of thymus development as well as in the adult thymus 
(21,183). This regulation was shown to occur in conjunction with CCL21 (CCR7-
ligand) which is not expressed by cTEC and therefore cTEC works in conjunction 
with other stromal populations to regulate thymus colonization in a CCL25 and 
CCL21-dependent manner (21,183). Connected to these two chemokines, cTEC also 
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express the atypical chemokine receptor 4 (ACKR4, formerly known as CCX-CKR1 
or CCRL1) which binds CCL21 and CCL25, as well as CCL19, and has been shown 
to regulate thymus colonization by T-cell progenitors, although ACKR4 has been 
shown to not play a role in T-cell development (184,185). The CXCR4 ligand 
CXCL12, expressed by cTEC, also promotes early thymocyte survival. CXCR4 is 
expressed by all thymocyte progenitors and absence of CXCR4 results in reduced 
survival of DN3 thymocytes and mislocalization of T-cell progenitors (30,186). 
 
Therefore cTEC have essential functions within the cortex of the thymus to regulate 
early stages of thymocyte development as well as the positive selection of DP 
thymocytes to generate SP4 and SP8 thymocytes. Despite the numerous functions of 
cTEC in positive selection as well as migration of early T-cell progenitors and their 
downstream populations, there is very little heterogeneity identified within the cTEC 
compartment, perhaps due to incomplete phenotypic characterization of cTEC. 
Therefore, cTEC heterogeneity is not as distinct in comparison to the clear 
separation of function seen in different mTEC populations. 
 
1.2.3.2 The function of medullary thymic epithelial cells 
mTEC, termed for their location within the medulla of the thymus, are the other 
primary population of TEC and are commonly identified using the following markers: 
UEA-1, Cytokeratin-5 and MTS10. 
 
As mentioned previously, cTECs have multiple functions, but due to the rather limited 
phenotypic markers used to characterize them, cTEC generally do not separate into 
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distinct populations. mTEC on the other hand can be broadly separated into two 
compartments based on their expression of CD80 and MHC Class II. mTEClo are 
identified as CD80-MHC Class IIlo and mTEChi are identified as CD80+MHC Class IIhi 
(187–189). This distinction into mTEClo and mTEChi extends beyond phenotypic 
description as each population has been shown to have specific, as well as shared, 
functions within the thymus.  
 
As previously discussed in Section 1.1.5, mTEC are essential in establishing central 
tolerance as they are optimized to remove self-reactive T-cells by producing tissue-
restricted antigens (TRAs) as well as being essential to the development of natural 
regulatory T-cells (nTregs). The ability to express such a vast array of self-Ags is 
often referred to as “promiscuous gene expression”, and is a major contributing factor 
whereby mTEC are able to identify developing SP thymocytes that carry TCRs 
specific to self-Ags and delete them (190).  
 
The autoimmune regulator Aire is a transcription factor which is expressed 
specifically within the mTEChi subpopulation and regulates the expression of TRAs 
within the thymus (187,190,191). Aire has been shown to be functionally important in 
both humans and mice, with human patients that carry a genetic mutation of Aire 
suffering from autoimmune-polyendocrinopathy-candidiasis-ectodermal dystrophy 
(APECED) and Aire-deficient mice exhibiting a similar autoimmune disorder (191–
193). Aire has been shown to be required for the deletion of specific self-reactive 
clones of T-cells carrying TCRs specific to Aire-dependent genes (191). It has also 
been shown that Aire+ mTEC co-express both Aire-dependent genes as well as Aire-
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independent genes (194). As well as Aire, mTEC express the transcription factor Fez 
family zinc-finger 2 (Fezf2) which has been shown to promote promiscuous gene 
expression of Aire-independent TRAs (160). Fezf2-deficient mice were shown to 
exhibit autoimmune deficiencies highlighting this transcription factor as a key 
regulator of central tolerance induction (160). Unlike Aire, Fezf2 expression was not 
restricted to a specific subset of mTEC, with expression present in mTEClo and 
mTEChi as well as being present in all Aire+ mTEChi (160). 
 
As well as a direct role of Aire in regulating tolerance, Aire has been shown to have 
additional functions within the medulla. As discussed in section 1.1.5, during negative 
selection self-antigens are presented to the developing thymocytes directly by mTEC 
but also indirectly through cross-presentation to thymic dendritic cells (DCs). As well 
as playing a role in the generation of TRAs cross-presented to the DCs, Aire may 
play an indirect role in this process by regulating thymic DC positioning. It was shown 
that the chemokine XCL1, whose receptor XCR1 is expressed on thymic DC, is 
expressed on mTEChi and it’s expression is diminished in mTEC of Aire-deficient 
mice (195). This alteration of XCL1 expression in Aire-deficient mice was 
accompanied by a lack of medullary accumulation of thymic DCs similar to that seen 
in XCL1-deficient mice suggesting Aire plays an important role in regulating XCR1-
XCL1 mediated thymic DC positioning (195). Interestingly this same study revealed 
that both the XCL1-deficient and Aire-deficient mice have reduced natural Treg 
(nTreg) development suggesting a role for Aire in regulating this process as well 
(195). Therefore the defective tolerance induction in Aire-deficient mice may also be 
due to altered cross-presentation of Ags to DCs as well as defective nTreg 
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generation. In support of this, Hubert et. al found that Aire regulates the transfer of 
Ags derived from mTEC to DCs (196). Aire also influences other chemokines such as 
the ligands for CCR4 and CCR7, which are involved in thymocyte migration following 
positive selection. Although the mechanisms involved in this regulation are not clear, 
Aire-deficient mTEC have reduced levels of CCR4-ligands and CCR7-ligands which 
are expressed by mTEChi and mTEClo, respectively, and given that Aire expression is 
restricted to mTEChi this suggests Aire can regulate the expression of chemokines on 
other mTECs (197). 
 
CCL21 expression by mTEClo is a key characteristic of mTEClo and is extremely 
important in the positioning of thymocytes within the thymus. In mice with absent 
CCR7-CCR7-ligand interactions such as CCR7-deficient or plt/plt mice, the latter is a 
mouse model carrying a natural mutation which results in absent CCR7-ligands, 
post-positive selection thymocytes are not able to migrate to the medulla (69). Within 
these mice T-cell development appears to progress normally which is consistent with 
recent studies showing that conventional T-cell development does not depend on 
mTEC interactions, however the T-cells generated in the thymus of these mice do not 
undergo a full negative selection program and results in autoreactive T-cells in the 
periphery of these mice (69,70,82). However CCR7 controls the balance of nTreg 
and Treg precursors as well as the development of iNKT cells highlighting a key role 
of CCR7-ligand expression by mTEClo in the development of non-conventional SP4 
thymocyte populations (74). 
 
An additional function of mTEC is also evident and pertains to the later stages of 
thymocyte development during thymocyte egress. As discussed in section 1.1.6, 
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thymocyte egress occurs once the developing thymocytes have undergone negative 
selection and have reached egress competence by downregulating CD69 and 
upregulating the S1P receptor S1PR1 (97,100,102,103). These S1PR1-bearing 
thymocytes then follow a S1P-gradient to the site of exit where they undergo S1P-
dependent exit from the thymus into the blood. There are multiple cell types that 
regulate this process, one of which are mTEC that produce the enzyme LPP3 which 
degrades intrathymic S1P to maintain low levels in the medulla relative to the site of 
egress (112). It has been shown that deletion of this enzyme selectively in mTEC, 
through the use of Ppap2bflox mice crossed with Keratin14cre mice which selectively 
targeted deletion of the Ppap2b gene to mTEC, resulted in an intrathymic 
accumulation of mature SP4 thymocyte indicative of their inability to exit the thymus 
as well as increased intrathymic levels of S1P (112). Therefore not only do mTEC 
regulate the selection of developing thymocytes but they also regulate the final stage 
of their time within the medulla before joining the peripheral T-cell pool. 
 
1.2.4 Non-Epithelial Thymic Stroma 
Non-epithelial stroma encompasses a diverse mix of cells types, which can be 
separated into the broad headings of endothelial cells and mesenchymal cells. In 
contrast to our current understanding of thymic epithelial cells, the development, 
characterization and function of these non-epithelial stroma populations remains 
relatively poorly defined.  
 
The importance of mesenchyme within the thymus was identified early on in thymic 
research. Early findings of Auerbach et al. revealed that enzymatic separation of 
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mesenchyme and epithelium led to inability of either compartment to develop and 
only together could they from a lobular, lymphoid tissue (198,199). In additional 
studies, the removal of neural crest (NC)-derived mesenchyme resulted in 
significantly reduced thymic size and mass revealing an essential role of thymic 
mesenchyme in the development of the thymus organ (123,198,199). The thymic 
mesenchyme has since been shown to play a key role in the earliest stages of fetal 
thymic development, however the role that thymic mesenchyme plays within the adult 
is less well defined. The current understanding of the roles of thymic mesenchyme in 
both embryonic and adult stages of thymus development and function are discussed 
in more detail in the following section. 
 
1.2.5 The Role Of Thymic Mesenchyme 
1.2.5.1 The role of thymic mesenchyme in the embryonic thymus 
A lot of what is known regarding the role of thymic mesenchyme centers on its 
involvement during thymus organogenesis. As mentioned above, there is an 
essential requirement for thymic mesenchyme during the development of the thymus. 
During thymus organogenesis, the endoderm-derived thymic epithelial rudiment is 
enveloped within a layer of migratory mesenchyme cells derived from the cardiac 
neural crest (123,125,200). After a short period of development, these NC-derived 
mesenchyme cells then colonize the thymic epithelial rudiment and form part of the 
stromal compartment of the thymus organ (125,201). Removal of thymic 
mesenchyme during early thymus organogenesis through in ovo and in vitro 
experiments resulted in defective thymus development, where thymic size was 
significantly reduced (199,201,202). Thymic mesenchyme also plays a role during 
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the positioning of the organ during thymus organogenesis as well as regulating 
thymus lobule formation (203). It has been shown that NC-derived mesenchyme 
regulates the separation of the thymus from the pharynx as well as its migration into 
the anterior mediastinum (204). During this early stage of thymus organogenesis, an 
absence of NC-derived mesenchyme results in altered thymus/parathyroid domain 
distribution where the border of the thymus shifts causing an increase of the thymus 
domain (204).  
 
Following the role of thymic mesenchyme in the earlier stages of thymic development 
there is also a role for thymic mesenchyme during later stages once the thymic 
rudiment is more developed. It has been shown that platelet-derived growth factor 
receptor α (PDGFRα) (also CD140a) expressing thymic mesenchyme supports the 
expansion of TEC during the early stage of thymic development (202). This is an 
important process that ensures the availability of sufficient intrathymic niches to 
support a normal programme of thymocyte development. Depletion of the PDGFRα+ 
thymic mesenchyme around day 12 of embryogenesis (E12) results in a hypoplastic 
thymus and it has been shown that the production of insulin-like growth factors 1 and 
2 (IGF1 and IGF2) by the thymic mesenchyme regulate TEC proliferation at this 
stage (202). It has also been shown that thymic mesenchyme also regulates 
epithelial cell proliferation through the production of fibroblast growth factors 7 and 10 
(FGF7 and FGF10) at a slightly later stage of thymus development (E14) and this 
regulation was dependent on sustained interactions with thymic mesenchyme (201). 
However Jenkinson et. al also revealed that TEC differentiation occurs independently 
of sustained interactions with thymic mesenchyme, suggesting thymic mesenchyme 
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may not regulate TEC development or cTEC/mTEC lineage commitment, however 
these studies cannot rule out thymic mesenchyme providing a transitory signal for 
TEC development prior to its removal in these experimental settings (201,202,205). 
In line with this, despite an absence of thymic mesenchyme, or deletion of FGF10, 
there is sufficient differentiation of TEC within the hypoplastic thymus to support 
CD4+CD8+ (DP) and a small amount of SP thymocyte development (201,202,205). In 
contrast to these studies, IGF production by thymic mesenchyme has been shown to 
induce MHC Class II expression on TEC during early stages of embryogenesis, 
which may explain why there is not a full programme of thymocyte development in 
the hypoplastic thymi with differentiated TEC (201,205–208). The development of the 
reaggregate thymic organ culture (RTOC) technique aided the investigation of the 
role of thymic mesenchyme in regulating early thymocyte development. Anderson et. 
al demonstrated that thymic mesenchyme is required for the development of 
thymocytes up until the CD25+CD44- precursor stage of development but 
development beyond this can be supported by TEC in the absence of thymic 
mesenchyme (208,209). The regulation of thymocyte development by thymic 
mesenchyme was shown to occur through both contact-dependent and -independent 
processes and one study proposed that the extra cellular matrix (ECM) produced by 
the thymic mesenchyme may play a role in this regulation (203,209). It has also been 
shown that MafB is strongly expressed by mesenchymal cells within the third 
pharyngeal pouch and is required for the production of Wnt 3 and BMP4 by thymic 
mesenchyme, both of which promote CCL21 and CCL25 production by thymic 




Furthermore, in addition to the positive regulation of TEC proliferation through the 
provision of growth factors, thymic mesenchyme has conversely been shown to 
negatively regulate TEC proliferation during embryonic development. The findings of 
Sitnik et. al revealed thymic mesenchyme are the primary source of retinoic acid (RA) 
through the mesenchyme’s production of key enzymes for RA within the embryonic 
thymus and that this production of RA influences TEC proliferation (211). 
Interestingly this thymic mesenchyme population that expresses RA enzymes also 
express IGF1 and FGF10 and therefore can both positively and negatively regulate 
TEC proliferation within the embryonic thymus (201,202,205,211). 
 
1.2.5.2 The role of thymic mesenchyme in the adult thymus 
Initial studies have long supported that NC-derived thymic mesenchyme does not 
persist beyond the embryonic thymus (200,212). It has only been relatively recently 
shown that this appears to not be the case and in fact NC-derived mesenchyme 
persists beyond embryogenesis and is detectable within the adult thymus (213). This 
study utilized NC specific Wnt-1cre and Sox10cre mouse models, which were both 
crossed to a Rosa26eYFP fate-mapper mouse strain and therefore Wnt1 and Sox10 
expressing neural crest cells express Cre which deletes the transcription stop in front 
of the enhanced yellow fluorescent protein (eYfp) gene causing the cell and its 
downstream progeny to express eYFP, identifying the cell as neural crest derived 
(213). These mouse strains enabled the identification of NC-derived mesenchymal 
cells within both the fetal and adult thymus (213).  Because of this it is not surprising 
that research of thymic mesenchyme has not been as well investigated and the role 
 
52 
that these cells may play within the adult thymus has been perhaps underappreciated 
until more recent years.  
 
The development of the MTS-15 antibody aided the identification of thymic 
mesenchymal fibroblasts within the adult thymus (214). MTS-15+ thymic 
mesenchyme were found at the capsule and trabeculae, where thymic mesenchyme 
has already been shown to contribute to, as well as around large blood vessels at the 
CMJ (214). These MTS-15+ fibroblasts were PGDFRα+, expressed the growth factors 
FGF7 and FGF10 which may suggest that these cells are the NC-derived thymic 
mesenchyme identified in previous studies which regulate thymic epithelial cell 
proliferation, however the neural crest origin of these MTS-15+ thymic mesenchyme 
was not confirmed (202,214). The MTS-15+ cells also express the chemokines 
CXCL12 and CCL19 suggesting that they may have a role in lymphocyte migration 
within the thymus (214).  
 
The study from Sitnik et. al which showed that the RA producing thymic mesenchyme 
which regulate TEC proliferation in the embryonic thymus also showed that these 
cells persist into the adult (211). This suggests that they may have an extended role 
beyond the support of TEC proliferation in during initial thymus development however 
this has not yet been directly evaluated (211). In a more recent study Sitnik et. al 
identified a common mesenchymal precursor population within lymph node and 
thymus mesenchyme, as well as identifying two subsets of thymic mesenchyme that 
associate with vascular endothelial cells (215). It was proposed that due to the 
pericyte-like phenotype of these cells as well as their expression of genes associated 
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with endothelial cell regulation and angiogenesis (such as angiopoietin and VEGF) 
that these thymic mesenchyme cells may support endothelial cell homeostasis in the 
adult thymus (215). This is inline with another previous study which showed that NC-
derived thymic mesenchyme give rise to pericytes and smooth muscle cells which 
support thymic blood vessels structurally as well as through the mesenchymal cell’s 
production of VEGF, an endothelial cell mitogen that stimulates endothelial cell 
proliferation, enabling the formation and sprouting process of blood vessel structures 
(213,216,217).  
 
As well as their role in supporting the vascular endothelium of the thymus, thymic 
pericytes have also been shown to regulate the egress of mature thymocytes. During 
the final stages of thymocyte development the mature thymocytes exit the thymus via 
blood vessels at the corticomedullary junction (CMJ) (111). Thymic pericytes have 
been proposed to regulate this process through the production of sphingosine-1-
phosphate (S1P) kinase 1 (SPHK1) and SPHK2 which catalyze the ATP-dependent 
phosphorylation of sphingosine to generate S1P and thereby maintain the intrathymic 
S1P gradient required for normal thymocyte egress of mature, S1PR1-expressing 
thymocytes (111). 
 
Whilst these studies highlight important roles for thymic mesenchyme within the adult 
thymus it is clear that there is still much left to understand about this population 
phenotypically and functionally. In addition to this little is known about the regulation 
of the development of the thymic mesenchyme compartment and thus we aim to 
investigate these two topics within Chapter 3. 
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1.3 STROMAL MICROENVIRONMENTS OF SECONDARY LYMPHOID TISSUES 
1.3.1 Lymph Node Fibroblastic Reticular Cell Function And Development 
Peripheral lymphoid tissues are an important component of the immune system. 
Their primary function is to maintain the naïve lymphocyte population and facilitate 
the interaction between lymphocytes and antigens. There are a number of peripheral 
lymphoid organs, each with distinct roles within immune regulation. For the purpose 
of this research, lymph nodes will be the main focus as their mesenchymal stromal 
compartments are well studied. 
 
Similar to the thymus, lymph nodes are comprised of a heterogeneous mix of stromal 
cell subtypes. The stromal populations within the lymph node are primarily 
mesenchymal and endothelial but, unlike the thymus, do not contain epithelial cells. 
Typically lymph node stroma are separated into endothelium such as blood and 
lymphatic endothelium, as well as mesenchyme incorporating fibroblastic reticular 
cells (FRC), follicular dendritic cells (FDC) and marginal reticular cells (MRC) (218). 
These different stromal cells reside in distinct regions of the lymph node such as the 
T-cell zone and the B-cell zone (218). As highlighted in section 1.2.5, there is still 
much to learn about the cellular and molecular regulation of thymic mesenchyme as 
well as the functional role mesenchyme may have during thymocyte development 
within the thymus. Due to the mesenchymal origin of FRCs as well as their 
localization within the T-cell zone, the current literature surrounding FRCs may 
provide a platform that might help inform studies elucidating the regulation and 




Phenotypically FRC are identified as non-hematopoietic (CD45-) stromal cells 
characterized by their expression of the glycoprotein podoplanin (PDPN) and 
absence of the platelet endothelial cells adhesion molecule 1 (PECAM-1, commonly 
referred to as CD31) (PDPN+CD31-) (220). They have also been shown to express 
platelet-derived growth factor α (PDGFRα) and α smooth muscle actin (αSMA) as 
well as a number of other molecules highlighting the extensive research of this 
population in recent years (218).   
 
One of the first functional roles attributed to lymph node stroma, including FRCs, is to 
provide and support the physical structure of the lymph node and to funnel Ags and 
APCs towards specific lymphocyte populations within the lymph node in order to 
increase the likelihood of rare T- and B-cells to interact with their cognate Ag and 
initiate an adaptive immune response (218). FRCs, along with extracellular matrix 
(ECM), contribute to the structure of the lymph node by creating a 3-dimensional 
network upon which T-cells and DCs can migrate along as well as 
compartmentalizing the T-cell zone to ensure suitable localization of lymphocyte 
populations (219,221). FRCs regulate the migration of T-cells and DCs throughout 
the T-cell zone through their production of the CCR7-ligands CCL19 and CCL21 
(220,222,223). This production of CCR7-ligands also regulates the entry of T-cells 
from the blood into the lymph node, as found in the naturally occurring mutant mouse 
strain paucity of lymph node T-cells (plt/plt) which lack CCL19 and CCL21 have 
perturbed T-cell recruitment to lymph nodes (224–226). FRCs also support the 
survival of T-cells and DCs within the T-cell zone through production of IL-7 which is 
essential for maintaining T-cell and DC homeostasis, maximizing the time these cells 
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can spend searching for their cognate Ag (220). Additionally the 3-dimensional 
network created by the FRCs and ECM creates a conduit system, which transports 
soluble low molecular weight antigens and chemokines deep into the lymph nodes, 
delivering these to leukocytes such as B-cells and DCs further facilitating adaptive 
immune responses (227,228). These functions of the FRC help to ensure that DC 
cells can receive and present Ags to T-cells within the T-cell zone within the lymph 
node and aide the screening that the T-cells carry out in order to find their cognate 
Ag.  
 
Within the thymus, RANK and LTβR signaling have been shown to play a vital role in 
the development and function of thymic epithelial cells. These two TNFSFR members 
are also essential for the development of lymph nodes and LN FRCs. During lymph 
node organogenesis, pre-adipocytes migrate into the lymph node anlage and 
differentiate into CXCL13-expressing lymphoid tissue organizer (LTo) cells (218). 
This expression of CXCL13 attracts lymphoid tissue inducer cells (LTi) which express 
CXCR5 (receptor for CXCL13) causing the LTi to cluster at the site where the lymph 
node development will occur (150,229). These LTi express both RANK and RANK-
ligand and LTi clustering allows RANK signaling to occur between the LTi cells 
triggering the expression of the LTβR heterotrimeric ligand LTα1β2 (230). LTβR 
signaling is essential for the initial development of the lymph node mesenchyme 
precursors from adipocyte precursors as evidenced by LTβR-deficient mice which 
lack peripheral lymph nodes (149,231). Benezech et. al revealed that development 
from the LTo mesenchymal precursor to an intermediate “primed stromal population”, 
which expressed intermediate levels of intracellular adhesion molecule 1 (ICAM-1) 
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and vascular cell adhesion molecule 1 (VCAM-1) (ICAM-1intVCAM-1int), was not 
dependent on LTβR signaling (232). However further development of this ICAM-
1intVCAM-1int to an ICAM-1hiVCAM-1hi mature population was dependent on LTβR 
signaling and this mature population express key functional molecules such as the 
chemokines CCL19 and CCL21, as well as the homeostatic regulator IL-7 which are 
critical for the antiviral immunity (232,233). This emphasizes that RANK and LTβR 
signaling is essential for the development of functional LN mesenchymal cell 
development.  
 
Together, the potential shared cellular and molecular similarities displayed by LN and 
thymic microenvironments raises the interesting question as to whether similar 
mesenchymal cell types are present within the thymus and whether their 
developmental regulation and/or function occurs through similar pathways. Such 
questions will be investigated within Chapter 3. 
1.4 GENERAL AIMS 
The stromal microenvironment is essential in supporting the development of 
thymocytes throughout their stepwise maturation progress within the thymus. This 
microenvironment is a complex and heterogeneous mix of epithelial, mesenchymal 
and endothelial cells however much of what is known of the thymic stroma focuses 
on the thymic epithelial compartment. Studies have highlighted the numerous 
functional roles of mesenchymal cells within peripheral lymph nodes as well as their 
developmental regulation, however knowledge of thymic mesenchyme in comparison 




In addition, despite the early identification of the role for LTβR as a potential regulator 
of T-cell egress, more recent and in-depth analysis of this role has been lacking and 
thus the precise mechanism whereby LTβR controls normal T-cell egress remains 
incompletely understood. Therefore, this programme of work seeks to investigate 
thymic mesenchyme and elucidate the intrathymic role of the LTβR signaling axis by 
addressing the following three key questions: 
 
1) What are the phenotypic and functional characteristics of thymic 
mesenchyme?  
2) How is thymic mesenchyme regulated at both the cellular and molecular level? 














The mice used within this study were housed and maintained within the  
 in accordance with Home 
Office regulations. Details of all mouse strains, including their phenotype and source, 
used throughout this study are listed in Table 2.1. 
 
The mice used were either wild type mice used to characterize a normal, un-
manipulated thymic microenvironment, or genetically manipulated mice to allow 
investigations into the functions of genes and mechanisms involved in thymus and T-
cell development and function. All adult mice were culled by a schedule one method, 
primarily cervical dislocation, in accordance with Home Office regulations. For each 
experiment, mice were age matched and adult mice were classified as 8-12 weeks of 
age and all mice detailed in Table 2.1 are on a C57BL/6 background. For 
experiments using embryonic tissues, timed matings were set up and the detection of 
a vaginal plug indicated successful mating and was classified as day 0 of gestation 
(embryonic day 0, E0).  
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Table 2.1 Mouse Strain Information 
 
Mouse Strain Phenotype Source 
C57BL/6 Wild type. BMSU 
BoyJ Congenic CD45.1 C57BL/6 Wild type. BMSU 
Balb/c Wild type. BMSU 
RAG-2-GFP 
(RAGgfp) 
Transgenic mice which have a bacterial 
artificial chromosome (BAC) modified by 
homologous recombination to encode a 
green fluorescent protein (GFP) reporter 




Mice have deletion of Tcra which 
prevents formation of an αβ TCR which 




Deletion of the major histocompatibility 
complex (MHC) Class II results in 





Mice carrying mutant CD1d1 gene have 
severe loss of invariant natural killer T-
cells (iNKT) in thymus spleen and the 
liver (236). This loss results in a 
decrease in early IL-4 production by 




Mice have a loss of Foxp3+ Treg which 
results in lethal autoimmune syndrome 







Center, New York 
Lta-/- 
Mice lack LTα resulting in defective 
development of secondary lymphoid 
organs, including absent Peyer’s 
patches and lymph nodes and disrupted 




Mice were generated by crossing mice 
which carried a floxed RANK allele with 
actin-Cre mice to generate RANK-
deficient mice (152). Rank-/- mice have 
stunted limbs and teeth giving a runted 











Table 2.1 Mouse Strain Information Continued… 
 
Mouse Strain Phenotype Source 
Ltbr-/- 
Deletion of Ltbr results in mice lacking 
Peyer’s patches, all peripheral lymph 
nodes and have disrupted architecture 
including a loss of marginal zones and 








Mice deficient for LTβR were crossed 
with RAG-2-GFP reporter mice to study 
intrathymic dwell time and recent thymic 
emigrants. 
Generated in 




The Ltbr allele was flanked with loxP, 








Mice were generated by pronuclear 
injection of Pdgfrb gene fragment and a 
cDNA encoding Cre recombinase(240). 
Mice were heterozygous for Cre and 
were used to target Flox mediated 
deletion to PDGFRβ-expressing thymic 
mesenchyme. Mice were also used as 







Pdgfrbcre and Ltbrflox mice were crossed 
to specifically delete Ltbr in PDGFRβ+ 
cells. 
Generated in 
house at the 
BMSU 
mT/mG 
 A fate mapper system where all cells 
express membrane-targeted tdTomato 
(mT) prior to Cre excision and 
membrane-targeted EGFP (mG) after 





Pdgfrbcre and mT/mG mice were 
crossed to identify the specificity and 
efficacy of Cre activity of the Pdgfrbcre 
mouse strain. 
Generated in 





Table 2.1 Mouse Strain Information Continued… 
 
Mouse Strain Phenotype Source 
Wnt-1cre/+2  
(Wnt-1cre) 
Mice express Cre recombinase under 
the control of the Wnt1 promoter (242). 
Mice were used to target Flox-mediated 
gene deletion to Wnt-1cre expressing 
thymic mesenchyme. Wnt-1cre mice 






Wnt-1cre and mT/mG mice were crossed 
to identify the specificity and efficacy of 
Cre activity of the Wnt-1cre mouse strain. 
Generated in 




Wnt-1cre and Ltbrflox mice were crossed 
to specifically delete Ltbr in PDGFRβ+ 
mesenchyme cells. 
Generated in 




Cre was inserted downstream of the 
Fonx-1 gene (243). Mice were 
heterozygous for Cre and were used as 






Foxn-1cre and Ltbrflox mice were crossed 
to specifically delete Ltbr in Foxn-1+ 
epithelial cells. 
Generated in 




Expression of Cre recombinase is driven 
by the endothelial-specific Tie2 
promoter (244). Mice were 





Tie2cre and Ltbrflox mice were crossed to 
specifically delete Ltbr in Tie2+ 
endothelial cells. 
Generated in 
house at the 
BMSU 
Tie2cremTmG 
Tie2cre and mT/mG mice were crossed 
to identify the specificity and efficacy of 
Cre activity of the Tie2cre mouse strain. 
Generated in 




Cre recombinase express is driven by 
expression of Flk-1 gene (245). Flk-1cre 
mice were used to target endothelial 
cells. Mice were heterozygous and were 





Flk-1cre and mT/mG mice were crossed 
to identify the specificity and efficacy of 
Cre activity of the Flk-1cre mouse strain. 
Generated in 
house at the 
BMSU 
Flk-1creLtbrflox 
Flk-1cre and Ltbrflox mice were crossed to 
specifically delete Ltbr in Flk-1+ 
endothelial cells. 
Generated in 




2.2 MEDIUM AND TISSUE CULTURE REAGENTS 
2.2.1 Medium 
Tissues were isolated and handled in a medium of RF10-H (details Table 2.2) and 
stored on ice prior to processing or culturing. Preparation of single cell suspensions 
either by mechanical disaggregation or enzymatic digestion, as well as storing of 
single cell suspensions, were carried out in RF10-H, whereas cell and tissue cultures 




Some experimental conditions required selective depletion of hematopoietic cells to 
investigate the thymic stroma. To achieve this, fetal thymic organ cultures (FTOC) 
(further information Section 2.7) were cultured in DMEM with 2-deoxyguanosine (2-
dGuo) added, this depletes hematopoietic cells that are rapidly dividing but does not 
impact thymic stroma resulting in thymic lobes that are empty of thymocytes but 
retain their stromal populations and structure. A stock solution of 9mM 2-dGuo was 
stored at -20°C and was added to culture mediums of DMEM to give a final 
concentration of 1.35mM when required. Unless otherwise stated all media was 
sourced from Sigma-Aldrich.  
 
65 
Table 2.2 Preparation Of RPMI-1640 Hepes (RF10-H) 
 
Medium and Additives Volume Final Concentration 
RPMI-1640 + 20mM Hepes, with L-
glutamine, without bicarbonate 500ml - 
200mM L-glutamine 5ml 2mM 
5000 IU/ml Penicillin and Streptomycin 10ml 100IU/ml 
Heat-inactivated fetal calf serum (FCS) 50ml 10% 
 
Table 2.3 Preparation Of DMEM 
 
Medium and Additives Volume Final Concentration 
Dulbecco’s Medium with 3.7g/l 
bicarbonate, without glutamine 20ml - 




L-Aspartic acid 13mg/ml 
Glycine 7.5mg/ml 




1M Hepes 200µl 10mM 
5x103 M2 Mercaptoethanol 200µl - 
200mM L-Glutamine 400µl 4mM 
5000 IU/ml 400µl 100 IU/ml 
Heat inactivated FCS 2ml 10% 
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2.3 DISSECTION OF MOUSE TISSUE 
Tissues such as thymic lobes, spleens, lymph nodes and kidneys were dissected 
from adult mice at BMSU and placed into RF10-H on ice. Excess fat or blood was 
removed from the isolated tissues and which were then stored in RF10-H on ice until 
the tissue was processed (see section 2.4). For fetal tissues, embryos were removed 
from pregnant mice on the required day of gestation, separated from the womb and 
egg sac and washed in RF10-H. Embryonic lobes were then dissected from the 
embryo under a dissection microscope and transferred into RF10-H until being used, 
either fresh for thymocyte/stromal cell isolation or for FTOC. Tissues required for cell 
transfer or cell culture, such as FTOC, were handled and processed within a laminar 
flow hood to provide a sterile environment, using sterile surgical equipment and 
sterile RF10-H and DMEM. 
2.4 CELL ISOLATION TECHNIQUES 
2.4.1 Isolation Of Thymocytes Or Splenocytes 
Two methods, either mechanical disaggregation or enzymatic digestion, were used to 
obtain single cell suspensions of thymocytes or peripheral lymphocytes from the 
thymus and spleen. For mechanical disaggregation, thymus or spleen were teased 
apart between two glass slides to release the cells into a petri-dish containing RF10 
to obtain a single cell suspension. Alternatively, for enzymatic digestion, tissues were 
place into 1.5ml eppendorfs containing 1ml RF10-H with 0.4mg/ml DNase1 and 
2.5mg/ml Collagenase D added and chopped into fine pieces using scissors to 
increase surface area, aiding digestion. The enzyme media and tissues were 
transferred into polypropylene round bottom tubes (BD) and incubated at 37°C using 
a thermomixer (Eppendorf) to keep the samples agitated. Samples were pipetted up 
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and down every 5 minutes until all tissue had digested (25-30 minutes) and 30µl of 
0.5M EDTA was added to each.  
 
Once a single cell suspension was obtained, cells were filtered through a mesh-
membrane filter to remove any cell clumps into 15ml centrifuge tubes (Corning) and 
centrifuged at 1400rpm for 4 minutes to form a pellet. Thymus samples were then re-
suspended in 2ml of staining buffer (500ml PBS + 2ml 0.5M EDTA + 2.5ml FCS) and 
placed on ice whereas spleen samples were re-suspended in 2ml of red blood cell 
lysis buffer (Sigma-Aldrich) and left at room temperature for 10 minutes to deplete 
erythrocytes within the samples. To neutralize the lysis reaction, an equal volume of 
RF10-H was then added to the cell suspension and centrifuged. If red blood cell lysis 
was incomplete, this step was repeated, however if lysis was successful the 
splenocytes were re-suspended in 2ml of staining buffer and placed on ice. 
Using Sphero AccuCount cell count beads (SpheroTech), cell counts were acquired 
by adding 5µl of cell count beads (equivalent to 5000 beads) to 100µl of staining 
buffer in a FACs tube. 50µl of sample was then added to the count tube, giving a final 
concentration of 1:40. These samples (FACs tube containing 100µl staining buffer, 
5µl of beads and 50µl of sample) were then run on a BD LSR Fortessa flow 
cytometer to count the number of cells and beads. Total cell numbers were then 
calculated using the following formula: 






2.4.2 Isolation Of Stromal Cell Populations 
For the isolation of stromal cells from the thymus, thymi were place into 1.5ml 
eppendorfs containing 1ml RF10-H with 0.4mg/ml DNase1 and 2.5mg/ml 
Collagenase Dispase added and chopped into fine pieces using scissors. The 
enzyme media and tissues were transferred into polypropylene round bottom tubes 
(BD) and incubated at 37°C using a thermomixer (Eppendorf) to keep the samples 
agitated. Samples were pipetted up and down every 5 minutes until all tissue had 
digested (25-30 minutes) and 30µl of 0.5M EDTA was added to each sample. Once a 
single cell suspension was obtained, the thymus samples were handled and counted 
using the same method as used in section 2.4.1. For stromal analysis, CD45-
depletion was carried out to enrich the non-hematopoietic stromal cells within the 
samples. 10µl of anti-CD45 microbeads (Miltenyi Biotec) were added to each sample, 
vortexed and incubated on ice for 20 minutes. Samples were then passed through 
primed LS MACs separation columns (Miltenyi Biotec) placed on QuadroMACs 
separator magnets and collected and placed on ice ready for staining whereas the 
CD45+ cells retained within the LS MACs separation column were discarded.   
 
2.5 FLOW CYTOMETRY 
2.5.1 Antibodies 
All primary antibodies used for flow cytometric analysis for this study are listed in 
Table 2.4 and secondary antibodies are listed in Table 2.5. Antibodies were 
conjugated with a fluorochrome or were biotinylated, which required a secondary 
streptavidin antibody for their detection. All antibodies were titrated prior to their use 
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and the working concentrations for each antibody are stated in Table 2.4 and Table 
2.5. 
2.5.2 Immunolabeling For Flow Cytometry 
Following single cell isolation and cell counting, approximately 5x106 cells from each 
sample was aliquoted into separate wells of a 96-well plate (Costar) and centrifuged 
at 1400 RPM for 2 minutes. For experiments investigating rare cell populations, 
1x107 cells were stained to increase the number of the rare population to aid 
analysis. The supernatant was discarded and re-suspended in 50µl (5x106 cells) or 
100µl (1x107 cells) of antibody mix. All antibody suspensions were made up in 
staining buffer at the concentrations indicated in Table 2.4 and Table 2.5 and 
samples were incubated on ice for 30 minutes. Single color controls were prepared 
for each individual fluorochrome used in the staining combination and these were 
used to set compensation parameters on the flow cytometer. After 30 minutes 
incubation on ice, each well was washed with 150µl of staining buffer and centrifuged 
at 1400RPM for 2 minutes. Following this the supernatant was removed and any 
secondary or tertiary steps were added in the same method as used for the primary 
antibody step. Following all necessary antibody staining steps, cells were washed, 
centrifuged, the supernatant was removed and samples were then re-suspended in 
100-200µl of staining buffer and transferred into 12.5ml polystyrene FACS tubes 
(Becton) to be run on the flow cytometer or stored short-term at 4°C until they were 




2.5.3 Intracellular Immunolabeling For Flow Cytometric Analysis 
Intracellular staining of transcription factors such as Foxp3 and Aire required a 
fixation/permeabilization step to achieve successful detection. Cells were stained for 
cell surface markers as described in Section 2.5.2. After the final step of surface stain 
was complete, samples were washed, centrifuged and the supernatant was 
discarded. Samples were then permeabilized using the eBioscience 
Foxp3/Transcription Factor Staining Buffer Set (ThermoFisher) in accordance with 
the manufacturer’s protocol. All samples, including single color controls, were re-
suspended in 150µl Fixation/Permeabilization solution made up of concentrate and 
diluent at a 1:3 ratio and were incubated for 45 minutes on ice. Cells were washed 
twice in 100µl of 10% 10X permeabilization buffer, made up in distilled water. 
Following permeabilization, cells were stained with either Foxp3 PE or Aire Alexa 
Fluor 488 (Table 2.4), which were diluted in 10% 10X permeabilization buffer and 
stained on ice for 30 minutes. Cells were washed and centrifuged twice in 100µl of 
10% 10X permeabilization buffer and then finally resuspended in staining buffer and 
transferred into FACS tube ready for acquisition by flow cytometry. The intracellular 
staining of CCL21 was carried out in the same manner as Foxp3 and Aire, however 
the CCL21 primary antibody requires further detection by a secondary goat anti-
rabbit Alexa Fluor 647 antibody detailed in Table 2.4 and Table 2.5.  
2.5.4 Flow Cytometric Analysis 
Samples were run on a BD LSR Fortessa flow cytometer using the accompanying 
BD FACS diva software and analysis of acquired flow cytometric data was carried out 
using FlowJo software (version 8.8.6). Voltages for each detection channel, as well 
as compensation between each fluorochrome was adjusted and set using single 
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color controls for each fluorochrome. Gating for positive staining was set by using 
negative control samples which either used isotype controls, fluorescence minus one 
or samples from knock-out mice lacking the particular protein being stained for, for 
example using lymphotoxin β receptor (LTβR)-deficient mice to control for LTβR 
straining levels. The number of events collected during sample acquisition depended 
on the frequency of the population under investigation. For the majority of samples, 
5x105 events were collected, however in instances of rare cells, such as CD4 IV+ 
cells, approximately 2-3x106 events were collected to improve accuracy of the 
analysis. Forward and side scatter gates were set to exclude any non-viable cells.  
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Table 2.4 Primary Reagents Used For Flow Cytometry Immunolabeling 
 
Specificity (Clone) Conjugate Working Dilution Supplier 
Anti-CD45 
(Clone 30-F11) 



































LIVE/DEAD Fixable Dead 
Cell Stain Kit Near-IR 1:1000 Invitrogen 
Anti-PDGFRα 
(Clone APA5) Biotin 1:200 eBioscience 
Anti-PDGFRβ 
Clone APB5 Biotin 1:200 eBioscience 
Anti-Ly-51 
(Clone 6C3) PE 1:200 eBioscience 
Anti-Ly-51 




Pacific Blue 1:200 BioLegend 
Anti-VCAM-1 (CD106) 
(Clone 429) Biotin 1:200 BioLegend 
Rat IgG2b, κ isotype 
(Clone RTK4530) Pacific Blue 1:200 BioLegend 
Rat IgG2a, κ isotype 










(Clone D7) Biotin 1:300 BioLegend 
Anti-CD34 
(Clone RAM34) Biotin 1:200 eBioscience 
Anti-CD29 
(Clone HMβ1-1) Biotin 1:200 BioLegend 
Anti-CD4 
(Clone GK1.5) PE Cy7 1:1500 eBioscience 
Anti-CD4 
(Clone RM4-5) Bv711 1:100 BioLegend 
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Table 2.4 Primary Reagents Used For Flow Cytometry Immunolabeling continued… 
 
















(Clone FJK-16s) PE 1:100 eBioscience 
Anti-TCRβ 
(Clone H57.597) APC eFluor 780 1:200 eBioscience 
Anti-CD25 
(Clone eBio3C7) eFluor 450 1:100 eBioscience 
Anti-CD25 
(Clone PC61.5) A700 1:100 eBioscience 
Anti-CD69 
(Clone H1.2F3) PerCP-Cy5.5 1:200 eBioscience 
Anti-CD62L 
(Clone MEL-14) APC 1:1500 BioLegend 
Anti-LTβR 
(Clone eBio3C8) Biotin 1:200 eBioscience 
Anti-UEA-1 Biotin 1:10000 Vector Laboratories 
Anti-IAIE 
(MHC Class II) 
(M5/114.15.2) 
Bv421 1:600 Biolegend 
Anti-CD80 
(Clone 16-10A1) BV605 1:400 Biolegend 
Anti-Aire 
(Clone 5H12) Alexa Fluor 488 1:1000 eBioscience 




FITC 1:400 BD Bioscience 
Anti-Ly6C 




- 1:10 R&D Systems 
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Table 2.4 Primary Reagents Used For Flow Cytometry Immunolabeling continued… 
 
 
Table 2.5 Secondary Reagents Used For Flow Cytometry Immunolabeling 
 
 
2.6 HIGH SPEED SORTING 
Samples were prepared by cell surface labeling by the same method as section 
2.5.2. To collect a enough cells to generate reaggregate thymic organ cultures 
(RTOCs) (detailed in Section 2.8) or for PCR, greater numbers of cells were 
prepared and therefore the staining volume was increased from 50µl antibody/5x106 
cells to 350µl of antibody/30x106 cells. Samples bigger than 30x106 were separated 
prior to staining but importantly stained using the same antibody mix and pooled after 
staining was complete. Samples were resuspended in 0.5ml of RF10-H and filtered 
through a 30mm mesh-membrane filter unit (Miltenyi Biotech). Samples were 
transferred to a polypropylene FACS tube (Becton Dickinson) and stored at 4°C prior 
to sort. Sorting was carried out using either a MoFlo XDP sorter (Beckman Coulter) 
or a FACSAria Fusion (BD). Sorted populations were collected into FACS tubes 
Specificity (Clone) Conjugate Working Dilution Supplier 
Anti-Rat IgG2a 
(Clone MRG 2a-83) Biotin 1:100 Biolegend 
Anti-CD45.1 
(Clone A20) PE Cy7 1:200 eBioscience 
Anti-CD45.2 
(Clone 104) A700 1:200 eBioscience 
Anti-CD3 
(Clone 145-2C11) PE 1:50 eBioscience 
Specificity Conjugate Working Dilution Supplier 
Streptavidin PE Cy7 1:1500 eBioscience 
Anti-rabbit IgG Alexa Fluor 647 1:200 Life Technologies 
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containing 0.5ml RF10-H, centrifuged, and re-suspended in 1ml of RF10-H. Cells 
were taken for cell counting as well as to check the cell purity for each of the isolated 
cell populations by comparing them to the pre-sorted samples, using a BD LSR 
Fortessa flow cytometer. Isolated cell populations were then centrifuged and washed 
in PBS to remove residual RF10-H media. If cells were isolated for PCR analysis, 
samples were centrifuged again, supernatant discarded and snap frozen on dry ice 
prior to storage in a -80°C freezer. 
2.7 FETAL THYMIC ORGAN CULTURE (FTOC) 
The FTOC system is a powerful tool that can be used for analysis of thymic stroma 
and thymocytes, as the cultured thymus can still support normal T-cell development 
and maintain its structure of the thymic stromal microenvironment in vitro. Under 
sterile conditions within a laminar flow cabinet, thymic lobes were dissected from 
embryos, typically at day 15 of gestation (E15), and placed on top of a 0.8µm sterile 
nucleopore filter (Millipore), which lay on top of a sterile anti-wrap sponge support 
(Medipost Ltd) within DMEM media. Prior to this, the sponge support had been cut to 
1cm2 squares and both the sponges and the nucleopore filters were boiled, 
separately, for 30 minutes to sterilize and left to air dry within a laminar flow cabinet. 
Thymic lobes were placed on the filter surface using a mouth-controlled sterile glass 
pipette. Up to 6 lobes were placed per filter-sponge, two of which were added per 
90mm petri dish (Sterilin) containing 4ml of DMEM. For the depletion of 
hematopoietic cells within the FTOC, 2-dGuo was added to the DMEM medium prior 
to adding the fetal lobes. 600µl of 2-dGuo stock was added to 4ml of DMEM in a 
90mm petri dish. Once the cultures had been set up they were stored in sterile 
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humidified chambers and gassed with 10% CO2 for 10 minutes to correct the pH of 
the culture medium to 7.2-7.4 and then sealed and stored at 37°C for 7 days. 
2.8 REAGGREGATE THYMIC ORGAN CULTURE (RTOC) 
The generation of RTOCs allows the investigation of specific individual cell types, 
both hematopoietic and stromal, within an in vitro 3-dimensional thymic 
microenvironment (208,246). The experimental design and generation of the RTOCs 
used in this study is described in Figure 3.10. For this study, CD4+CD8-TCR
+Tetramer-Foxp3- SP4 thymocyte, CD4+CD8-TCRβ+Tetramer-Foxp3+ regulatory T-
cells (Tregs) and CD4+CD8-TCR+Tetramer+ invariant natural killer T-cells (iNKTs) 
were sorted from adult mice using a MoFlo cell sorter as described in Section 2.6. 
Under sterile conditions, the isolated populations were mixed with a cell suspension 
of 2-dGuo-treated FTOC (Section 2.7) that have been digested and CD45+ depleted 
to enrich for stroma. Thymocyte populations were added at a 3:1 ratio with the 2-
dGuo treated, CD45-depleted, FTOC stroma within a 1.5ml eppendorf. The 
combined cell suspension was centrifuged at 1000rpm for 10 minutes and the 
supernatant was removed, leaving <5µl of supernatant. The pellet was vortexed and 
using a finely drawn mouth pipette (finer than typically used for FTOC), the cell 
suspension was dropped, under a dissection microscope, onto the center of a 0.8µm 
sterile Whatman filter, which sat on top of a sterile anti-wrap sponge in DMEM. 
RTOCs were limited to one per filter-sponge and culture conditions were the same 
used for FTOCs in Section 2.7. RTOCs were cultured for 7 days before enzymatic 
digestion and analysis of the stromal populations. 
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2.9 THYMIC KIDNEY CAPSULE TRANSFER 
To investigate the contribution of thymic stroma in regulating thymocyte egress Ltbr+/+ 
or Ltbr-/- E15 2-dGuo-treated FTOC lobes were transferred under the kidney capsule 
of WT hosts. Mice used for surgery were 6-8 weeks old and were weighed prior to 
surgery to ensure the correct dose of analgesia was administered as well as to 
monitor weight changes of the mice following the surgical procedure. Mice were 
anaesthetized using a chamber containing 4% isoflurane (May and Barker, 
Degenham, UK) carried within oxygen. Once mice were unconscious they were 
transferred onto a heat pad and anesthesia administration was maintained using a 
facemask. 2mg/kg of pre-operative Buprenorphine (Temgesic, AnimalCare, UK) was 
administered sub-cutaneously.  
 
Mice were laid on their stomach and using an electric trimmer, fur surrounding the 
site of incision was removed and the site was cleaned and sterilized using 70% 
ethanol. Two incisions were made; the first was a small incision into the skin using 
blunt-ended scissors within the region of the left kidney. The skin and peritoneum in 
this region were separated and the second incision was made into the peritoneum. 
The kidney was then carefully drawn out of the body using blunt-ended forceps to 
grab the fat attached to the kidney. The kidney was maintained outside of the body 
by the small size of the incision into the skin, which prevented the kidney from 
reentering the body, and the kidney throughout the manipulation outside of the body 
was kept hydrated with sterile gauze soaked in PBS. A small incision was then made 
into the capsule of the kidney and the fetal thymic lobes were transferred under the 
kidney capsule using an iris cutter, with a maximum of two lobes grafted per kidney. 
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The kidney was gently drawn back into the body cavity and the peritoneum, followed 
by the skin, was sutured (Vicryl, 16mm round bodied sutures) and the skin was also 
sealed using a surgical staple to aide wound closure. The mice were removed from 
anesthesia and placed into a warming box and visually monitored until they had 
regained consciousness. BMSU staff monitored the recovery of the mice until they 
were sacrificed between 6-8 weeks later and the thymus tissue was retrieved from 
the kidney and processed for FACS analysis. 
2.10 GENERATION OF BONE MARROW CHIMERAS 
To investigate the role of hematopoietic cell populations in regulating thymocyte 
egress, CD45.1 WT hosts were reconstituted with either CD45.2 WT or CD45.2 Ltbr-/- 
bone marrow (BM) (experimental design detailed in Figure 4.11). BM was obtained 
from the femur and tibia of the CD45.2 WT and CD45.2 Ltbr-/- donors by flushing the 
bones with sterile RF10-H using a syringe and a 27-gauge needle under sterile 
conditions. The BM was flushed into a 35mm petri dish containing RF10-H and the 
extracted BM was passed through the needle several times to obtain a single cell 
suspension and the cell suspension was then filtered using a 30mm mesh-membrane 
filter (Miltenyi Biotech). Samples were centrifuged and re-suspended in 2ml red blood 
cell lysis buffer (Sigma-Aldrich) and left at room temperature for 10 minutes. An equal 
volume of RF10-H was added to neutralize the lysis buffer, the sample was 
centrifuged and then resuspended in RF10-H and counted. Following this, the BM 
samples were then T-cell depleted, first by staining the samples in 2ml of anti-CD3 
PE antibody mix (Table 2.4) to ensure adequate staining of T-cells and samples were 
incubated for 30 minutes on ice. Samples were then washed, centrifuged and 
resuspended in sterile staining buffer containing 1:10 dilution of anti-PE microbeads 
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(Miltenyi Biotec), where 10µl of microbeads was added per 1x107 cells. Samples 
were incubated on ice for 15 minutes and then passed though a primed LS MACs 
separation column (Miltenyi Biotec) placed on QuadroMACs separator magnets. The 
column was washed twice using staining buffer and all CD3- cells that passed 
through the column were collected. Samples were centrifuged, resuspended in sterile 
RF10-H and counted. Aliquots were made in 1.5ml eppendorfs, at a concentration of 
5x106 cells/200µl PBS (without calcium and magnesium) and stored on ice until 
transfer into the host mouse.  
 
CD45.1 WT hosts receiving BM transfers that weighed over 18g were placed onto 
drinking water containing baytril antibiotic drinking water for one week prior to 
irradiation. Hosts were irradiated using a CIS IBL 437 Cs-137 irradiator (CIS BIO 
International, Cedex, France) with two 450 Rad doses over two days (dose one: 
10am first day, dose 2: 10am second day) and the bone marrow transfer was 
performed in the afternoon on the day of the second irradiation. 200µl of BM was 
transferred intravenously via the tail vein into each host, which had been warmed in a 
warming box to aid visualization of the tail vein, using a 25-gauge needle and 1ml 
syringe. BMSU staff monitored the recovery of the mice post-injection and the mice 
remained on baytril drinking water for a week following BM transfer. The chimera 
mice were harvest 12 weeks after bone marrow transfer to maximize the amount of 
time for the thymocytes to accumulate and thymocyte emigration was measured 




2.11 ANTI-CD4 INTRAVENOUS (IV) LABELING 
To measure the frequency of cells within the perivascular space in WT and 
genetically altered mice an intravenous (IV) labeling approach was used. WT or 
genetically altered mice were each injected with 1µg of anti-CD4 PE antibody 
intravenously using a 25-gauge needling attached to a 1ml syringe. The anti-CD4 PE 
was prepared at a concentration of 1µg of CD4 PE (GK1.5; BioLegend) in 200µl of 
PBS (without calcium and magnesium). Each mouse was harvested 3 minutes after 
injection and the thymus was immediately dissected and mechanically dissociated 
using glass slides in 20ml of RF10-H to dilute any excess, unbound anti-CD4 PE 
antibody, and stored on ice. Injections were staggered every 3 minutes to ensure 
enough time to process each sample. As a control for the anti-CD4 IV labeling, a 
control mouse was first administered FTY720 18 hours prior to anti-CD4 
administration. FTY720 blocks sphingosine-1-phosphate mediated egress and entry 
into the perivascular space, therefore mice receiving FTY720 treatment act as a 
negative control for PVS labeling by anti-CD4 IV. FTY720 (Sigma Aldrich) was 
administered at 1mg/mouse and made up in distilled water prior to injection. 
2.12 IN VIVO BRDU LABELLING  
For in vivo labeling of proliferating cells, 1.5mg/mouse of BrdU (Sigma Aldrich) was 
administered by intraperitoneal injections and mice were harvested 18 hours after. 
Cells were isolated and stained for cell surface markers as described in Section 2.5.2 
in a 96-well plate. Samples were then resuspended in 100µl of BD fix/perm for 30 
minutes in the fridge and then washed with 150µl of perm/wash. Cells were spun 
down, supernatant removed and resuspended in BD Cytoperm buffer Plus for 10 
minutes on ice. Cells were then washed in 150µl of perm/wash, spun down, 
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supernatant removed and resuspended in 100µl of BD fix/perm and incubated on ice 
for 5 minutes. Following this cells were washed in 150µl of perm/wash, spun down, 
supernatant removed and resuspended in 100µl of diluted DNAse (30µl of stock 
DNAse, 70µl PBS with calcium and magnesium) and incubated for 1 hour at 37°C. 
Samples were then washed with perm/wash, centrifuged, supernatant removed and 
resuspended in 100µl of anti-BrdU (1:100 dilution in perm/wash buffer) and incubated 
for 40 minutes at room temperature. The samples were washed a final time and 
resuspended in staining buffer and stored at 4°C until ran on the Flow Cytometer. 
2.13 IMMUNOHISTOLOGY TECHNIQUES 
2.13.1 Sectioning And Fixation Of Frozen Tissues 
Thymus tissue was harvested from adult mice, cleaned of any excess fat and blood, 
placed on tin foil sections and frozen down as soon as possible on dry ice. Frozen 
tissues were then mounted in optimal cutting temperature (OCT) compound onto a 
microtome. Sections were cut at a thickness of 7µm and mounted onto four spot 
glass slides (Hendley-Essex) and left to air dry at room temperature for 40 minutes 
before being fixed in acetone (Sigma Aldrich) for 20minutes at 4°C. Sections where 
removed from acetone and allowed to air dry for 5-10 minutes and then immediately 
stained for immunolabeling or stored in sealed bags at -20°C until used for 
immunolabeling.  
2.13.2 Immunolabeling Of Frozen Tissue Sections 
Sections freshly removed from acetone following fixation were left to air dry for 5-10 
minutes or sections removed from -20°C were left at room temperature to air dry for 
30 minutes prior to placing in PBS bath for 10-15 minutes to rehydrate the sections. 
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The details of the primary antibodies used for staining of frozen sections for confocal 
analysis are listed in Table 2.6 and secondary antibodies are listed in Table 2.7. 
Antibodies were made up in PBS containing 1% bovine serum albumin (BSA) and 
100µl of each antibody mix was applied to each section, ensuring full coverage of 
each tissue section and incubated for 30 minutes in a dark, humidified chamber at 
room temperature. Excess PBS was removed from the edges of the slides as well as 
between each section before adding antibodies to prevent the antibodies staining 
multiple sections. Sections were washed within a PBS bath for 10 minutes between 
each staining step. Once all staining steps were complete the sections were fully 
emerged in a DAPI (4’,6-diamidino-2-phenylindole) solution for 10 seconds to stain 
the nucleus of the cells throughout the whole section. Sections were immediately 
washed in a fresh PBS bath for 30 seconds, twice. Excess PBS was removed from 
the edges of the slides as well as between the sections and then a small drop of 
DABCO (1,4 diazabicyclooctane), in glycerol at pH 7, or ProLong Gold Antifade 
Mountant (Life Technologies) was added to each section to prevent fading of the 
fluorochromes. The slide was mounted with a cover slip (Sigma Aldrich) and sealed 
using nail varnish around the outer edges of the cover slip and allowed to air dry. 




Table 2.6 Details Of Primary Antibodies Used For Immunohistology 
Specificity 










(Clone 8.1.1) Hamster IgG - 1:10 
Kind gift from 
Andrew Farr 
(247) 
Anti-ERTR5 Rat IgM - 1:5 
Kind gift from 










Anti-β5t Rabbit - 1:100 MBL 
Anti-CD8 
(Clone 53-6.7) Rat Biotin 1:200 eBioscience 
Anti-ERTR7 Rat IgG - 1:10 
Kind gift from 
Van Vliet E 
(248) 
 
Table 2.7 Details Of Secondary Antibodies Used For Immunohistology 
Specificity 






555  1:500 
Invitrogen 
(Thermofisher) 
Anti-Rat IgG Goat  Alexa Fluor 594 1:200 
Invitrogen 
(Thermofisher) 















2.13.3 Confocal Analysis And Quantitation 
To quantify the medullary area within WT, Ltrb-/-, Foxn-1cre and Foxn-1creLtbrflox mice, 
full tissue immunofluorescence scans were taken using a Zeiss Axio ScanZ1 and 
each tissue scan was analyzed using Zeiss Zen Blue software to measure the area 
of each medullary region. Medullas were defined as containing either CD4 or CD8 
single positive thymocytes and areas of ERTR5+ staining (which stains medullary 
thymic epithelial cells). Three sections were analyzed per mouse, each from different 
depths within the tissues for quantitation, with a minimum of three mice per strain. 
We adopted a previously published method to categorize the medullary areas 
according to their area in mm2 and the mean number of medullas within each size 
category was calculated (249). For the imaging of the perivascular space in Section 5 
and thymic mesenchyme in Section 3 images were taken using a Zeiss LSM 780 and 
analyzed using Zeiss Zen Black software. 
 
2.14 PREPERATION OF SAMPLES FOR GENE EXPRESSION ANALYSIS 
All gene expression analysis was carried out in collaboration with S. Parnell, 
University of Birmingham. 
2.14.1 mRNA Extraction And cDNA Synthesis 
Prior to their use, all buffers were equilibrated to room temperature. 0.9cm3 of 
lysis/binding buffer was added to a maximum of 1x107 cells and lysed by vigorous 
vortexing or passing through a 21-gauge needle with care. Lysate was applied on top 
of Lysate Clear Column in a centrifuge tube and centrifuged at 13,000g for 3 minutes. 
50µl of oligo (dT) microbeads were then added to the lysate and gently mixed to 
allow hybridization of mRNA to oligo (dT) microbeads. A MACSµ column was placed 
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in a magnetic field of a thermo MACS Separator and primed with 100µl of 
lysis/binding buffer. Lysate was then added to the column matrix, within which the 
magnetically labeled mRNA will bind to the column whereas the unwanted protein 
and DNA will not. To remove the proteins and DNA, the MACSµ columns were rinsed 
twice with 200µl of lysis/binding buffer and washed four times with 100µl of wash 
buffer to remove rRNA and DNA. 100µl of equilibration/wash buffer was then added 
to the column twice and following this the reverse transcription mastermix was added 
to the top of the column matrix. 1µl of sealing solution was applied to prevent 
evaporation and the column matrix was incubated for 1 hour at 42°C on the thermo 
MACs block. The column was then rinsed twice with 100µl equilibration/wash buffer 
and finally 20µl of release solution was added to the column and incubated at 42°C 
for 30 minutes. The synthesized cDNA was then eluted with 50µl of cDNA elution 
buffer, collected in an eppendorf and stored at -20°C until use.  
 
2.14.2 Real Time Quantitative PCR 
Real time quantitative PCR was performed using a RotorGene RG-3000 (Qiagen) 
using SYBR green with primers specific for the variety of genes of interest. Details of 
the primers used, including the forward 5’ and reverse 3’ sequences are detailed in 
Table 2.8. Prior to the amplification of the target genes of interest, β-actin was used 
as the housekeeping gene for sample normalization. Oligonucleotides of the genes of 
interest were synthesized by Sigma-Genosys. PCR reactions were performed in 
replicates within a 15µl reaction buffer containing 7.5µl of 2X qPCR mastermix 
(Bioline Sensimix NoRox SybrGreen QT 650-05) containing heat-activated Taq 
polymerase, dNTPs, MgCl2, Sybr green and reaction buffer. The 15µl reaction buffer 
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also contained 0.15µl (20µM stock concentration) of both forward and reverse 
primers (final concentration 0.2µM), 6.2µl DNAse-free/RNAse-free, PCR grade water 
(Life Technologies 10977035) and 1µl cDNA template. β-actin primers were 
designed and synthesize by QIAGEN (QuantiTect Mm Actb 1SG Primer Assay: 
QIAGEN QT00095242) and used at a 1x concentration. The amplification program 
included an initial denaturation step at 95°C for 10 minutes, followed by cycling at 
95°C for 15 seconds, 60-62°C (primer pair specific) for 20 seconds and 72°C for 15 
seconds (40 cycles). At the end of each cycle the fluorescent signal produced from 
the amplicon was obtained and at the final amplification a dissociation curve was 
generated (72-99°C, hold 30 seconds on the first step, then 5 seconds on the next 
steps), per primer pair, to verify the specificity of the amplicon. The reaction 
amplification efficiency and Ct values were acquired from Rotor Gene 6.0 software 
(Qiagen) using standard curves generated from mouse universal cDNA (Biochain). 
The Pfaffl model was adopted to calculate the relative expression values of each 
sample, normalized to β-actin. The Pfaffl model was selected as it takes into account 
gene dependent efficiencies within the amplification process. 
 
2.15 GRAPHS AND STATISTICAL ANALYSIS 
All graphs and statistical analysis were generated using GraphPad Prism 6 software. 
The statistical test carried out is described in the figure legend accompanying each 





Table 2.8 Details Of Primers Used For qPCR 
Primer NCBI Reference Sequence Forward 5’ End Sequence 
Reverse 3’ End 
Sequence 
Fgf10 NM_008002.4 CAGCGGGACCAAGAATGAAG 
TGACGGCAACAACTC
CGATTT 
Il-7 NM_008371.4 TTCCTCCACTGATCCTTGTTCT 
AGCAGCTTCCTTTGTA
TCATCAC 
Enpp2 NM_001136077.2 GGAGAATCACACTGGGTAGATGATG 
ACGGAGGGCGGACAA
AC 
Cxcl13 NM_018866.2 CATAGATCGGATTCAAGTTACGCC 
TCTTGGTCCAGATCAC
AACTTCA 
Ccl19 NM_011888.2 GCTAATGATGCGGAAGACTG 
ACTCACATCGACTCTC
TAGG 
Ccl21 NM_011124.4 ATCCCGGCAATCCTGTTCTC 
GGGGCTTTGTTTCCC
TGGG 
Sphk1 NM_011451.3 GAGCTCCGAGCTGTTTGCA 
TGACACCCCCGCACG
TA 
Rank NM_009399.3 GCTGGCTACCACTGGAACTC 
GTGCAGTTGGTCCAA
GGTTT 
Ltbr NM_010736.3 CAGAGAGCTGGAGGCTGAAC 
GGAGCTCCCTCTTCA
GGAGT 
Lta NM_010735.2 GCTTGGCACCCCTCCTGTC 
GATGCCATGGGTCAA
GTGCT 
Ltb NM_008518.2 TGGCAGGAGCTACTTCCCT 
TCCAGTCTTTTCTGAG
CCTGT 
Light NM_019418.3 GTTTCTCCTGAGACTGCATCAA 
TGGCTCCTGTAAGAT
GTGCTG 
Ppap2b NM_080555.2 GGTGGCCTGCTGCATAGTGTT 
TCCTGTCGATGATCCA
CGGG 
Sgpl1 NM_009163.3 TATTGCACCAAATATGAGCC 
CTGTTGTTCGATCTTA
CGTC 
Spns2 NM_153060.3 CCATCCTGAGTTTAGGCAACG 
GATCACCTTTCTATTG
AAGCGGT 
Foxo1 NM_019739.3 TGTCAGGCTAAGAGTTAGTGAGCA 
GGGTGAAGGGCATCT
TTG 
Klf2 NM_008452.2 CTCAGCGAGCCTATCTTGCC 
CACGTTGTTTAGGTCC
TCATCC 
S1pr1 NM_007901.5 AAATGCCCCAACGGAGACT 
CTGATTTGCTGCGGC
TAAATTC 











CHAPTER THREE: CHARACTERISATION AND 




The thymic stromal microenvironment is a highly specialized, heterogeneous 
component of the thymus organ and is essential for the support and regulation at all 
stages of T-cell development. The thymic stromal compartment is made up of 
epithelial and non-epithelial cells, with much of what is known about thymic stroma 
focusing on the epithelial compartment due to the vital functions this subset of 
stromal cells carry out to generate a functional and self-tolerant T-cell pool. 
 
However the non-epithelial cell populations within the thymus have numerous 
important functions that make their research an inviting prospect. Studies have 
highlighted the key role of thymic endothelial cells in regulating the entry of T-cell 
progenitors through the expression of P-selectin and the adhesion molecules ICAM-1 
and VCAM-1 by endothelial cells and absence or blockade of these interactions with 
T-cell progenitors causes significant reductions in ETP within the thymus (20,22,24). 
In addition, it was shown that regulation of T cell progenitor entry by thymic 
endothelial cells was dependent on signaling through the lymphotoxin β receptor 
(LTβR) (22,24). Furthermore, thymic endothelial cells produce cytokines such as Kit-
ligand (KitL), with the membrane-bound form of KitL (mKitL) expressed by endothelial 
cells within the thymic cortex being required for the proliferation and differentiation of 
DN1 stage thymocytes (31,33). 
 
The other main non-epithelial stromal population identified within the thymus is the 
thymic mesenchyme. During embryogenesis, neural-crest (NC)-derived thymic 
mesenchyme is essential for the normal development of the thymus, with removal of 
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the thymic mesenchyme resulting in a hypoplastic thymus and an associated 
disruption of the normal programme of T-cell development 
(123,199,201,202,208,209). Embryonic thymic mesenchyme also produce a number 
of growth factors which are essential for the proliferation of the TEC compartment 
and furthermore thymic mesenchyme has also been implicated in the regulation of 
MHC Class II expression on TEC during embryogenesis (201,202,205–208). 
Together these highlight the functional significance of this cellular compartment 
during thymus development. 
 
Through the use of NC-derived mesenchyme specific Wnt-1cre and Sox10cre mouse 
models crossed with a Rosa26 fate-mapper, where fluorescent protein expression 
was driven by Wnt-1cre or Sox10cre expression within the NC-derived cells, NC-
derived thymic mesenchyme was identified within the adult thymus (213,250). Within 
the adult, thymic mesenchyme contributes to the structure of the thymus, including 
provision of a cellular contribution to the capsule of the thymus (214,250). In addition, 
mesenchymal cells also comprise thymic pericytes, which produce the enzymes 
SPHK1 and SPHK2. These kinases act to phosphorylate sphingosine to produce 
sphingosine-1-phosphate (S1P), with this pericyte-mediated production of S1P being 
essential to maintain the S1P gradient required for mature thymocyte egress (111).  
 
Still, despite what has currently been discovered, much remains unknown about the 
cellular and molecular developmental regulation, phenotypic heterogeneity and 
functional roles of thymic mesenchymal populations within the adult thymus, together 
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highlighting a need for further phenotypic and functional characterization of these 
cells.  
 
Lymph node (LN) stromal populations can be divided into a number of 
subpopulations based on their expression of specific phenotypic markers including 
podoplanin (PDPN) and the platelet endothelial cell adhesion molecule 1 (PECAM-1 
or CD31). These two markers can identify a PDPN+CD31- mesenchymal population 
termed fibroblastic reticular cells (FRCs), which have a number of key functions 
within the lymph nodes including the maintenance of T-cell homeostasis through the 
production of interleukin-7 (IL-7), production of migratory signals essential for entry 
into the lymph node as well as migration to and within the T-cell zone (220,222–226). 
Additionally the cellular and molecular developmental mechanisms of this LN 
mesenchymal population, such as signaling through TNFRSF members RANK and 
LTβR, as well as the requirement for stroma-lymphocyte interactions for their 
development, share similarities with the mechanisms in place for the development of 
thymic epithelial stromal cells (149,151,152,161,230–232). Thus studies of LN 
mesenchymal populations may provide a platform from which investigation of the 
thymic mesenchyme can be based on. 
 
The following section aims to identify the phenotypic and functional characteristics of 
the thymic mesenchyme population, as well as the cellular and molecular pathways 




3.2.1 Identifying And Characterizing Non-Epithelial Stromal Populations Within 
The Adult Murine Thymus 
To determine the stromal populations that exist within the non-hematopoietic, non-
epithelial compartment of the thymus, flow cytometric analysis was carried out on 
digested adult mouse thymi and mesenteric lymph nodes (mLN). During 
development the thymus is derived from the foregut and may potentially share some 
phenotypic similarities with mLN and therefore was chosen for comparison. Firstly a 
staining panel was assembled to identify the stromal populations of peripheral lymph 
nodes. TER119 and CD45 were included to exclude erythrocytes and hematopoietic 
cells, respectively. Additionally PDPN and CD31 were included to identify the three 
main LN stromal populations; fibroblastic reticular cells (PDPN+CD31-, FRC), 
lymphatic endothelial cells (PDPN+CD31+, LEC) and blood endothelial cells 
(PDPN+CD31-, BEC) and in our hands all three populations were identifiable (Fig 
1.A.) (220). In contrast to LN stroma, the thymic stromal compartment consists 
largely of epithelial cells and therefore in order to exclude epithelial cells from our 
thymic analysis, the epithelial cell adhesion molecule EpCAM-1 was included in the 
staining panel (Fig 3.1.B.). Interestingly the non-epithelial stromal population was 
predominantly made up of PDPN+CD31- mesenchymal cells loosely matching the 
FRC within the LN (Fig 3.1.B.). In addition, PDPN-CD31+ thymic endothelial cells 
were easily identifiable and consistent with previous reports there were no detectable 
population of lymphatic stromal cells (Fig 3.1.B.C) (111). From here on in, the term 













Figure 3.1. Identification Of PDPN+ Thymic Mesenchyme Within The Non-
Epithelial Thymic Stromal Compartment 
Adult B6 WT thymi were digested using a Collagenase Dispase and DNase enzyme 
mix and isolated stromal cells were stained for FACS analysis. 
 (A) Gating strategy to identify the different lymph node stromal populations based on 
PDPN and CD31 within lymph nodes; fibroblastic reticular cells (FRC, PDPN+CD31-), 
lymphatic endothelial cells (LEC, PDPN+CD31+) and blood endothelial cells (BEC, 
PDPN-CD31+). 
(B) Gating strategy of PDPN and CD31 on TER119-CD45-EpCAM-1- thymic non-
epithelial stroma to identify PDPN+CD31- mesenchyme and PDPN-CD31+ endothelial 
cells. 
(C) Table comparing the presence or absence of the three stromal populations within 
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stromal population and thymic endothelium will refer to the TER119-CD45-EpCAM-1-
CD31+PDPN- thymic stromal population. 
 
Knowing the cell position within the thymus is important when attempting to 
understand the role of a stromal population as it can provide context to the cells 
location relative to other cells in the thymus. Using CD31 and PDPN, as identified 
above, as well as ER-TR5 (a marker of medullary TEC (mTEC) (248)), β5t (a 
proteasome subunit expressed by cortical TEC (cTEC) (165)) and pancytokeratin 
(stains cTEC) we investigated the intrathymic positioning of PDPN+ thymic 
mesenchyme. Co-staining of CD31, PDPN, ER-TR5 and pancytokeratin revealed 
that broadly, PDPN is restricted to the medulla where it is expressed by some mTEC 
but also non-mTEC (Fig 3.2.A.) consistent with flow cytometric analysis (Fig 3.1.B.). 
PDPN+ cells appeared to surround/ensheath CD31+ endothelial cells both at the 
cortico-medullary junction and within the cortex in a perivascular manner (Fig 
3.2.A.B.). These perivascular PDPN+ cells were present in the medulla, near the 
cortico-medullary junction (CMJ) where endothelial cells are thought to be the site of 
thymocyte egress and within the deeper cortex (Fig 3.2.B.). Previous studies have 
identified a role for thymic mesenchyme contributing to the capsule and septea of the 
thymus structure and PDPN+ cells were identifiable in both structures (Fig 3.2.C.) 
(251). 
 
Expression of additional cell surface markers was performed by flow cytometry in 












Figure 3.2. Localization Of PDPN+ Thymic Mesenchyme 
Adult B6 WT thymi were frozen and 7µm think thymus sections were cut and stained 
for immunofluorescence confocal microscopy. 
(A) High resolution image of a thymic area stained for CD31 (white), PDPN (red), 
ERTR5 (blue) and pancytokeratin (green). Smaller images on the left show single 
color images for each marker and the larger image on the right is an image of the 
four combined colors. Scale bars represent 50µm. 
(B) High resolution image of a thymic area stained for CD31 (blue), PDPN (red) and 
pancytokeratin (green). Scale bars represent 50µm. 
(C) Low resolution tile scan image of a thymic area stained for ERTR5 (blue), PDPN 
(red) and b5t (green). Scale bars represent 200µm. 
 



















better understanding of their potential role within the thymus. Such markers were 
selected based on reported phenotypes of embryonic thymic mesenchyme (PDGFRα 
(202)), adult thymic pericytes (PDGFRβ (111,213)) and previously identified cortical 
thymic mesenchyme (Ly-51) (217). As well as CD24 (heat stable antigen, HSA), Sca-
1, CD34 and CD29 which are associated with mesenchymal stem cells and 
intercellular adhesion moledule-1 (ICAM-1) and vascular cell adhesion molecule 
(VCAM-1) which have been associated with peripheral lymphoid tissues. Thymic 
mesenchyme expressed PDGFRα, PDGFRβ, Ly-51, ICAM-1 and VCAM-1 at 
comparable levels to mLN FRC (Fig 3.3.A.B). Interestingly the expression profile of 
ICAM-1 and VCAM-1 on thymic mesenchyme mirrors that of lymph node FRC that 
has previously been reported which separates expression into distinct ICAM-
1loVCAM-1lo, ICAM-1intVCAM-1int and ICAM-1hiVCAM-1hi populations (Fig 3.3.C.). 
Thymic mesenchyme also expresses Sca-1, CD34 and CD29, markers associated 
with a adipocyte/pre-adipocyte phenotype whilst not expressing HSA (Fig 3.3.D.) 
(231). 
 
In addition to cell surface phenotype, PDPN+ thymic mesenchyme cells were sorted 
for qPCR for gene expression analysis to gather additional data on a potential role 
within the thymus (Fig 3.4.A.). Mesenteric LN FRCs were sorted and run alongside 
the sorted thymic mesenchyme and genes were selected based on their previously 
reported roles in thymocyte migration and homeostasis within lymph nodes (Fig 
3.4.B.C.). Consistent with previous reports, thymic mesenchyme expressed Fgf-10 
known for a role in supporting TEC during thymus organogenesis (Fig 3.4.C.). 
Thymic mesenchyme also expressed Enpp2, which encodes autotaxin (ATX), an 
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ectoenzyme that is required for the production of lysophosphatidic acid (LPA) which 
plays a role in lymphocyte trafficking into lymph nodes and regulation of lymphocyte 
migration (252,253) (Fig 3.4.C.). Cxcl13, Ccl19 and Il-7, which are genes involved in 
regulating lymphocyte migration and homeostasis were also expressed by thymic 
mesenchyme (Fig 3.4.C.). To gain a thymic context for the level of expression of 
these genes, sorted thymic mesenchyme was compared to sorted mTEC isolated 
from embryonic thymus cultured in fetal thymic organ culture (FTOC) conditions. 
Interestingly, whilst comparing thymic mesenchyme to mLN revealed a low level of 
expression of Ccl19 in thymic mesenchyme, in the context of the thymus thymic 
mesenchyme expresses higher levels than mTEC and thus thymic mesenchyme may 
express Ccl19 at a functionally significant level within the thymus (Fig 3.4.D.). 
Conversely, whilst compared to mLN, thymic mesenchyme appears to express Il-7, 
comparing to mTEC revealed that thymic mesenchyme express low levels of Il-7 
suggesting mTEC are the primary thymic source of IL-7 (Fig 3.4.D). The localization 
of mesenchyme and mTEC would suggest that IL-7 production by thymic 
mesenchyme is redundant (Fig 3.2.A.). Additionally the PCR reveals that thymic 
mesenchyme is a major source of CXCL13 and ATX within the thymus compared to 
mTEC (Fig 3.4.D.). 
 
As discussed above, thymic mesenchyme can be separated based on the expression 
of ICAM-1 and VCAM-1 in a similar manner to LN FRC (Fig 3.3.C.). In LN FRCs, the 
ICAM-1hiVCAM-1hi population is the functionally mature compartment of the FRCs 
and follow a developmental transition from ICAM-1loVCAM-1lo lymphoid tissue 










Figure 3.3. Phenotypic Characterization Of Thymic Mesenchyme 
Thymi and mesenteric lymph nodes (mLN) were harvested from WT B6 adult mice 
and digested for stromal analysis by FACS.  
(A) Expression profile of PDGFRα, PDGFRβ and Ly-51 on TER119-CD45-EpCAM-1-
PDPN+CD31- thymic mesenchyme (Thymic Mes, red) and TER119-CD45- 
PDPN+CD31- mLN fibroblastic reticular cells (mLN FRC, blue) compared with 
staining controls for each tissue.  
(B) Expression profile of ICAM-1 and VCAM-1 on TER119-CD45-EpCAM-1-
PDPN+CD31- thymic mesenchyme (Thymic Mes, red) and TER119-CD45- 
PDPN+CD31- mLN fibroblastic reticular cells (mLN FRC, blue), compared with 
staining controls for each tissue. 
(C) Expression pattern of ICAM-1 and VCAM-1 plotted together on TER119-CD45-
EpCAM-1-PDPN+CD31- thymic mesenchyme and TER119-CD45- PDPN+CD31- mLN 
fibroblastic reticular cells (mLN FRC), where ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int 
and ICAM-1hiVCAM-1hi populations are gated.  
(D) Expression profile of HSA, Sca-1, CD34 and CD29 on TER119-CD45-EpCAM-1-
PDPN+CD31- thymic mesenchyme (Thymic Mes, red) compared with staining 
controls and CD45+ hematopoietic cells (blue).  












































Figure 3.4. Genotypic Analysis And Comparison Of Functional Gene 
Expression On Thymic Mesenchyme, Epithelium and LN FRCs 
(A) Pre sort stained stromal cells and post sort purity check of sorted PDPN+CD31- 
thymic mesenchyme from adult B6 WT mice.  
(B) Pre sort stained stromal cells and post sort purity check of sorted PDPN+CD31- 
mesenteric lymph node fibroblastic reticular cells from adult B6 WT mice.  
(C & D) Quantitative real time PCR was performed on the following populations 
sorted from adult B6 WT mice for mLN FRC and thymic mesenchyme and FTOC for 
mTEC: 
CD45-PDPN+CD31- mLN PDPN+CD31- (blue) 
CD45-EpCAM-1-PDPN+CD31- Thymic PDPN+CD31- (red)  
  CD45-EpCAM-1+UEA-1+ Thymic mTEC (green) FTOC  
Error bars indicate the SEM and mRNA levels were normalized to housekeeping 
gene β-actin. Data is from at least two independently sorted biological samples; with 
each gene analyzed a minimum of two times and each PCR ran in triplicates to 
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this, we studied the temporal emergence and development of the ICAM-1hiVCAM-1hi 
PDPN+ thymic mesenchyme population. We chose developmental time points that 
included three main stages of development: embryogenesis (embryonic day 14-18, 
E14-E18), neonatal development (day 0, D0 and day 1, D1) and young adult (week 
1, W1 and week 2, W2).  Our analysis revealed that the ICAM-1hiVCAM-1hi PDPN+ 
mesenchyme began appearing postnatally around D0-D1 (Fig 3.5.A-B.). Full 
maturation occurred within the first two weeks of thymus development, where the 
percentage of ICAM-1hiVCAM-1hi increased to its maximum at W2 (Fig 3.5.C.). 
Additionally ICAM-1 MFI increased steadily up to W1 (Fig 3.5.D-E.).  
 
This ontogenic analysis suggests a potential precursor-product relationship between 
the ICAM-1loVCAM-1lo and ICAM-1hiVCAM-1hi and suggests that ICAM-1hiVCAM-1hi 
cells may be the mature population of thymic mesenchyme. To test whether ICAM-
1loVCAM-1lo and ICAM-1hiVCAM-1hi are functionally distinct populations, thymic 
mesenchyme was separated based on the expression of ICAM-1 and VCAM-1 and 
sorted into two populations, ICAM-1lo PDPN+ mesenchyme and ICAM-1hi PDPN+ 
mesenchyme (Fig 3.6.A.B.). Similarly to LN FRC, the ICAM-1hi fraction of thymic 
mesenchyme appeared to have the highest expression levels of Ccl19, Enpp2 and 
Sphk1 (a kinase involved in regulating thymocyte egress) suggesting that these 
ICAM-1hiVCAM-1hi mesenchyme cells are vital to the function of the thymic 
mesenchyme population (Fig 3.6.C.). Interestingly the ICAM-1lo fraction had the 
highest levels of expression of Cxcl13 suggesting an important function role of ICAM-









Figure 3.5. Temporal Emergence Of ICAM-1hiVCAM-1hi PDPN+ Thymic 
Mesenchyme During Thymic Development 
Thymic lobes were harvested from B6 WT mice from different stages of 
development: embryonic days 14-18 (E14-E18), neonatal days 0, 1 (D1 and D2) and 
week 1 and week 2 (W1 and W2). All thymic lobes were digested for FACS analysis 
of the stromal populations using an enzyme mix of Collagenase D and DNase. 
(A) Expression pattern of ICAM-1 and VCAM-1 on TER119-CD45-EpCAM-
PDPN+CD31- mesenchyme from embryonic thymi where ICAM-1hiVCAM-1hi 
population is gated.  
(B) Expression pattern of ICAM-1 and VCAM-1 on TER119-CD45-EpCAM-
PDPN+CD31- mesenchyme from neonatal thymi where ICAM-1hiVCAM-1hi population 
is gated.  
(C) Percentage and cell number of ICAM-1hiVCAM-1hi cells within the PDPN+CD31- 
mesenchyme compartment of embryonic and neonatal thymi.  
(D) MFI of ICAM-1 on PDPN+CD31- thymic mesenchyme. 
(E) Histogram showing the expression of ICAM-1 on PDPN+CD31- thymic 
mesenchyme from E14 (green), E18 (dark blue), D0 (red), D1 (purple) and W1 (light 
blue) mice, compared to a isotype staining control. 
 
For E18, D0, D1, W1 and W2 are typical of 2 independent repeats and E14, E15, 
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Figure 3.6. Genotypic Analysis ICAM-1lo And ICAM-1hi PDPN+ Thymic 
Mesenchyme  
(A) Pre sort stained stromal cells from adult B6 WT mice to identify ICAM-1 and 
VCAM-1 expressing cells within CD45-EpCAM-1-PDPN+ thymic mesenchyme.  
(B) Post sort purity checks of sorted ICAM-1lo and ICAM-1hi PDPN+ thymic 
mesenchyme from adult B6 WT mice.  
(C) Quantitative real time PCR was performed on the following populations sorted 
from B6 WT mice: 
CD45-EpCAM-1-PDPN+ICAM-1loVCAM-1lo ICAM-1loPDPN+ (blue) 
CD45-EpCAM-1-PDPN+ICAM-1hiVCAM-1hi ICAM-1hiPDPN+ (red) 
Error bars indicate the SEM and mRNA levels were normalized to housekeeping 
gene β-actin. Data is from at least two independently sorted biological samples; with 
each gene analyzed a minimum of two times and each PCR ran in triplicates to 
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Collectively these analyses identify a PDPN+ thymic mesenchyme population that 
shares key phenotypic similarities with peripheral lymph node FRCs. The data 
suggests a role for thymic mesenchyme in supporting thymocyte migration and 
egress through their expression of key chemotactic factors including Ccl19, Cxcl13, 
Enpp2 and Sphk1 as well as the cell position within the thymus in both the medulla 
and surrounding CD31+ blood vessels. In addition, this analysis provides evidence of 
an ICAM-1hiVCAM-1hi fraction of thymic mesenchyme that express key factors linked 
to a potential role of thymic mesenchyme in thymocyte migration and/or egress. 
3.2.2 Thymocyte-Mesenchyme Interactions Are Essential For The Development 
Of ICAM-1hiVCAM-1hi Thymic Mesenchyme 
After identifying the potential functional importance of the ICAM-1hiVCAM-1hi PDPN+ 
mesenchyme as well as the developmental kinetics of how the population arises, we 
investigated how their development is regulated. We found it interesting that the 
emergence of the ICAM-1hiVCAM-1hi population coincided with the timing of 
thymocyte development and subsequent egress of αβ+ T-cells, which occurs 
postnatally. This could suggest cross-talk between mature thymocytes and the 
developing thymic mesenchyme to trigger their development. To test whether 
interactions between thymocytes and thymic mesenchyme are required for the 
development of the ICAM-1hiVCAM-1hi PDPN+ thymic mesenchyme, WT FTOCs 
were cultured either in the absence or presence of 2’-deoxyguanosine (2-dGuo), a 
compound that is toxic to hematopoietic cells. We found that treatment of FTOC with 
2-dGuo led to an almost complete loss of the ICAM-1hiVCAM-1hi expressing PDPN+ 









Figure 3.7. Thymocyte:Mesenchyme Interactions Are Essential For ICAM-
1hiVCAM-1hi PDPN+ Mesenchyme Development 
E15 WT lobes were cultured in fetal thymic organ culture (FTOC) conditions in the 
presence or absence of 2-deoxyguanosine (2-dGuo) for 5-7 days and then harvested 
and digested for FACS analysis of the stromal populations.  
(A) Expression pattern of PDPN and CD31 on TER119-Viability-CD45-EpCAM-1- non-
epithelial stroma where PDPN+CD31- mesenchyme and PDPN-CD31+ endothelial 
cells are gated. 
(B) Expression pattern of ICAM-1 and VCAM-1 on PDPN+CD31- mesenchyme where 
ICAM-1hiVCAM-1hi population is gated.  
(C) The percentage of ICAM-1hiVCAM-1hi cells was within the PDPN+CD31- 
mesenchyme compartment of FTOC (blue circle) and FTOC + 2-dGuo (red square) 
was calculated. 
(D) Histogram showing the expression of ICAM-1 and VCAM-1 on PDPN+ thymic 
mesenchyme and the plotted MFI of each adhesion molecule represented as a ratio 
of the MFI of FTOC + 2-dGuo:FTOC.  
 
The standard error bars display the SEM and a mann-whitney test was performed in 
(C) and an unpaired parametric T-tests was performed in (D), where ** denotes a 
significant difference as p<0.01 and *** as p<0.001. All data is typical of 3 
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3.7.B.C.) and reduced ICAM-1 and VCAM-1 MFI represented as a ratio of 2-dGuo 
MFI:FTOC MFI (Fig 3.7.D.).  
 
Previous studies have shown there is an essential requirement for αβ+ thymocyte 
crosstalk in the development of thymic epithelial stroma, to investigate whether this 
was also the case for thymic mesenchyme we investigated Tcra-/- mice which lack 
αβ+ thymocytes (140,254). These mice showed no alterations in total thymic 
cellularity (Fig 3.8.B.) but they do show a significant reduction in the percentage and 
cell number of ICAM-1hiVCAM-1hi PDPN+ mesenchyme (Fig 3.8.A.C.). This data 
reveals that αβ+ T-cells are essential for the development of ICAM-1hiVCAM-1hi 
PDPN+ thymic mesenchyme and removing hematopoietic cells in vitro results in a 
loss of this population. 
 
The αβ T-cell compartment is a heterogeneous mix of conventional and non-
conventional T-cell subsets, many of the cells within this compartment have 
previously been shown to influence thymic epithelial cells such as SP4 thymocytes, 
Treg and iNKT cells (145,146). To determine which of these subsets are essential for 
mesenchyme development we used mouse models where the genes MHC class ii, 
Cd1d or Foxp3 are knocked out, resulting in a loss of CD4+ thymocytes, CD1d+ 
invariant natural killer T (iNKT) cells or regulatory T-cells (Tregs), respectively. When 
CD4+ thymocytes were absent in MHC class ii-/- there was no difference in total 
thymic cellularity or the PDPN+ thymic mesenchyme compartment (Fig 3.8.D-F). 
Fitting with their role in regulating mTEC, there was a reduction in the number and 
the proportion of ICAM-1hiVCAM-1hi, suggesting a role for SP4 thymocytes in ICAM-
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1hiVCAM-1hi thymic mesenchyme development (Fig 3.8.F.) (145). When iNKT cells 
were absent in the Cd1d-/- model there was no evidence of altered PDPN+ thymic 
mesenchyme development (Fig 3.9.A-C) however when Tregs were absent there 
was a small significant reduction in the proportion of ICAM-1hiVCAM-1hi PDPN+ 
mesenchyme (Fig 3.9.D-E). Together these data support that αβ+ T-cells are 
essential for the development of ICAM-1hiVCAM-1hi PDPN+ mesenchyme, but the 
loss of one specific population is not enough to recapitulate a reduction in ICAM-
1hiVCAM-1hi PDPN+ thymic mesenchyme with the same severity as seen in the Tcra-/- 
mouse, suggesting there is redundancy among the different αβ T-cell subsets to 
ensure the development of this population. 
 
The knockout models above test if any one-thymocyte population is essential for the 
development of ICAM-1hiVCAM-1hi PDPN+ mesenchyme, but it does not indicate 
whether any of the populations alone are sufficient for this process. One approach 
that enables this analysis is the use of reaggregate thymic organ cultures (RTOCs) to 
add each of the three thymocyte populations (SP4, iNKT and Tregs) separately to an 
in vitro organ culture. SP4, iNKT and Tregs were sorted and added at a 3:1 ratio with 
digested 2-dGuo treated FTOC to create RTOCs with different conditions; empty, 
with total thymocytes added or with SP4, iNKT cells or Tregs added (Fig 3.10.A.). As 
expected from our previous analysis of 2-dGuo treated FTOC (Fig 7), when no cells 
were added there were no ICAM-1hi VCAM-1hi cells present highlighting the essential 
role for continued interactions with thymocyte populations (Fig 3.10.B.C.). 
Furthermore the addition of total thymocytes restored the ICAM-1hi VCAM-1hi 
population indicating that the thymic mesenchyme remains responsive to thymocytes 
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within the RTOC system (Fig 3.10.B.C.). Consistent with the potential redundancy 
between the T-cell populations highlighted by the knockout mice, just adding one of 
the sorted thymocyte populations to a RTOC was sufficient to support ICAM-1hi 
VCAM-1hi development (Fig 3.10.B.C.). Whilst all three populations were sufficient to 
drive some degree of ICAM-1hi VCAM-1hi development, it did appear that SP4 
thymocytes were much better in their ability to induce ICAM-1hi VCAM-1hi 










Figure 3.8. αβ+ T-cells Are Essential For ICAM-1hiVCAM-1hi PDPN+ Thymic 
Mesenchyme Development 
(A) Expression pattern of ICAM-1 and VCAM-1 on TER119-CD45-EpCAM-1-
PDPN+CD31- mesenchymal stroma isolated from control (Tcra+/+, left) and TCRα-
deficient (Tcra-/-, right) mice where ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int and 
ICAM-1hiVCAM-1hi populations are gated. 
(B) The cell number of total thymus was calculated from Tcra+/+, (blue, n=10) and 
Tcra-/-, (red n=10) mice.  
(C) The cell number and percentages of ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int and 
ICAM-1hiVCAM-1hi PDPN+CD31- mesenchyme were calculated from Tcra+/+, (blue, 
n=10) and Tcra-/-, (red n=10) mice.  
(D) Expression pattern of ICAM-1 and VCAM-1 on TER119-CD45-EpCAM-1-
PDPN+CD31- mesenchymal stroma isolated from control (Class ii+/+, left) and MHC 
Class II-deficient (Class ii-/-, right) mice where ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int 
and ICAM-1hiVCAM-1hi populations are gated. 
(E) The cell number of total thymus was calculated from Class ii +/+, (blue, n=5) and 
Class ii -/-, (red n=5) mice.  
(F) The cell number and percentages of ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int and 
ICAM-1hiVCAM-1hi PDPN+CD31- mesenchyme were calculated from Class ii +/+, 
(blue, n=5) and Class ii -/-, (red n=5) mice.  
 
The standard error bars display SEM and a mann-whitney test was performed on 
statistics, where ** denotes p<0.01, *** denotes p<0.001 and **** denotes p<0.0001. 







































































































































































































































Figure 3.9. Deficiency In Foxp3+ Treg, But Not iNKT Cells, Impacts ICAM-
1hiVCAM-1hi PDPN+ Thymic Mesenchyme 
(A) Expression pattern of ICAM-1 and VCAM-1 on TER119-CD45-EpCAM-1-
PDPN+CD31- mesenchymal stroma isolated from control (Cd1d+/+, left) and iNKT-
deficient (Cd1d-/-, right) mice where ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int and 
ICAM-1hiVCAM-1hi populations are gated. 
(B) The cell number of total thymus, were calculated from Cd1d+/+, (blue, n=8) and 
Cd1d-/-, (red n=7) mice.  
(C) The cell number and percentages of ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int and 
ICAM-1hiVCAM-1hi PDPN+ mesenchyme were calculated from Cd1d+/+, (blue, n=8) 
and Cd1d-/-, (red n=7) mice.  
(D) Expression pattern of ICAM-1 and VCAM-1 on TER119-CD45-EpCAM-1-
PDPN+CD31- mesenchymal stroma isolated from control (Foxp3+/+, left) and Foxp3+ 
Treg-deficient (Foxp3-/-, right) mice where ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int 
and ICAM-1hiVCAM-1hi populations are gated. 
(E) The percentages of ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int and ICAM-1hiVCAM-
1hi PDPN+ mesenchyme were calculated from Foxp3+/+, (blue, n=9) and Foxp3-/-, (red 
n=15) mice.  
The standard error bars display SEM and a mann-whitney test was performed, where 
* denotes a statistical difference as p<0.05. Data is typical of two independent 



























































































































































































Figure 3.10. Redundancy Among Thymocyte Populations Ensures The 
Development Of ICAM-1hiVCAM-1hi PDPN+ Thymic Mesenchyme 
(A) Reaggregate thymic organ cultures (RTOCs) were created by mixing SP4, Treg 
and iNKT cells, isolated from adult B6 WT mice by highspeed cell sorting, at a 3:1 
ratio with a cell suspension of E15 2-dGuo treated FTOC that had been digested and 
CD45+ cell depleted. The RTOCs were cultured for 7 days and harvested for FACS 
analysis 
(B) Expression pattern of ICAM-1 and VCAM-1 on TER119-CD45-EpCAM-1-
PDPN+CD31- mesenchymal stroma isolated from RTOCs made with the following 
conditions: 
dGuo Empty 
dGuo + unsorted thymocytes + Thymocytes (red) 
dGuo + CD4+CD8-TCRβ+Tetramer-Foxp3- +SP4 (blue)  
dGuo + CD4+CD8-TCRβ+Tetramer-Foxp3+ +Treg (green) 
dGuo + CD4+CD8-TCRβ+Tetramer+ +iNKT (purple)  
(C) Percentages of ICAM-1hiVCAM-1hi PDPN+ mesenchyme for each of the RTOC 
conditions.  
 
The standard error bars display SEM and an one-way ANOVA was performed, where 
* denotes a statistical difference as p<0.05, ** denotes p<0.01 and *** denotes 
p<0.001. All data is typical of two independent repeats.  
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3.2.3 Thymocyte Mediated Conditioning Of ICAM-1hiVCAM-1hi Thymic 
Mesenchyme Occurs Through Signaling Via The Lymphotoxin Beta Receptor 
Pathway 
After identifying thymocytes as a cellular regulator of ICAM-1hiVCAM-1hi 
mesenchyme conditioning we explored the molecular pathways that may be involved 
in this process. Members of the tumor necrosis factor receptor superfamily (TNFRSF) 
have been shown to play a key role in stromal development in both secondary 
lymphoid tissues as well as the thymus, two of which that are well defined and have 
been shown to be essential for stromal development are RANK (Tnfrsf11a) and 
lymphotoxin beta receptor (LTβR, Tnfrsf3) (149,151,152,161,230–232). To 
investigate whether these two molecular pathways were involved in the conditioning 
of ICAM-1hiVCAM-1hi mesenchyme, PCR analysis was carried out on sorted mTEC 
and PDPN+CD31- mesenchyme for gene expression of Rank and Ltbr. This analysis 
revealed that mesenchyme had a high level of gene expression of Ltbr but Rank was 
only detectable at very small levels suggesting that RANK signaling may not be 
involved in mesenchyme conditioning (Fig 3.11.A.). To confirm this, thymi were 
harvested from mice deficient for RANK (Rank-/-) and cultured in FTOC conditions for 
7-days before being digested for FACs analysis. This approach was taken because 
RANK is essential for bone development and Rank-/- mice have stunted growth of 
limbs and teeth resulting in a runted appearance and struggle to thrive and thus are 
culled before reaching adulthood (238). The total mesenchyme population was 
normal in Rank-/- thymi and the proportion and absolute number of ICAM-1hiVCAM-1hi 
mesenchyme was also normal (Fig 3.11.B.C.). Thus this data along with the PCR 
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analysis support that RANK signaling is not essential for the development of ICAM-
1hiVCAM-1hi mesenchyme. 
 
The PCR analysis also revealed that PDPN+CD31- thymic mesenchyme express high 
levels of Ltbr; to investigate whether LTβR is essential for the development of ICAM-
1hiVCAM-1hi mesenchyme the same analysis was carried out on LTβR-deficient mice 
(Ltbr-/-). Consistent with its role in secondary lymphoid tissue development there was 
a significant reduction in the total number of PDPN+ thymic mesenchyme (Fig 
3.12.A.). This was associated with a massive loss of the number of ICAM-1hiVCAM-
1hi cells but there was also a reduction of the ICAM-1intVCAM-1int populations, 
however percentages show that it is predominantly the ICAM-1hiVCAM-1hi being 
affected (Fig 3.12.C.D.). 
 
Together the above data reveal an essential role for LTβR, but not RANK, signaling 
in the development of ICAM-1hiVCAM-1hi thymic mesenchyme and suggests that 
thymocyte-mesenchyme cross-talk could be occurring through this pathway. To 
investigate this further, SP4, SP8, iNKT and Tregs were sorted and PCR was carried 
out to determine the expression of the three known ligands of LTβR, LTα, LTβ and 
LIGHT (Fig 3.13.A.B). Consistent with previous reports all three ligands were present 
on all sorted thymocyte populations (Fig 3.13. C). Surprisingly Lta and Light were 
expressed at their highest on Treg and iNKT cells, respectively, however the analysis 











Figure 3.11. RANK Signaling Is Not Essential For ICAM-1hiVCAM-1hi PDPN+ 
Mesenchyme Development 
(A) Quantitative real time PCR was performed on the following populations sorted 
from B6 WT mice: 
TER119-CD45-EpCAM-1-PDPN+ thymic mesenchyme (red) 
CD45-EpCAM-1-UEA-1+ mTEC (blue)  
Error bars indicate the SEM and mRNA levels were normalized to housekeeping 
gene β-actin. Data is from at least two independently sorted biological samples; with 
each gene analyzed a minimum of two times and each PCR ran in triplicates to 
obtain a SEM.  
(B) Embryonic thymic lobes were harvested from E15 control (Rank+/+, left) and 
RANK-deficient (Rank-/-, right) mice and cultured in fetal thymic organ culture 
conditions for 7 days prior to harvesting for FACS analysis. Thymic mesenchyme 
was identified as TER119-Viability-CD45-EpCAM-1-PDPN+CD31- and the expression 
pattern of ICAM-1 and VCAM-1 was investigated, where ICAM-1hiVCAM-1hi 
population is gated. 
(C) The percentages and cell number of total thymus, PDPN+CD31- mesenchyme 
and ICAM-1hiVCAM-1hi PDPN+ mesenchyme were calculated from Rank+/+ (blue, 
n=7) and Rank-/- (red n=9) mice. The standard error bars display SEM and a mann-


















































































































Figure 3.12. LTβR Signaling Is Essential For ICAM-1hiVCAM-1hi PDPN+ 
Mesenchyme Development 
(A) Expression pattern of PDPN and CD31 on non-epithelial stroma, identified as 
TER119-Viability-CD45-EpCAM-1-, isolated from control (Ltbr+/+, left) and LTβR-
deficient (Ltbr-/-, right) mice where PDPN+CD31- thymic mesenchyme cells are gated. 
(B) Expression pattern of ICAM-1 and VCAM-1 on PDPN+CD31- mesenchymal 
stroma isolated from control (Ltbr+/+, left) and LTβR-deficient (Ltbr-/-, right) mice 
where ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int and ICAM-1hiVCAM-1hi populations 
are gated. 
(C) The cell number of total thymus, PDPN+CD31- mesenchyme and ICAM-1loVCAM-
1lo, ICAM-1intVCAM-1int and ICAM-1hiVCAM-1hi PDPN+ mesenchyme were calculated 
from Ltbr+/+, (blue, n=6) and Ltbr-/-, (red, n=6) mice.  
(D) The percentages of ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int and ICAM-1hiVCAM-
1hi PDPN+ mesenchyme were calculated from Ltbr+/+, (blue, n=6) and Ltbr-/-, (red, 
n=6) mice.  
 
The standard error bars display SEM and a mann-whitney test was performed, where 
























































































































































Figure 3.13. Genotypic Analysis Of Lymphotoxin Beta Receptor Ligand 
Expression On Sorted Thymocyte Populations 
(A) Pre sort purity check of stained thymocytes from adult B6 WT mice.  
(B) Post sort purity check of thymocytes populations sorted from adult B6 WT mice.  
(C) Quantitative real time PCR was performed on the following populations sorted 
from B6 WT mice: 
CD4+CD8-TCRβ+mCD1d PBS-57 Tetramer-Foxp3- cSP4 thymocytes (red) 
 CD4-CD8+TCRβ+ SP8 thymocytes (blue) 
CD4+CD8-TCRβ+mCD1d PBS-57 Tetramer-Foxp3+ Foxp3+ Treg (green) 
CD4+CD8-TCRβ+mCD1d PBS-57 Tetramer+ iNKT cells (orange) 
 
Error bars indicate the SEM and mRNA levels were normalized to housekeeping 
gene β-actin. Data is from at least two independently sorted biological samples; with 
each gene analyzed a minimum of two times and each PCR ran in triplicates to 








































































































To further investigate the role of LTβR ligands in ICAM-1hiVCAM-1hi development 
thymi were harvested from LTα-deficient mice (Lta-/-). Deletion of Lta prevents the 
formation of the heterodimer and homotrimer forms of the LTβR ligands LTα1β2 and 
LTα3. Unlike Ltbr-/ mice, there was no alteration to the total PDPN+ mesenchyme 
population in Lta-/- mice, which would be consistent with the overall less severe 
phenotype of Lta-/- mice, compared to Ltbr-/- mice (Fig 3.14.A.D.) (237). Within the 
PDPN+ mesenchyme compartment there was a significant, but not complete, 
reduction in percentage and cell number of the ICAM-1hiVCAM-1hi population (Fig 
3.14.B-D.). Additionally there was a significant increase in the number and 
percentage of the ICAM-1loVCAM-1lo population as well as the percentage of the 
ICAM-1intVCAM-1int suggesting the PDPN+ mesenchyme is halted at the earlier 
development stages (Fig 3.14.B-D.). This data reveals that preventing signaling 
between LTβR on stroma and LTα3/LTα1β2 on thymocytes inhibits the complete 
development of ICAM-1hiVCAM-1hi PDPN+ mesenchyme, however signaling via 
LTβR-LIGHT may compensate for LTα3 and LTα1β2 for the development of the 
PDPN+ population as a whole. 
 
In the previous analysis we have shown that thymocyte:mesenchyme interactions are 
essential for the development of ICAM-1hiVCAM-1hi PDPN+ mesenchyme and using 
the RTOC system we have shown that single thymocyte populations that express 
LTβR ligands are sufficient for this development. To further understand the role of 
LTβR in this process we investigated whether stimulation of LTβR in the absence of 
thymocytes is sufficient to drive the development of ICAM-1hiVCAM-1hi PDPN+ 









Figure 3.14. LTα Expression On Thymocytes Is Essential For ICAM-1hiVCAM-1hi 
PDPN+ Mesenchyme Development 
(A) Expression pattern of PDPN and CD31 on non-epithelial stroma, identified as 
TER119- CD45-EpCAM-1-, isolated from control (Lta+/+, left) and LTα-deficient (Lta-/-, 
right) mice where PDPN+CD31- thymic mesenchyme cells are gated. 
(B) Expression pattern of ICAM-1 and VCAM-1 on PDPN+CD31- mesenchymal 
stroma isolated from control (Lta+/+, left) and LTα -deficient (Lta-/-, right) mice where 
ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int and ICAM-1hiVCAM-1hi populations are 
gated. 
(C) The cell number of total thymus, PDPN+CD31- mesenchyme and ICAM-1loVCAM-
1lo, ICAM-1intVCAM-1int and ICAM-1hiVCAM-1hi PDPN+ mesenchyme were calculated 
from Lta+/+, (blue, n=6) and Lta-/-, (red n=6) mice.  
(D) The percentages of ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int and ICAM-1hiVCAM-
1hi PDPN+ mesenchyme were calculated from Lta+/+, (blue, n=6) and Lta-/-, (red n=6) 
mice.  
 
The standard error bars display SEM and a mann-whitney test was performed, where 

































































































































































agonistic anti-LTβR antibody. This stimulation caused a complete restoration of the 
ICAM-1hiVCAM-1hi population, both absolute numbers and proportions, within the 2-
dGuo culture treated with the anti-LTβR antibody (Fig 3.15.A.B.). Interestingly the 
total number of PDPN+ thymic mesenchyme was increased in the stimulated cultures 
further highlighting a key role for LTβR in the development of the PDPN+ 
mesenchyme as a whole (Fig 3.15.B.). As an in vivo test of this hypothesis, Tcra-/- 
mice were stimulated with the same agonistic anti-LTβR antibody injected 
intraperitoneally for 3 consecutive days. Due to reagent and mouse availability this 
experiment could only be performed once, however the preliminary results suggest a 
restoration of the ICAM-1hiVCAM-1hi PDPN+ mesenchyme in the stimulated Tcra-/- 
mouse compared to un-stimulated Tcra-/- shown by the percentage of ICAM-
1hiVCAM-1hi and MFI increase of ICAM-1 and VCAM-1 (Fig 3.15.C-E.).  This data 
suggests that not only is LTβR signaling necessary for the development of ICAM-
1hiVCAM-1hi thymic mesenchyme but is also sufficient to support their development. 
 
Following on from these experiments we investigated whether continuous LTβR 
signaling was required to maintain the ICAM-1hiVCAM-1hi thymic mesenchyme. To 
do this, a similar in vivo stimulation was carried out in the context of thymic recovery 
in WT mice that had received congenically marked WT bone marrow following lethal 
total body irradiation (TBI). This experiment was carried out to introduce a period of 
time where thymocytes were absent within the thymus, which would occur in the 
initial stages of thymic recovery following TBI and bone marrow reconstitution. Within 
this experiment mice received two doses of 500 rad irradiation and were 





Figure 3.15. Stimulation Of LTβR Is Sufficient For ICAM-1hiVCAM-1hi Thymic 
Mesenchyme Development 
(A) 2-dGuo-treated FTOC were cultured in the presence or absence of an agonistic 
anti-LTβR antibody for 7 days and then harvested for FACS analysis. FACS plots 
show the expression pattern of ICAM-1 and VCAM-1 on TER119-Viability-CD45-
EpCAM-1-PDPN+CD31- thymic mesenchyme where the ICAM-1hiVCAM-1hi 
population is gated. 
(B) The cell number of total thymus, PDPN+CD31- mesenchyme and ICAM-1hiVCAM-
1hi PDPN+ mesenchyme were calculated, as well as the percentage of ICAM-
1hiVCAM-1hi, for + PBS (blue n=7) or + anti LTβR (red n=6).  
(C) Adult Tcra-/- were injected IP with isotype (left) or 100µg of agonistic anti-LTβR 
antibody (right) everyday for three days and then harvested for FACS analysis on the 
fourth day. FACS plots show the expression pattern of PDPN and CD31 on TER119-
Viability-CD45-EpCAM- cells for each condition. 
(D) Expression pattern of ICAM-1 and VCAM-1 on PDPN+CD31- thymic 
mesenchyme for Tcra-/- with isotype (left) and Tcra-/- with anti LTβR (right). 
(E) Cell number of total thymus was calculated for Tcra-/- with isotype (blue n=3) and 
Tcra-/- with anti LTβR (red n=3). 
(F) The percentages of ICAM-1hiVCAM-1hi PDPN+ mesenchyme was calculated for 
Tcra-/- with isotype (blue n=3) and Tcra-/- with anti LTβR (red n=3). 
G) The MFI of ICAM-1 and VCAM-1 on PDPN+CD31- mesenchyme Tcra-/- with 
isotype (blue n=3) and Tcra-/- with anti LTβR (red n=3).   
 
The standard error bars display SEM and a mann-whitney test was performed in A&B 
and an unpaired parametric T-test in C-G. * denotes a statistical difference as p<0.05 
and ** p<0.01. Data is typical of two independent repeats for A&B and only one 




























































































































































































Figure 3.16. In vivo Stimulation Of LTβR During Bone Marrow Chimera Boosts 
ICAM-1 and VCAM-1 Expression 
(A) Bone marrow chimeras were generated by giving adult, CD45.2+, B6 WT mice 
two 500 rad doses of irradiation and reconstituting these mice with CD45.1+ BoyJ WT 
bone marrow. These mice were subsequently IP injected with 100µg of isotype or 
agonistic anti-LTβR on days 1, 3, 5, 7 and 9 post-bone marrow transfer and 
harvested on D10 post- transfer for FACS analysis.  
(B) Expression pattern of ICAM-1 and VCAM-1 on TER119-Viability-CD45-EpCAM-1-
PDPN+CD31- thymic mesenchyme of isotype (left) and with anti-LTβR (right) treated 
mice. 
(C) Cell number of total thymus and PDPN+ thymic mesenchyme was calculated for 
isotype (blue n=7) and anti-LTβR treated (red n=5) mice. 
(D) Cell number and percentages of ICAM-1loVCAM-1lo, ICAM-1intVCAM-1int and 
ICAM-1hiVCAM-1hi PDPN+ mesenchyme was calculated for isotype (blue n=7) and 
anti-LTβR treated (red n=5). 
E) The MFI of ICAM-1 and VCAM-1 on PDPN+CD31- mesenchyme of isotype (blue 
n=7) and anti-LTβR treated (red n=5) mice.   
 
The standard error bars display SEM and a mann-whitney test was performed, where 
* denotes a statistical significance as p<0.05 and ** as p<0.01. All data is typical of 2 
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anti-LTβR antibody every-other day for 10 days (Fig 3.16.A.). Interestingly the mice 
that received isotype has a much lower population of ICAM-1hiVCAM-1hi thymic 
mesenchyme compared to the anti-LTβR stimulated mice and had much lower 
expression of ICAM-1 and VCAM-1 (Fig 16.B-E.). Surprisingly the total population of 
PDPN+ thymic mesenchyme was reduced in the mice receiving the anti-LTβR 
antibody as well as the percentage and cell number of ICAM-1loVCAM-1lo and ICAM-
1intVCAM-1int thymic mesenchyme (Fig 3.16.D.). 
 
Together these experiments reveal that stimulation of LTβR in the absence of 
thymocytes is sufficient for the development of ICAM-1hiVCAM-1hi PDPN+ thymic 
mesenchyme. Additionally, not only does anti-LTβR stimulation support ICAM-
1hiVCAM-1hi development when thymocytes are missing but it can also boost ICAM-
1hiVCAM-1hi development during thymic recovery following TBI and bone marrow 
grafting. 
3.3 DISCUSSION 
This chapter aimed to further identify and characterize the non-epithelial stroma 
populations within the thymus as well as understand pathways involved in their 
development.  
 
We were able to identify TER119-CD45-EpCAM-1- stromal cells that could be 
separated into PDPN+CD31- mesenchyme and PDPN-CD31+ endothelium similarly to 
fibroblastic reticular cells (FRCs) and blood endothelial cells (BECs) of peripheral 
lymphoid tissues (220). This approach of identifying thymic endothelium and 
mesenchyme using gp38 and CD31 together for FACS analysis has previously been 
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used in a study to identify lymphatic endothelial cells (LECs) in the thymus (111). 
This study identified PDPN+CD31- mesenchyme and PDPN-CD31+ endothelium 
within the thymus but did not further characterize either population. The presence of 
lymphatic endothelium within the thymus has previously been controversial, the 
findings of Zacharia et. al revealed inconclusive evidence of lymphatic endothelium 
within the thymus using a LYVE-1crexRosa26eYFP fate-mapper mouse model, where 
LYVE-1 is expressed by lymphatic endothelial cells (111). Our analysis revealed no 
detectable PDPN+CD31+ lymphatic endothelial population within the adult thymus 
supporting against a lymphatic endothelial population within the thymus. Additional 
studies have identified thymic mesenchyme using alternative markers to gp38 and 
CD31 used in our study. Recently a study was published investigating thymic 
mesenchymal cells and comparing their transcriptional and cell surface protein 
expression to bone and skin mesenchymal cells (255). The comparative analysis 
carried out by Patenaude et. al provided some insights into a population of thymic 
mesenchyme defined as lineage cocktail-Sca-1+ cells (255). The analysis of the Lin-
Sca-1+ thymic mesenchyme population revealed that 98% ± 2% expressed PDPN, 
which would suggest this is the same population of thymic mesenchyme identified in 
our study. Our cell surface phenotypic analysis was consistent with the findings of 
Patenaude et. al, revealing PDPN+ thymic mesenchyme expresses the platelet-
derived growth factor receptors (PDGFR) α and β. During fetal stages, PDGFRα+ 
mesenchyme have been shown to play a key role in supporting TEC proliferation by 
the production of fibroblast growth factor 10 (FGF10), our data provide evidence that 
this population of PDGFRα+ cells are persisting into the adult thymus (202). This is 
also consistent with our PCR analysis, which revealed Fgf10 expression is 
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maintained in PDPN+ thymic mesenchyme. The persistence of this population could 
suggest that PDPN+ thymic mesenchyme is supporting not only the initial 
development of TEC, but also the maintenance of the TEC compartment. If this 
hypothesis is correct this could highlight a key role for thymic mesenchyme in 
regulating TEC within the adult thymus in the steady state and may even implicate a 
role for mesenchyme-dependent maintenance of TEC in the context of acute or age-
associated atrophy and could therefore represent a target in the attempts to reverse 
these. PDGFRβ is a marker often used to identify thymic pericytes, which are 
mesenchymal cells that are situated around blood vessels (perivascular) and support 
the blood vessel structure as well as regulating the exit of egress-competent mature 
thymocytes through the production of the enzymes SPHK1 and SPHK2 (111,216). 
The expression of PDGFRβ by PDPN+ thymic mesenchyme is consistent with the 
perivascular positioning of PDPN+ thymic mesenchyme surrounding CD31+ 
endothelial cells shown by confocal microscopy. However further analysis of pericyte-
associated markers such as NG2 and desmin would be required to definitively 
identify this population as pericytes (213). Our analysis also identified Ly-51 
expression on the thymic mesenchyme. Ly-51 expression has previously been used 
as a marker to identify what were previously termed cortical mesenchyme based on 
Ly-51 being a cTEC associated marker and the Ly-51-expressing thymic 
mesenchyme located within the cortex, before they were later reclassified as thymic 
NC-derived mesenchyme (NC-Mes) (217,250). These NC-derived mesenchymal 
cells represent pericytes surrounding the endothelial layer of the vasculature and 
also express PDGFRβ, phenocopying the PDPN+ thymic mesenchyme identified in 
our study. Interestingly, the NC-Mes identified in the 2008 study by Muller et. al 
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reportedly did not express PDGFRα, suggesting that PDPN+ thymic mesenchyme 
may incorporate separate PDGFRα and PDGFRβ expressing cells (250). This 
hypothesis is supported by our confocal analysis which revealed that PDPN+ thymic 
mesenchyme cells were located around CD31+ endothelial cells, but also at the 
capsule of the thymus and within the medulla, where the expression of PDPN was 
present on both TR5+ mTEC but importantly non-epithelial mesenchymal cells.  
 
Our analysis revealed that PDPN+ thymic mesenchyme express the adhesion 
molecules ICAM-1 and VCAM-1. This is consistent with a previous study that 
identified heterogeneous levels of ICAM-1 and VCAM-1 expression on CD31-
PDGFRβ+ thymic mesenchyme (211). The expression pattern of ICAM-1 and VCAM-
1 on thymic mesenchyme is similar to that of LN FRC. During LN FRC development 
different populations of ICAM-1/VCAM-1 expressing cells can be identified based on 
their developmental progression from ICAM-1loVCAM-1lo to ICAM-1intVCAM-1int and 
then mature ICAM-1hiVCAM-1hi (232). Through analysis of the expression of ICAM 
and VCAM on PDPN+ mesenchyme during different developmental stages we found 
that ICAM-1hiVCAM-1hi cells were not present until after birth. This data suggests a 
development transition from ICAM-1loVCAM-1lo to ICAM-1hiVCAM-1hi however it does 
not directly demonstrate this. An experiment to definitively prove this hypothesis 
would be to sort fluorescently labeled ICAM-1loVCAM-1lo thymic mesenchyme and 
introduce them into an RTOC and then look for the presence of ICAM-1hiVCAM-1hi 
thymic mesenchyme. This would provide evidence for direct precursor-product 
relationship between the two populations and reveal whether the ICAM-1loVCAM-1lo 
thymic mesenchyme are an immature population that give rise to ICAM-1hiVCAM-1hi 
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mesenchymal cells. Preliminary experiments of this design were carried out to 
address this hypothesis however technical limitations precluded accurate analysis.  
 
Our analysis of 2-dGuo-treated FTOC, as well as Tcra-/- mouse models, revealed that 
the development of ICAM-1hiVCAM-1hi thymic mesenchyme was dependent on 
thymocyte:mesenchyme interactions, as absence of these interactions resulted in a 
loss of ICAM-1hiVCAM-1hi and suggested a potential block at the ICAM-1intVCAM-1int 
stage. This mirrors the block in development seen in lymph node stromal cells of Ltbr-
/- mice, where the deletion of LTβR prevents the interaction of LTα1β2 expressing 
lymphoid tissue inducer (LTi) cells with ICAM-1intVCAM-1int stroma, which is required 
for the development of ICAM-1hiVCAM-1hi mature LN stromal cells (232). It has been 
shown that there is an essential requirement of thymocyte crosstalk with thymic 
epithelial cells for TEC development within the thymus, with one study showing that 
specific loss of αβ thymocytes in Tcra-/- mice have a significant loss of medulla (142). 
Our analyses reveal an essential requirement for thymocyte interactions with thymic 
mesenchyme highlighting a novel cellular regulatory mechanism in the development 
of thymic mesenchyme.  
 
Lymphocyte mediated development of both lymph node stroma and thymic stroma 
has been shown to occur through signaling of a number of TNFRSF members. Within 
the thymus, RANK signaling, through provision of RANKL by intrathymic CD4+CD3- 
inducer cells, is required for the development of Aire+ mTEC (152). Additionally, 
RANK signaling is essential for LN development (238). LTβR signaling is also 
required for stromal development as LTβR-deficient mice have defective medullary 
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organization and mTEC development (151). Previous studies have shown that both 
germ line deletion or the specific deletion of LTβR on FRCs, through the use of 
Ccl19creLtbrfl/fl mice, both result in a complete loss of ICAM-1hiVCAM-1hi cells on 
lymph node stroma (232,233). Interestingly we found no requirement for RANK 
signaling but an essential requirement for LTβR signaling for the development of 
ICAM-1hiVCAM-1hi thymic mesenchyme, consistent with LTβR’s role in LN stroma 
development.  
 
From our analysis it is clear that each of the thymocyte populations SP4, SP8, Treg 
and iNKT cells express the three known LTBR ligands LTα3, LTα1β2 and LIGHT and 
this is consistent with previous reports (159). Therefore it is not surprising that there 
is only a modest reduction of ICAM-1hiVCAM-1hi thymic mesenchyme in the SP4 and 
Treg deficient mice and normal ICAM-1hiVCAM-1hi thymic mesenchyme in iNKT cell 
deficient knockouts. The Tcra-/- model disrupts the formation of the αβ TCR, resulting 
in a loss of all αβ thymocytes and therefore SP4, SP8, Treg and iNKT cells (141). 
Therefore it was expected that the magnitude of loss of ICAM-1hiVCAM-1hi would be 
similar to that seen in the dGuo treated FTOC. MHC Class II deletion prevents the 
development of MHC Class II restricted CD4+CD8- thymocytes, including SP4 and 
Tregs, but not SP8 (MHC Class I restricted) or iNKT cells (CD1d restricted). 
Therefore it would appear that the absence of signaling from SP4 and Treg is 
required for ICAM-1hiVCAM-1hi development to some degree, but there is sufficient 
LTβR ligand provision by SP8 thymocytes and iNKT cells to limit the loss of ICAM-
1hiVCAM-1hi thymic mesenchyme. The data suggested that none of the populations 
tested above are essential for the development of ICAM-1hiVCAM-1hi thymic 
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mesenchyme suggesting a redundant mechanism is in place to ensure the 
development of ICAM-1hiVCAM-1hi thymic mesenchyme. 
 
Building on this, the addition of each population separately in an RTOC system can 
support the development of the ICAM-1hiVCAM-1hi population. Suggesting that whilst 
each population is not essential, they are sufficient to support ICAM-1hiVCAM-1hi 
development on their own. Interestingly the broad expression of LTβR ligands across 
multiple thymocyte populations differs to that of other TNFRSFs ligands. Whilst 
RANKL is expressed by SP4, SP8 thymocytes and Tregs, its expression on SP4 
thymocytes is enriched on immature SP4 thymocytes (CD69+) (159,162). Additionally 
the ligand for another TNFRSF member CD40, which is involved in mTEC 
development, has been shown to be expressed on SP4 but not SP8 thymocytes or 
Tregs and is thought to be expressed mainly on mature SP4 thymocytes (CD69-) 
(159,162). This suggests that LTβR regulated development of thymic mesenchyme 
does not rely on specific populations of thymocytes as with other thymocyte:stroma 
cross talk mechanisms within the thymus or peripheral lymphoid tissues. An 
interesting further experiment to directly investigate the role of LTβR within the RTOC 
system would be the inclusion of an additional control group, which would receive an 
antagonistic anti-LTβR blocking antibody alongside each of the single thymocyte 
populations. This would directly test if the development of the ICAM-1hiVCAM-1hi 





Not only is the addition of a single LTβR-ligand expressing thymocyte population 
sufficient for the development of ICAM-1hiVCAM-1hi thymic mesenchyme our data 
revealed that in vitro and in vivo anti-LTβR stimulation is also sufficient for ICAM-
1hiVCAM-1hi development. This is similar to studies of peripheral lymphoid tissues 
where anti-LTβR stimulation induces ICAM-1hiVCAM-1hi cells in mLNs in culture 
(232). In addition to steady state, the effects of LTβR stimulation on thymic 
mesenchyme within the context of bone marrow chimeras were investigated. This 
system was used to introduce an absence of SP thymocytes, resulting in a 
reduction/loss of LTβR-ligand provision and therefore disrupt LTBR signaling. We 
found that maintaining LTβR signals by injecting anti-LTβR prevented the loss of 
ICAM-1hiVCAM-1hi thymic mesenchyme observed in the mice receiving the isotype 
control, suggesting that not only is LTβR signaling required for the initiation of ICAM-
1hiVCAM-1hi thymic mesenchyme, but it may also be required for the ongoing 
maintenance of this population.  
 
A preliminary experiment was carried out to investigate the potential requirement for 
persistent signaling from thymocytes for the maintenance of ICAM-1hiVCAM-1hi 
thymic mesenchyme. Using a tetracycline inducible Zap70 mouse model (TetZap70) 
which have a block at the pre-selection DP stage of thymocyte development unless 
Zap70 is induced via administering doxycycline (dox), upon which development of SP 
T-cells is enabled (256). Therefore TetZap70 mice are phenotypically similar to Tcra-/- 
mice, with absence of SP thymocytes resulting in a loss of ICAM-1hiVCAM-1hi thymic 
mesenchyme. Upon administration of dox, the restored SP T-cell development 
programme did give rise to ICAM-1hiVCAM-1hi thymic mesenchyme development. 
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This system would allow us to take the findings of the LTβR BMC experiments a step 
further by first switching on SP thymocyte development, through administration of 
dox, and then switching them off, cessation of dox, to investigate whether prolonged 
interactions with thymocytes are required for the maintenance of ICAM-1hiVCAM-1hi 
thymic mesenchyme.   
 
A surprising finding of the anti-LTβR treated BMCs was that the total PDPN+ 
population was reduced which had a knock on effect on the size of each of the ICAM-
1/VCAM-1 expressing populations. Specifically there was a reduction in the number 
and percentage of the ICAM-1loVCAM-1lo and ICAM-1intVCAM-1int thymic 
mesenchyme populations. This could suggest that the treatment of anti-LTβR is 
stimulating premature maturation of the immature thymic mesenchyme populations, 
which may otherwise be required to establish the PDPN+ thymic mesenchyme 
population. Additionally we cannot rule out that the expression of the adhesion 
molecules themselves is increased due to LTβR stimulation as it has been previously 
shown that ICAM-1 and VCAM-1 are known target of LTβR signaling (257,258). 
 
Finally our analysis revealed some potential roles for thymic mesenchyme through 
PCR analysis of genes associated with homeostasis and lymphocyte migration. We 
found that PDPN+ thymic mesenchyme express Ccl19, Cxcl13 and Enpp2 but did not 
express Ccl21. Enpp2 encodes autotaxin (ATX), an ectoenzyme that is required for 
the production of lysophosphatidic acid (LPA) which plays a role in lymphocyte 
trafficking into lymph nodes and regulation of lymphocyte migration (252,253). 
However an intrathymic role for ATX remains to be discovered. CXCL13 is a B-cell 
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chemoattractant and could therefore play a role in migration of thymic B-cells which 
have been shown to reside in the medulla at the corticomedullary junction (CMJ) 
similarly to where our confocal analysis shows thymic mesenchyme (259). Thymic B-
cells have been shown to play a role in the generation of Treg and central tolerance 
suggesting thymic mesenchyme may indirectly regulate these processes through 
thymic B-cells (260,261). 
 
CCL19 and CCL21 are ligands for CCR7 and have been shown to be essential for 
the migration of developing thymocytes from the cortex to the medulla as well as 
thymus colonization by T-cell precursors (21,69). Additionally CCR7 has been shown 
to play a key role in thymocyte egress in neonatal but not adult mice (69,116). 
Further PCR analysis was carried out on ICAM-1lo and ICAM-1hi thymic mesenchyme 
to understand the functional importance of the ICAM-1hi cells, which appeared to be 
mature cells, based on our ontogeny results. Consistent with lymph node stroma, 
ICAM-1hiVCAM-1hi thymic mesenchyme expressed higher levels of Ccl19, Enpp2 and 
Sphk1 compared to ICAM-1loVCAM-1lo thymic mesenchyme. SPHK1 was included 
as it has been shown to be expressed by thymic pericytes and is essential for the 
regulation of thymocyte egress by the production and maintenance of an 
sphingosine-1-phosphate (S1P)-gradient (111). Expression of Sphk1 is consistent 
with the pericyte-like phenotype of PDGFRβ expression and perivascular positioning 
within the thymus identified for the PDPN+ thymic mesenchyme. 
 
This chapter identifies a population of thymic mesenchyme within which are ICAM-
1hiVCAM-1hi expressing cells whose development is dependent on signaling through 
 
131 
LTβR via interactions with LTβR-ligand bearing αβ+ T-cells. This ICAM-1hiVCAM-1hi 
mesenchyme population is positioned at the gateway between the thymus and the 
periphery and express genes linked with thymocyte migration, precursor entry and T-
cells exit; as summarized in Figure 3.17. Together our analyses highlight a potential 
key, novel role of LTβR regulating thymus colonization and/or mature T-cell egress 








Figure 3.17. αβ T-Cell:Thymic Mesenchyme Cross-Talk Via LTβR Is Essential 
For The Development of ICAM-1hiVCAM-1hi Thymic Mesenchyme 
(A) αβ T-cells regulate the development of ICAM-1hiVCAM-1hi PDPN+ thymic 
mesenchyme from ICAM-1loVCAM-1lo via signaling through LTβR. 
 
Gene analysis of sorted PDPN+ thymic mesenchyme as well as the ICAM-1loVCAM-
1lo and ICAM-1hiVCAM-1hi PDPN+ thymic mesenchyme populations suggests 
potential roles of these populations: 
 
(B) Gene analysis reveals ICAM-1loVCAM-1lo PDPN+ thymic mesenchyme express 
high levels of Cxcl13 suggesting that they may regulate intrathymic CXCR5+ B-cell 
migration. 
(C) Gene analysis reveals PDPN+ thymic mesenchyme express Fgf10 that previous 
studies have shown regulates TEC proliferation in the embryonic thymus, highlighting 
a potential role for thymic mesenchyme regulating TEC proliferation in the adult 
thymus via FGF10. 
(D) Gene analysis reveals ICAM-1hiVCAM-1hi PDPN+ thymic mesenchyme express 
high levels of Ccl19 suggesting that they may regulate CCR7+ T-cell and DC 
migration or entry/egress. 
(E) Gene analysis reveals ICAM-1hiVCAM-1hi PDPN+ thymic mesenchyme express 
high levels of Sphk1 (enzyme that catalyzes production of S1P) suggesting that they 
may regulate S1P-dependent T-cell egress of S1PR1+ T-cells.  
ICAM-1hiVCAM-1hi 




































CHAPTER FOUR: REGULATION OF THYMOCYTE EGRESS 
BY THYMIC ENDOTHELIAL CELLS AND LYMPHOTOXIN 




Thymocytes go through many tightly regulated processes throughout their 
development from initial early T-cell precursors (ETP), right through to their eventual 
exit from the thymus. Whilst regulation of developing thymocytes via positive and 
negative selection are extremely important in ensuring the peripheral T-cell pool is 
functional, diverse and self tolerant, the egress of the thymocytes must also be 
regulated and is equally important to ensure only fully mature thymocytes are able to 
leave the thymus. Previous studies have highlighted two main mechanisms through 
which thymocyte egress is controlled. Firstly, C-C chemokine receptor type 7 (CCR7) 
has been shown to play a role in regulating thymocyte egress. Interactions between 
CCR7 expressed by thymocytes and CCR7 ligands expressed by thymic stroma 
(CCL19 and CCL21) are essential for the egress of mature thymocytes in neonatal 
mice (116). Interestingly however this process was subsequently shown to be non-
essential for thymocyte egress in the adult thymus indicating that the mechanisms 
regulating T cell egress may alter in a temporal manner (69). Alternatively the 
sphingosine-1-phosphate (S1P)-sphingosine-1-phosphate receptor 1 (S1PR1) 
pathway has been identified as an essential regulatory pathway of thymocyte egress 
in the adult thymus. S1PR1 is expressed by mature SP thymocytes and mediates the 
migration of the mature SP thymocyte towards the site of exit via an S1P gradient 
(95,98,262).  Multiple studies have highlighted key roles of many different cell types 
in regulating thymocyte egress through the maintenance of the S1P gradient where 
S1PR1-bearing mature thymocytes migrate from low levels of S1P within the thymus 
to high levels of S1P at the site of exit and in the blood. This regulation occurs either 
through regulating the production of S1P to maintain high levels of S1P at/near the 
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site of exit, or the degradation of S1P to maintain low intrathymic S1P levels. An 
example of the essential role of degrading S1P to maintain low levels of S1P is the 
production of lipid phosphate phosphatase 3 (LPP3) by TEC and thymic endothelial 
cells which is a dephosphorylating enzyme that inactivates S1P to maintain low 
intrathymic S1P levels (112). Endothelial cells also express the S1P transporter 
spinster homolog 2 (Spns2), which is essential to establish the S1P gradient needed 
for T-cell egress and thus highlights a positive regulatory role of thymic endothelial 
cells regulating intrathymic S1P levels (113). Another S1P degrading enzyme, S1P 
lyase (SGPL), is also produced by bone marrow-derived cells, including thymic 
dendritic cells, and irreversibly degrades S1P to maintain low intrathymic S1P levels 
(114). Alternatively thymic pericytes have been show to produce sphingosine kinase 
1 (SPHK1) and SPHK2 which are enzymes required for the production of new S1P 
and its production by PDGFRβ+ pericytes is essential for thymocyte egress (111). 
Although the mechanism of S1P-regulated thymocyte egress is relatively well known, 
cellular and molecular regulators of this process and thymocyte egress remain poorly 
understood.  
 
The previous chapter shows that thymic mesenchyme express egress associated 
molecules such as Sphk1, include thymic pericytes, which have previously been 
linked to regulation of thymocyte egress and are regulated by LTβR signaling through 
interactions with T-cells. Given that previous studies have suggested that LTβR 
regulates egress via regulation of thymic stroma, we hypothesized that LTβR 





Thus the following chapter aimed to further characterize the thymocyte egress defect 
found within LTβR deficient mice, investigate the mechanism of LTβR-dependent 
thymocyte egress and identify the thymic population that this is occurring through. 
4.2 RESULTS 
4.2.1 LTβR Signaling Is Required For Normal Thymocyte Egress 
To study thymocyte egress we needed to ensure we had suitable methods in place to 
correctly measure it when it is altered. The initial phenotypic description of a 
thymocyte egress defect within LTβR deficient mice used the expression of CD69 
and CD62L to separate the single positive CD4+CD8-TCRβhi (SP4) thymocytes and 
CD4-CD8+TCRβhi (SP8) thymocytes into immature (CD69+CD62L-) and mature 
(CD69loCD62L+) cells (151). Using this strategy it was revealed that LTβR-deficient 
(Ltbr-/-) mice have a significant intrathymic accumulation of mature thymocytes, 
indicative of an inability of the mature thymocyte to egress the thymus (151). To 
refine this analysis, CD25 and FoxP3 were included in our analysis to exclude 
CD25+FoxP3+ regulatory T-cells (Tregs) as well a CD25+FoxP3- Treg precursors, 
allowing the investigation of conventional SP4 (cSP4) thymocytes (Fig 4.1.A.). Based 
on the study by Boehm et. al, CD69 and CD62L were used to identify immature and 
mature populations within SP8 and cSP4 thymocytes of wildtype (WT) mice (Fig 
4.1.A.). These WT mice had been crossed with a RAGgfp mouse model, a reporter 
system first created to identify recent thymic emigrants (RTE) and can also be used 
to identify different maturational stages of thymocytes within the thymus (74,263). 
The RAGgfp model works through utilizing the temporal expression of RAG during 
CD4+CD8+ DP thymocyte development (263). When the gene is switched off after the 
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DP stage, residual RAGgfp protein can be used to measure the age of the cell, where 
the amount of GFP in a cell is inversely proportional to the cell’s age (Fig 4.3.A.). 
Gating using RAGgfp expression also ensures that the SP4 and SP8 cells have 
recently developed and are not recirculating cells. Within both RAGgfp+ cSP4 and 
SP8 thymocytes it was clear that the immature fraction of each population was 
distinct from the mature fraction in terms of their expression of RAGgfp, where mature 
cells had significantly lower levels of RAGgfp and therefore were significantly older 
than immature cells (Fig 4.1.B.C.). Another important distinction between immature 
thymocytes and mature thymocytes is the ability to egress the thymus via the 
sphingosine-1-phosphate pathway by expressing the S1P receptor 1 (S1PR1) on 
their cell surface (262). Consistent with this, within RAGgfp+ cSP4 thymocytes, only 
mature cSP4 thymocytes express S1PR1 (Fig 4.1.D.). Together these data provide 
multiple methods of identifying different maturation statuses within cSP4 and SP8 
thymocytes.  
 
To confirm the presence of a thymocyte egress defect within LTβR deficient mice we 
first repeated the CD69/CD62L analysis of immature and mature thymocyte 
populations using the cSP4 gating strategy identified in Fig 4.1. Consistent with 
Boehm et al.’s analysis, Ltbr-/- mice had increased percentage of CD4+CD8- 
thymocytes and a significant increase in the percentage and number of mature cSP4 
and SP8 thymocytes (Fig 4.2.A-F). Importantly the increase was specific to mature 
thymocytes with no increase detected within the immature fraction of either cSP4 or 
SP8 thymocytes (Fig 4.2.C-F). As suggested in Boehm et al.’s study, this increase in 










Figure 4.1. Separating Single Positive Thymocytes Into Distinct Immature and 
Mature Populations 
Thymic lobes were harvested from WT RAGgfp reporter mice and mechanically 
disrupted for FACS analysis of the thymocyte populations. 
(A) Conventional single positive CD4 (cSP4) and single positive CD8 (SP8) 
thymocytes were identified as CD4+CD8-TCRβhiCD25-Foxp3- and CD4-CD8+TCRβhi, 
respectively. Immature and mature thymocytes were identified as CD69+CD62L- and 
CD69loCD62L+, respectively. 
(B) Within the immature and mature cSP4 thymocytes, RAGgfp+ cells were gated on. 
The RAGgfp MFI was calculated for each population shown on the right.  
(C) Within the immature and mature SP8 thymocytes, RAGgfp+ cells were gated on. 
The RAGgfp MFI was calculated for each population shown on the right.  
(D) Within the immature and mature cSP4 thymocytes, the expression of S1PR1 was 
plotted (left) and the S1PR1 MFI was calculated for each population shown on the 
right. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where ** denotes a significant difference as p<0.01. All data is typical of 3 


























































































































Figure 4.2. Deletion of LTβR Results In An Intrathymic Accumulation Of Mature 
Single Positive Thymocytes 
Thymic lobes were harvested from control (Ltbr+/+) and LTβR-deficient (Ltbr-/-) mice 
and enzymatically digested for FACS analysis of the thymocyte populations. 
(A) Expression pattern of CD4 and CD8 within Ltbr+/+ (left) and Ltbr-/- (right) thymi to 
identify CD4+CD8- SP4, CD4+CD8+ DP and CD4-CD8+ SP8 thymocytes.  
(B) Cell number of the thymus, cSP4, SP8 and DP thymocytes and percentages of 
CD4+CD8- and CD4-CD8+ were calculated for Ltbr+/+ (blue, n=13) and Ltbr-/- (red, 
n=12) mice.  
(C) Expression pattern of CD69 and CD62L within cSP4 thymocytes of Ltbr+/+ (left) 
and Ltbr-/- (right) mice. 
(D) Cell numbers and percentages of immature and mature cSP4 thymocytes were 
calculated for Ltbr+/+ (blue, n=13) and Ltbr-/- (red, n=12) mice. 
(E) Expression pattern of CD69 and CD62L within SP8 thymocytes of Ltbr+/+ (left) 
and Ltbr-/- (right) mice. 
(F) Cell numbers and percentages of immature and mature SP8 thymocytes were 
calculated for Ltbr+/+ (blue, n=13) and Ltbr-/- (red, n=12) mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where * denotes a significant difference as p<0.05,  ** p<0.01 and **** denotes 
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accumulation of cells and is not due to increased proliferation. Following this, Ltbr-/- 
mice were crossed with RAGgfp reporter mice to create Ltbr-/-RAGgfp mice to directly 
investigate the impact of LTβR deficiency on intrathymic dwell time and thymocyte 
egress. Therefore if the increase in mature thymocytes within the Ltbr-/- mouse is truly 
an intrathymic accumulation it would be expected that the mature thymocytes within 
the Ltbr-/- thymus are older, with lower levels of RAGgfp, compared to Ltbr+/+ controls 
(Fig 4.3.A.). Through analysis of immature and mature SP4 thymocytes within Ltbr-/-
RAGgfp mice, it is clear that mature SP4 thymocytes have much lower levels of 
RAGgfp expression compared to Ltbr+/+RAGgfp control mice and therefore do have an 
increased intrathymic dwell time (Fig 4.3.B.C.). Importantly the expression of RAGgfp 
by immature SP4 thymocytes is the same between both mice indicating the dwell 
time defect is specific to mature thymocytes (Fig 4.3.B.C.). The RAGgfp model can 
also be used to identify recent thymic emigrants (RTE) due to the residual RAGgfp 
present within cells that have recently left the thymus (263). Therefore this can be 
used to directly investigate whether LTβR deficiency and the accompanied 
intrathymic accumulation has an impact on the peripheral T-cell pool. Consistent with 
the increased intrathymic dwell time, SP4 RTE within the spleen of Ltbr-/- mice have 
significantly lower levels of RAGgfp (Fig 4.3.D.E.). As previously reported, Ltbr-/- mice 
have increased splenic cellularity associated with the increased lymphocytes within 
the spleen as a result of absent peripheral lymph nodes (Fig 4.3.F.) (264). This 
increase of cells within the spleen resulted in an overall increase in the number of 
RAGgfp- and RAGgfp+ SP4 RTE, however the proportion of RAGgfp+ SP4 RTE with the 
SP4 compartment was reduced, suggesting there are relatively fewer RAGgfp+ SP4 




Figure 4.3. Deletion of LTβR Results In Reduced Recent Thymic Emigrants  
Thymic lobes and spleens were harvested from control (Ltbr+/+RAGgfp) and LTβR-
deficient (Ltbr-/-RAGgfp) mice and mechanically disrupted for FACS analysis. 
(A) Model of the RAGgfp reporter model. Green fluorescent protein (gfp) is produced 
when Rag is expressed in DP thymocytes. Subsequently the gene is switched off, 
stopping production of new gfp. The gfp remaining in the cell decays over time and 
the amount of gfp present within a cell is inversely proportional to its age. Therefore 
RAGgfp expression can be used to measure intrathymic dwell time and to also identify 
recent thymic emigrants (RTE).  
(B) The expression of RAGgfp on immature (CD4+TCRβhiCD25-CD69+CD62L-) and 
mature (CD4+TCRβhiCD25-CD69loCD62L+) SP4 thymocytes within Ltbr+/+RAGgfp 
(blue) and Ltbr-/-RAGgfp (red) mice.  
(C) RAGgfp MFI for immature and mature SP4 thymocytes from Ltbr+/+RAGgfp (blue, 
n=5) and Ltbr-/-RAGgfp (red, n=5) mice where the data is represented as a ratio of 
mean RAGgfp MFI of Ltbr-/-:Ltbr+/+ for each experiment. 
(D) Expression pattern of CD4 and TCRβ to identify SP4 RTE within the spleen 
within Ltbr+/+ mice.  
(E) Expression of RAGgfp on SP4 RTE of Ltbr+/+RAGgfp (blue) and Ltbr-/-RAGgfp (red) 
mice. RAGgfp MFI for SP4 RTE from Ltbr+/+RAGgfp (blue, n=5) and Ltbr-/-RAGgfp (red, 
n=5) mice where the data is represented as a ratio of mean RAGgfp MFI of Ltbr-/-
:Ltbr+/+ for each experiment. 
(F) Cell numbers of spleen, RAG- SP4 T-cells and RAG+ SP4 RTE as well as 
percentages of SP4 T-cells and SP4 RTE were calculated for Ltbr+/+ (blue, n=9) and 
Ltbr-/- (red, n=12) mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where * denotes a significant difference as p<0.05,  ** p<0.01 and **** denotes 
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These data provide a more refined analysis of the impact of LTβR deficiency on 
thymocyte egress and provides a method to directly confirm that LTβR is playing a 
role in regulating intrathymic dwell time and thymocyte egress of mature thymocytes. 
 
4.2.2 Identifying The Cellular And Molecular Regulators Of LTβR-Dependent 
Thymocyte Egress 
It has previously been shown that multiple cell types of both hematopoietic and 
stromal origin influence and regulate thymocyte egress through the S1P pathway and 
the CCR7 pathway (69,111,112,114,116). To identify which cell types may be playing 
a role in LTβR-dependent thymocyte egress, the expression of LTβR was measured 
on each of the main cell types within the thymus: TER119-CD45+EpCAM-1- 
hematopoietic cells, TER119-CD45-EpCAM-1+ TEC, TER119-CD45-EpCAM-1-
PDPN+CD31- thymic mesenchyme and TER119-CD45-EpCAM-1-PDPN-CD31+ 
thymic endothelium (Fig 4.4.A.). LTβR expression appeared mainly restricted to the 
stromal compartment, where it was expressed by TEC, mesenchyme and 
endothelium (Fig 4.4.B.). However previous studies have shown that LTβR is 
expressed by thymic dendritic cells (DCs), which make up an extremely small 
population relative to the CD45+ compartment as a whole (157). Therefore our 
analysis could be diluting the expression of some scarce CD45+ thymocyte 
populations. To address this, two approaches were taken to separate the role of 
LTβR expressing hematopoietic cells and LTβR expressing thymic stromal cells.  
 
To investigate if hematopoietic expression of LTβR is essential for thymocyte egress, 













Figure 4.4. LTβR Is Expressed By All 3 Of The Main Thymic Stromal 
Populations 
Thymic lobes were harvested from mice and enzymatically digested for FACS 
analysis of thymic stromal populations.  
(A) Identification of TER119-Viability-CD45+EpCAM-1- hematopoietic cells as well as 
the three main thymic stromal populations: TER119-Viability-CD45-EpCAM-1+ thymic 
epithelial cells (TEC), TER119-Viability-CD45-EpCAM-1-PDPN+CD31- thymic 
mesenchyme and TER119-Viability-CD45-EpCAM-1-PDPN-CD31+ thymic 
endothelium of WT mice. 
(B) Expression of LTβR on hematopoietic cells as well as TEC, mesenchyme and 
endothelium from WT mice with an Ltbr-/- mouse as a staining control. 
 




































irradiated and reconstituted with CD45.2+ control (Ltbr+/+) or CD45.2+ LTβR deficient 
(Ltbr-/-) bone marrow and harvested 12 weeks after reconstitution (Fig 4.5.A.). This 
approach restricts LTβR deficiency to hematopoietic cells, as the host’s radio-
resistant stromal cells will continue to express LTβR. WT hosts receiving either 
Ltbr+/+ or Ltbr-/- bone marrow appeared identical, with no increase in the percentage 
or number of mature SP4 thymocytes (Fig 4.5.B.C.). This data indicates that LTβR 
expression by hematopoietic cells is dispensable for thymocyte egress however it 
does not rule out redundancy between stroma and hematopoietic cells. To directly 
investigate an essential role for LTβR expression by thymic stroma, a complementary 
experiment was set up to restrict loss of LTβR to thymic stromal cells. Embryonic day 
15 (E15) thymic lobes were harvested from Ltbr+/+ and Ltbr-/- mice and cultured in 
fetal thymic organ culture conditions (FTOC) in the presence of 2-dGuo to deplete 
hematopoietic cells within the thymus graft prior to transplant. These lobes were then 
grafted under the kidney capsule of a WT host; therefore host-derived bone marrow 
and subsequent developing thymocytes will be LTβR sufficient whilst the donor-
derived thymic stroma within the grafts will either be LTβR sufficient (Ltbr+/+) or LTβR 
deficient (Ltbr-/-) (Fig 4.5.D.). Analysis of the thymocyte populations within the grafts 
revealed a reduction of immature cSP4 (Im cSP4) and an increase in the number and 
percentage of mature cSP4 (Ma cSP4) thymocytes within the Ltbr-/- grafts consistent 
with a blockade in mature thymocyte egress (Fig 4.5.E.). Together these two 
experiments reveal that LTβR expression by thymic stroma, but not hematopoietic 











Figure 4.5. Expression Of LTβR By Thymic Stroma Is Essential For Thymocyte 
Egress 
(A) CD45.1 WT mice were lethally irradiated with 2x500 rad doses and reconstituted 
with CD45.2 Ltbr+/+ or Ltbr-/- bone marrow (BM) and harvested 12 weeks later. 
(B) Expression pattern of CD69 and CD62L on CD4+CD8-TCRβhiCD25-FoxP3- 
conventional SP4 (cSP4) thymocytes in WT mice receiving Ltbr+/+ (left) or Ltbr-/- 
(right) BM. 
(C) Cell numbers of thymus, cSP4, CD69+CD62L- immature cSP4 (Im cSP4) and 
CD69loCD62L+ mature cSP4 (Ma cSP4) thymocytes, as well as percentages of Im 
cSP4 and Ma cSP4 thymocytes, were calculated for WT mice receiving Ltbr+/+ (blue, 
n=6) or Ltbr-/- (red, n=6) BM. 
(D) Thymic lobes were harvested from E15 Ltbr+/+ or Ltbr-/- mice and cultured with 
dGuo for 7 days and then grafted under the kidney capsule of WT host mice. Grafted 
mice were then harvested 6 weeks after initial engraftment.  
(E) Cell numbers of thymus, cSP4, Im cSP4 and Ma cSP4 thymocytes, as well as 
percentages of Im cSP4 and Ma cSP4 thymocytes, were calculated for WT mice 
receiving Ltbr+/+ (blue, n=17) or Ltbr-/- (red, n=20) BM.  
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where * denotes a significant difference as p<0.05,  ** p<0.01 and *** denotes 
p<0.001. Data of A-C is typical of 2 independent repeats and data of D+E is typical of 
3 independent repeats. 
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The expression profile of LTβR on thymic stromal populations revealed that TEC, 
mesenchyme and endothelial cells express LTβR (Fig 4.4.B.). Additionally our own 
data shows that Ltbr-/- mice have a reduction of ICAM-1hiVCAM-1hi PDPN+ thymic 
mesenchyme, which express genes known to regulate thymocyte egress such as 
Ccl19 and Sphk1 (Chapter 3). Moreover, thymic mesenchymal production of SPHK1 
and SPHK2 is essential for normal S1P-dependent egress of mature thymocytes 
from the adult thymus (111). This data suggests that thymic mesenchyme may be a 
candidate for the stromal population that regulates LTβR-dependent thymocyte 
egress. To directly investigate this, the Cre/LoxP mouse model system was used to 
specifically delete LTβR on thymic mesenchyme by crossing the mesenchyme 
specific mouse strain Pdgfrbcre/+ mice with Ltbrflox/flox mice. Pdgfrbcre mice have 
previously been used to successfully target PDGFRβ+ perivascular cells within LNs 
and therefore appeared to be a suitable model to delete Ltbr specifically on thymic 
mesenchyme (265). These mice should have Ltbr deleted on all Pdgfrbcre expressing 
cells, which our analysis revealed that PDGFRβ is expressed by all PDPN+ thymic 
mesenchyme cells (Chapter 3). Thymocytes were analyzed from Pdgfrbcre control 
mice and from PdgfrbcreLtbrflox mice however there was no detectable accumulation 
of mature cSP4 or SP8 thymocytes (Fig 4.6.A-C.).  
 
To ensure that the phenotype observed in the PdgfrbcreLtbrflox mice was truly 
representative of a non-essential role in regulating thymocyte egress, the efficiency 
and specificity of the Pdgfrbcre strain was tested through two approaches. Pdgfrbcre 
mice were crossed with mT/mG mice, a fate mapper system in which all cells 
express membrane-targeted tdTomato (mT) prior to Cre excision and membrane-
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targeted EGFP (mG) after Cre excision and therefore can be used to accurately 
identify Cre- and Cre+ cells (241). PdgfrbcremT/mG mice revealed that Cre expression 
was not specific to thymic mesenchyme (Fig 4.6.D.E.). Whilst Cre activity was 
detected in 80.9% (± 3.17%) of mesenchyme, it was also expressed by 69.9% (± 
7.26%) of thymic endothelium (Fig 4.6.D.E). Alternatively, stroma was isolated from 
the PdgfrbcreLtbrflox mice and LTβR protein expression was measured on thymic 
mesenchyme via flow cytometry (Fig 4.6.F.). Despite the PdfgrbcremT/mG model 
demonstrating efficient targeting of thymic mesenchyme, there was not a complete 
loss of LTβR expression on PDPN+ thymic mesenchyme within PdgfrbcreLtbrflox mice 
suggesting Pdgfrbcre is a sub-optimal model to target Ltbr deletion to thymic 
mesenchyme (Fig 4.6.F.). Therefore these data reveal that LTβR deletion in the 
PdgfrbcreLtbrflox mouse model is inefficient and furthermore the Cre activity of the 
Pdgfrbcre is non-specific. This highlights an essential requirement to test and confirm 
specificity and efficacy when using mouse models such as the Cre/LoxP system.  
 
Due to the inefficiency of the Pdgfrbcre mouse strain, an alternative mesenchyme 
specific mouse strain was chosen. Previous studies have shown that Wnt-1cre mice 
can target gene deletion to neural crest derived mesenchyme, where it has been 
used to delete sphingosine kinase on thymic mesenchyme which causes an 
intrathymic accumulation of mature thymocytes (111). To verify the specificity of the 
Wnt-1cre mouse model, Wnt-1cre mice were crossed to mT/mG mice. As expected 
mT/mG control mice showed no Cre activity within any of the cell populations (Fig 
4.7.A.), whereas Wnt-1cremT/mG mice showed Cre activity was specific to thymic 
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mesenchyme and efficient, with ~75.0% (± 3.35%) of PDPN+ thymic mesenchyme 
switching from mT+ to mG+ (Fig 4.7.C.D.).  
 
Following confirmation that the Wnt-1cre was in fact specifically targeting thymic 
mesenchyme, Wnt-1cre mice were crossed with Ltbrfl/fl mice to delete LTβR on thymic 
mesenchyme. The expression of LTβR was significantly reduced and deletion was 
specific to thymic mesenchyme within Wnt-1creLtbrflox mice (Fig 4.8.A.B.). It should be 
noted that expression levels of LTβR were not fully reduced to the levels seen in Ltbr-
/- mice (Fig 4.8.A.B.). As a further test to determine whether the deletion of Ltbr within 
the Wnt-1creLtbrflox is efficient, the thymic mesenchyme was stained for ICAM-1 and 
VCAM-1 to identify the ICAM-1hiVCAM-1hi population of PDPN+ thymic mesenchyme 
who’s development is dependent on LTβR signaling (Chapter 3). Consistent with 
Ltbr-/- mice, there was a significant loss of ICAM-1hiVCAM-1hi PDPN+ thymic 
mesenchyme in Wnt-1creLtbrflox mice compared to Wnt-1cre controls (Fig 4.8.C.D.). 
This data confirms the specificity and efficacy of the Wnt-1creLtbrflox model for 
targeting LTβR deletion to PDPN+ thymic mesenchyme.  
 
To investigate if thymic mesenchyme is required for thymocyte egress the thymocyte 
populations of Wnt-1creLtbrflox mice were analyzed. Repeating the analysis that was 
used for Ltbr-/- mice revealed no intrathymic accumulation of mature cSP4 or SP8 
thymocytes when Ltbr was deleted on thymic mesenchyme (Fig 4.9.A-F). This 
suggests that contrary to our initial hypothesis, which proposed a role for thymic 
mesenchyme in regulating thymocyte egress in an LTβR-dependent manner, deletion 








Figure 4.6. Deletion of LTβR On Thymic Mesenchyme Is Not Efficient In 
PdgfrbcreLtbrflox Mice 
Thymic lobes were harvested from adult mice and enzymatically digested for FACS 
analysis of stromal populations. 
(A) Expression pattern of CD69 and CD62L within CD4+CD8-TCRβhiCD25-Foxp3- 
cSP4 thymocytes of control (Pdgfrbcre/+, left) and mesenchyme specific LTβR-
deficient (Pdgfrbcre/+Ltbrfl/fl, right) mice. 
(B) Expression pattern of CD69 and CD62L within CD4-CD8+TCRβhi SP8 thymocytes 
of Pdgfrbcre (left) and PdgfrbcreLtbrflox  (right) mice. 
(C) Cell numbers of thymus, cSP4, SP8, CD69loCD62L+ mature cSP4 and 
CD69loCD62L+ mature SP8 thymocytes were calculated for Pdgfrbcre (blue, n=9) and 
PdgfrbcreLtbrflox  (red, n=9) mice. 
(D) Expression of mT and mG within TER119-Viability-CD45-EpCAM-1+ thymic 
epithelial cells (TEC), TER119-Viability-CD45-EpCAM-1-PDPN+CD31- thymic 
mesenchyme and TER119-Viability-CD45-EpCAM-1-PDPN-CD31+ thymic 
endothelium from Pdgfrbcre/+ mice crossed with mT/mG fate mapper mice (n=10). 
(E) Percentage of mT-mG+ ‘switched’ cells within each stroma population.  
(F) Deletion of LTβR on PDPN+ thymic mesenchyme of Pdgfrbcre, (blue) 
PdgfrbcreLtbrflox (red) and Ltbr-/- (grey) mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed. All 






















































































































































Figure 4.7. Wnt-1cre Specifically Targets PDPN+ Thymic Mesenchyme  
Thymic lobes were harvested from adult mice and enzymatically digested for FACS 
analysis of stromal populations. 
(A) Expression of mT and mG within TER119-Viability-CD45-EpCAM-1+ thymic 
epithelial cells (TEC), TER119-Viability-CD45-EpCAM-1-PDPN+CD31- thymic 
mesenchyme and TER119-Viability-CD45-EpCAM-1-PDPN-CD31+ thymic 
endothelium of mT/mG control mice. 
(B) Example of gating to identify mT+mG- cells that have not switched and are 
therefore Cre- and mT-mG+ cells that have switched and are Cre+. 
(C) Expression of mT and mG within TEC, thymic mesenchyme and CD31+ 
endothelium of Wnt-1cre/+ mice crossed with mT/mG fate mapper mice (n=9). 
(D) Percentage of mT-mG+ ‘switched’ cells within each stroma population.  
 


































































Figure 4.8. Targeted Deletion Of Ltbr On Wnt-1cre Expressing PDPN+ Thymic 
Mesenchyme 
Thymic lobes were harvested from adult mice and enzymatically digested for FACS 
analysis of stromal populations. 
(A) Expression of LTβR on TER119-Viability-CD45-EpCAM-1+ TEC, TER119-Viability-
CD45-EpCAM-1-PDPN+CD31- thymic mesenchyme and TER119-Viability-CD45-
EpCAM-1-PDPN-CD31+ thymic endothelium on Wnt-1cre (blue, n=7) and Wnt-
1creLtbrflox (red, n=9) mice alongside a Ltbr-/- (grey, n=2) control. 
(B) LTβR MFI on TEC, mesenchyme and endothelium of Wnt-1cre (blue, n=7) and 
Wnt-1creLtbrflox (red, n=9) mice alongside a Ltbr-/- (grey, n=2) control. 
(C) Expression pattern of PDPN and CD31 on TER119-Viability-CD45-EpCAM-1- 
non-epithelial thymic stroma in Wnt-1cre (left) and Wnt-1creLtbrflox (right) mice.  
(D) Expression pattern of ICAM-1 and VCAM-1 on PDPN+ thymic mesenchyme from 
Wnt-1cre (left) and Wnt-1creLtbrflox (right) mice and percentage of ICAM-1hiVCAM-1hi 
PDPN+ thymic mesenchyme. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where *** denotes a significant difference as p<0.001. Data of A-C is typical of at 























































































Figure 4.9. Deletion of Ltbr On Thymic Mesenchyme Does Not Impact 
Thymocyte Egress 
Thymic lobes were harvested from control (Wnt-1cre/+) and mesenchyme specific 
LTβR-deficient (Wnt-1cre/+Ltbrfl/fl) mice and enzymatically digested for FACS analysis 
of the thymocyte populations. 
(A) Expression pattern of CD4 and CD8 within Wnt-1cre (left) and Wnt-1creLtbrflox 
(right) thymi to identify CD4+CD8- SP4, CD4+CD8+ DP and CD4-CD8+ SP8 
thymocytes.  
(B) Cell number of the thymus, cSP4, SP8 and DP thymocytes and percentages of 
CD4+CD8- and CD4-CD8+ were calculated for Wnt-1cre (blue, n=6) and Wnt-1creLtbrflox 
(red, n=8) mice.  
(C) Expression pattern of CD69 and CD62L within cSP4 thymocytes of Wnt-1cre (left) 
and Wnt-1creLtbrflox  (right) mice. 
(D) Cell numbers and percentages of immature and mature cSP4 thymocytes were 
calculated for Wnt-1cre (blue, n=6) and Wnt-1creLtbrflox (red, n=8) mice. 
(E) Expression pattern of CD69 and CD62L within SP8 thymocytes of Wnt-1cre (left) 
and Wnt-1creLtbrflox (right) mice. 
(F) Cell numbers and percentages of immature and mature SP8 thymocytes were 
calculated for Wnt-1cre (blue, n=6) and Wnt-1creLtbrflox (red, n=8) mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed. All 













































































































































































As our data revealed no role for LTβR expression on thymic mesenchyme for T-cell 
egress, we attempted to identify which of the remaining stromal populations, TEC or 
endothelium, is required for LTβR-dependent thymocyte egress. Ltbr-/- mice have 
previously been reported to have an mTEC defect, with a reduction in the population 
of UEA-1+ medullary TEC and a gross disorganization of the medullary architecture 
(151). Therefore there could be some mechanism that is altered in the absence of 
normal thymic medulla that is causing a thymocyte egress defect within the Ltbr-/- 
thymus. For this reason we investigated whether LTβR expression on TEC is 
required for thymocyte egress.  
 
Initially we confirmed the TEC defect of germ-line LTβR knockout mice. Consistent 
with the initial description of the thymus of LTβR deficient mice, TEC were 
significantly reduced in Ltbr-/- mice (Fig 4.10.A-C). This reduction maps to a reduction 
of medullary thymic epithelial cells (mTEC) whereas cortical TEC (cTEC) are 
unaffected (Fig 4.10.A-C). Within the mTEC compartment both CD80hiMHC Class IIhi 
mTEChi and CD80loMHC Class IIlo mTEClo are reduced (Fig 4.10.C) and whilst there 
is a modest reduction of Aire+ mTEChi, there is a substantial reduction of CCL21+ 
mTEClo consistent with previous reports, however neither population is completely 
absent (Fig 4.10.C) (156). This data suggests that LTβR plays a key role in the 
development of both subsets of mTEC and whilst there is a significant reduction in 
the number of CCL21 expressing mTEC there is not a complete absence which 
would suggest that CCR7-CCL21 signaling may still occur between thymocytes and 













Figure 4.10. Absence Of LTβR Signaling Impacts Medullary Thymic Epithelial 
Cell Development  
Thymic lobes were harvested from control (Ltbr+/+) and LTβR-deficient (Ltbr-/-) mice 
and enzymatically digested for FACS analysis of stroma. 
(A+B) Identification of CD45-EpCAM-1+ thymic epithelial cells (TEC), UEA-1+Ly51- 
medullary TEC (mTEC), MHC Class IIhi (IAIE hi) CD80hi mTEChi and IAIE loCD80lo 
mTEClo cells within Ltbr+/+ and Ltbr-/- mice. Also shown is the expression of Aire and 
CCL21 within mTEChi and mTEClo, respectively. 
(C) Cell numbers for thymus, TEC and the different subsets of TEC were calculated 
for Ltbr+/+ (blue, n=8) and Ltbr-/- (red, n=9) mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where * denotes a significant difference as p<0.05, ** p<0.01 and **** p<0.0001. All 
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In addition to flow cytometric analysis, immunofluorescence microscopy was carried 
out to determine the medullary organization of Ltbr-/- mice by staining for ER-TR5 to 
identify the medulla and CD8 to identify the cortex. CD8 is expressed by CD4+CD8+ 
DP thymocytes within the cortex and CD4-CD8+ SP8 thymocytes within the medulla, 
however due to the much higher frequency of DP compared to SP8 thymocytes 
within the thymus CD8 can be used to identify the cortex. Visually it is clear that Ltbr-/- 
mice lack the normal distribution and organization of few, large medullary areas that 
are characteristic of the steady state thymus and instead have a large number of 
small medullary areas (Fig 4.11.A.). To quantify this difference in the frequency of 
differing sizes the area of each ER-TR5+ medullary area was calculated and 
recorded into three size categories: <0.1mm2, <0.1mm2-0.5mm2 and ≥0.5mm2. This 
analysis revealed that Ltbr-/- thymi has significantly more medullary areas that are 
<0.1mm2 and <0.1mm2-0.5mm2 and significantly fewer large (≥0.5mm2) medullas 
(Fig 4.11.B.). Therefore this analysis highlights a key role of LTβR signaling for 
development of mTEC and medullary organization. 
 
To separate the disorganization phenotype of the Ltbr-/- mice we investigated the 
mature SP thymocyte population within plt/plt mice, which lack CCL19 and CCL21 
and have a known medullary disorganization phenotype (69,266). Consistent with the 
previous description of these mice there was no observable intrathymic accumulation 
of mature thymocytes (Fig 4.12.) (69). This suggested that disorganization of the 












Figure 4.11. Absence Of LTβR Signaling Impacts Medullary Thymic Epithelial 
Cell Organization 
Thymic lobes were harvested from control (Ltbr+/+) and LTβR-deficient (Ltbr-/-) mice 
and snap-frozen on dry ice. Lobes were then cut 7µm thick and stained for 
immunofluorescence microscopy. 
(A) Thymic sections of Ltbr+/+ (left) and Ltbr-/- (right) were stained with ER-TR5 to 
identify the medulla (red) and CD8 to identify the cortex (green). Scale bars indicated 
500µm. 
(B) The area of each medulla was measured by drawing round the medullas of 
thymic sections taken from different depths of the thymic tissue to ensure an 
accurate average number of medullary areas was calculated. Areas from Ltbr+/+ 
(blue, n=3) and Ltbr-/- (red, n=3) were sorted into three categories: <0.1mm2, 
<0.1mm2-0.5mm2 and ≥0.5mm2.  
 
The standard error bars display the SEM and a parametric T-test was performed, 
where * denotes a significant difference as p<0.05 and ** p<0.01. All data is typical of 
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Figure 4.12. CCR7 Ligands Are Not Essential For Thymocyte Egress 
Thymic lobes were harvested from WT and plt/plt adult mice and enzymatically 
digested for FACs analysis.  
(A) Expression pattern of CD4 and CD8 within WT (left) and plt/plt (right) thymi to 
identify CD4+CD8- SP4, CD4+CD8+ DP and CD4-CD8+ SP8 thymocytes.  
(B) Cell number of the thymus, cSP4 and SP8 thymocytes and percentages of 
CD4+CD8- and CD4-CD8+ were calculated for WT (blue, n=6) and plt/plt (red, n=6) 
mice.  
(C) Expression pattern of CD69 and CD62L within cSP4 thymocytes of WT (blue, 
n=6) and plt/plt (red, n=6) mice. 
(D) Cell numbers and percentages of immature and mature cSP4 thymocytes were 
calculated for WT (blue, n=6) and plt/plt (red, n=6) mice. 
(E) Expression pattern of CD69 and CD62L within SP8 thymocytes of WT (blue, n=6) 
and plt/plt (red, n=6) mice. 
(F) Cell numbers and percentages of immature and mature SP8 thymocytes were 
calculated for WT (blue, n=6) and plt/plt (red, n=6) mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 










































































































































































To investigate the role of LTβR expression by TEC in thymocyte egress, Ltbr was 
deleted on TEC by crossing the TEC-specific Cre mouse model Foxn-1cre/+ with 
Ltbrfl/fl mice (243). LTβR deletion was specific and efficient within the Foxn-1creLtbrflox 
mice, where only TEC had a significant loss of LTβR expression and the expression 
was similar to an Ltbr--/- used as a staining control (Fig 4.13.A.B.). Consistent with 
germ line Ltbr-/- mice, Foxn-1creLtbrflox mice have reduced numbers of TEC which 
map to a loss of both mTEChi and mTEClo, as well as a small decrease in Aire+ 
mTEChi and significant loss of CCL21+ mTEClo (Fig 4.13.C.). Whilst CCL21+ mTEClo 
are significantly reduced, they are not absent, consistent with Ltbr-/- mice (Fig 
4.13.C.).  In addition to this, the medullary disorganization that was prevalent in Ltbr-/- 
mice was also present in Foxn-1creLtbrflox mice, where Ltbr deletion on TEC resulted 
in an increased frequency of smaller medullas (<0.1mm2 and <0.1mm2-0.5mm2) and 
significantly fewer large medullas (≥0.5mm2) (Fig 4.14.A.B.). These data indicate that 
the Foxn-1creLtbrflox mouse model phenocopies Ltbr-/- mice and is therefore suitable 
to investigate the role of TEC in regulating LTβR-dependent T-cell egress. 
 
Thymocytes were isolated from Foxn-1cre and Foxn-1creLtbrflox mice and stained for 
analysis of immature and mature cSP4 and SP8 thymocytes. There was no increase 
in the number or percentages of immature or mature cSP4 and SP8 thymocytes 
when Ltbr was deleted on TEC (Fig 4.15.A-F). Surprisingly there was a very modest, 
but significant, reduction in the percentage of CD4-CD8+ thymocytes, however this 
was not matched by a loss of the cell number of these cells (Fig 4.15.B.). Therefore, 










Figure 4.13. Targeted Deletion Of LTβR on Foxn-1cre Expressing TEC Results In 
Reduced mTEC 
Thymic lobes were harvested from control (Foxn-1cre/+), thymic epithelial specific 
LTβR-deficient (Foxn-1cre/+Ltbrfl/fl) and Ltbr-/- mice and enzymatically digested for 
stromal analysis by FACS. 
A) Expression of LTβR on TER119-Viability-CD45-EpCAM-1+ TEC, TER119-Viability-
CD45-EpCAM-1-PDPN+CD31- thymic mesenchyme and TER119-Viability-CD45-
EpCAM-1-PDPN-CD31+ thymic endothelium on Foxn-1cre (blue, n=6) and Foxn-
1creLtbrflox (red, n=6) mice alongside a Ltbr-/- (grey, n=3) control. 
B) LTβR MFI on TEC, mesenchyme and endothelium of Foxn-1cre (blue, n=6) and 
Foxn-1creLtbrflox (red, n=6) mice alongside a Ltbr-/- (grey, n=3) control. 
C) Cell numbers of thymus, CD45-EpCAM-1+ thymic epithelial cells (TEC), UEA-1-
Ly51+ cortical TEC (cTEC), UEA-1+Ly51- medullary TEC (mTEC), MHC Class IIhi (IAIE 
hi) CD80hi mTEChi and IAIE loCD80lo mTEClo were calculated as well as the number of 
Aire+ mTEChi and CCL21+mTEClo from Foxn-1cre (blue, n=12) and Foxn-1creLtbrflox 
(red, n=12) mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where * denotes a significant difference as p<0.05, ** as p<0.01 *** p<0.001 and **** 
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Figure 4.14. Absence Of LTβR On Thymic Epithelial Cells Impacts Medullary 
Thymic Epithelial Cell Organization 
Thymic lobes were harvested from control (Foxn-1cre/+) and thymic epithelial specific 
LTβR-deficient (Foxn-1cre/+Ltbrfl/fl) mice and snap-frozen on dry ice. Lobes were then 
cut 7µm thick and stained for immunofluorescence microscopy. 
A) Thymic sections of Foxn-1cre (left) and Foxn-1creLtbrflox (right) were stained with 
ER-TR5 to identify the medulla (red) and CD8 to identify the cortex (green). Scale 
bars indicated 500µm. 
B) The area of each medulla was measured by drawing round the medullas of thymic 
sections taken from different depths of the thymic tissue to ensure an accurate 
average number of medullary areas was calculated. Areas from Foxn-1cre (blue, n=3) 
and Foxn-1creLtbrflox (red, n=3) were sorted into three categories: <0.1mm2, <0.1mm2-
0.5mm2 and ≥0.5mm2.  
 
The standard error bars display the SEM and a parametric T-test was performed, 
where * denotes a significant difference as p<0.05 and ** p<0.01. All data is typical of 
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Figure 4.15. Deletion of LTβR On Thymic Epithelial Cells Does Not Impact 
Thymocyte Egress 
Thymic lobes were harvested from control (Foxn-1cre/+) and mesenchyme specific 
LTβR-deficient (Foxn-1cre/+Ltbrfl/fl) mice and enzymatically digested for FACS analysis 
of the thymocyte populations. 
(A) Expression pattern of CD4 and CD8 within Foxn-1cre (left) and Foxn-1creLtbrflox 
(right) thymi to identify CD4+CD8- SP4, CD4+CD8+ DP and CD4-CD8+ SP8 
thymocytes.  
(B) Cell number of the thymus, cSP4, SP8 and DP thymocytes and percentages of 
CD4+CD8- and CD4-CD8+ were calculated for Foxn-1cre (blue, n=15) and Foxn-
1creLtbrflox (red, n=14) mice.  
(C) Expression pattern of CD69 and CD62L within cSP4 thymocytes of Foxn-1cre 
(left) and Foxn-1creLtbrflox  (right) mice. 
(D) Cell numbers and percentages of immature and mature cSP4 thymocytes were 
calculated for Foxn-1cre (blue, n=15) and Foxn-1creLtbrflox (red, n=14) mice. 
(E) Expression pattern of CD69 and CD62L within SP8 thymocytes of Foxn-1cre (left) 
and Foxn-1creLtbrflox (right) mice. 
(F) Cell numbers and percentages of immature and mature SP8 thymocytes were 
calculated for Foxn-1cre (blue, n=15) and Foxn-1creLtbrflox (red, n=14) mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where * denotes a significant difference as p<0.05. All data is typical of 4 






















































































































































































Foxn-1creLtbrflox mice, there was no intrathymic accumulation when Ltbr was deleted 
on TEC and therefore LTβR-dependent thymocyte egress is not regulated by TEC. 
 
So far these analyses have ruled out a role for thymic mesenchyme and thymic 
epithelium in regulating thymocyte egress through the LTβR pathway, leaving thymic 
endothelial cells to be investigated. Previous studies have shown thymic endothelium 
can regulate thymocytes egress, which is logical based on the fact that endothelial 
cells represent the final barrier to egressing thymocytes to leave the thymus and 
enter the blood. Additionally thymic endothelial cells regulate LTβR-dependent T-cell 
progenitor entry (22,24).  
 
As with the TEC and mesenchyme specific models of LTβR deletion, the Cre/LoxP 
approach was taken to delete Ltbr on thymic endothelial cells. The Tie2cre model was 
chosen as previous studies have shown it to be suitable to target deletion to 
endothelial cells (244). Analysis of Tie2creLtbrflox thymocytes revealed no alteration to 
the SP4 or SP8 thymocyte percentages nor did they have an intrathymic 
accumulation of mature cSP4 of SP8 thymocytes (Fig 4.16.A-C.). To ensure that the 
Tie2cre was efficiently and specifically targeting thymic endothelial cells, Tie2cre mice 
were crossed with mT/mG mice. Analysis of the stroma of these mice revealed that 
whilst Tie2cre was specific to thymic endothelial cells, only 27.7% (± 6.83%) of thymic 
endothelium expressed Cre (Fig 4.16.D.E.). Consistent with the Tie2cremT/mG data 
there was inefficient deletion of LTβR on CD31+ thymic endothelium within 
Tie2creLtbrflox mice (Fig 4.16.F.). These data further support our previous conclusion 
that the efficiency and specificity of Cre mouse models need to be scrutinized to 
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ensure the correct conclusions are being made about data acquired through their 
use. 
 
Following the inefficiency of the Tie2cre an alternative endothelial-specific Cre was 
chosen. Previous studies have had success at targeting gene deletion to endothelial 
cells by using the endothelial-specific Flk-1cre/+ mouse strain (245). Flk-1cre mice were 
crossed with mT/mG mice to check the specificity of the Flk-1cre, revealing that 97.7% 
(± 0.48%) of thymic endothelium is Cre+ (Fig 4.17.A-D). Flk-1cre mice were then 
crossed to Ltbrflox mice and the thymic stromal populations were stained for LTβR to 
check for deletion (Fig 4.17.E). There was efficient deletion of LTβR on thymic 
endothelium, which was reduced to levels similar to Ltbr-/- mice (Fig 4.17.E.F.). There 
was a slight reduction of LTβR on thymic mesenchyme, however this reduction was 
not comparable to Ltbr-/- suggesting deletion of LTβR is occurring mainly within the 
endothelial compartment (Fig 4.17.E.F.). Therefore, unlike the Tie2creLtbrflox model, 
the Flk-1creLtbrflox model is a suitable method of deleting Ltbr on thymic endothelial 
cells to look at the impact on thymocyte egress. However a caveat of using 
endothelial cell Cre models, including the Flk-1cre strain, is that the Cre is also 
present in hematopoietic cell due to sharing an upstream precursor (245). However 
our BMC analysis has ruled out a role of LTβR expression by hematopoietic cells for 
thymocyte egress and therefore this should not impact our findings (Figure 4.5.).  
 
Thymocytes were isolated from Flk-1creLtbrflox and stained to examine the immature 
and mature fractions of cSP4 and SP8 thymocytes as performed previously. 










Figure 4.16. Inefficient And Non-Specific Targeting Of Thymic Endothelium By 
Tie2cre 
Thymic lobes were harvested from adult mice and enzymatically digested for FACS 
analysis of thymocytes populations 
(A) Expression pattern of CD69 and CD62L within cSP4 thymocytes of control 
(Tie2cre/+, left) and endothelial specific LTβR-deficient (Tie2cre/+Ltbrfl/fl, right) mice. 
(B) Expression pattern of CD69 and CD62L within SP8 thymocytes of Tie2cre (left) 
and Tie2creLtbrflox (right) mice. 
(C) Cell numbers of thymus, mature cSP4 and mature SP8 thymocytes were 
calculated for Tie2cre (blue, n=6) and Tie2creLtbrflox  (red, n=6) mice. 
(D) Expression of mT and mG within TEC, thymic mesenchyme and thymic 
endothelium from Tie2cre/+mice crossed with mT/mG fate mapper mice. 
(E) Percentage of mT-mG+ ‘switched’ cells within each stroma population (n=4).  
(F) Expression of LTβR on thymic endothelium in Tie2cre/+Ltbrfl/fl mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed. All 





















































































































































Figure 4.17. Targeted Deletion Of LTβR On Flk-1cre Expressing CD31+ Thymic 
Endothelium 
Thymic lobes were harvested from adult mice and enzymatically digested for FACS 
analysis of stromal populations 
(A) Expression of mT and mG within TER119-Viability-CD45-EpCAM-1+ thymic 
epithelial cells (TEC), TER119-Viability-CD45-EpCAM-1-PDPN+CD31- thymic 
mesenchyme and TER119-Viability-CD45-EpCAM-1-PDPN-CD31+ thymic 
endothelium of mT/mG control mice. 
(B) Example of gating to identify mT+mG- cells that have not switched and are 
therefore Cre- and mT-mG+ cells that have switched and are Cre+. 
(C) Expression of mT and mG within TEC, thymic mesenchyme and CD31+ 
endothelium of Flk-1cre/+ mice crossed with mT/mG fate mapper mice (n=13). 
(D) Percentage of mT-mG+ ‘switched’ cells within each stroma population.  
(E) Expression of LTβR on TEC, thymic mesenchyme and thymic endothelium of Flk-
1cre (blue, n=6) and Flk-1creLtbrflox (red, n=5) mice alongside a Ltbr-/- (grey, n=2) 
control. 
(F) LTβR MFI on TEC, mesenchyme and endothelium of Flk-1cre (blue, n=6) and Flk-
1creLtbrflox (red, n=5) mice alongside a Ltbr-/- (grey, n=2) control. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where * denotes a significant difference as p<0.05 and ** denotes p<0.01. Data of A-


































































































and SP8 thymocytes within the Flk-1creLtbrflox mice compared to Flk-1cre controls (Fig 
4.18.A.B.). Importantly, this increase mapped specifically to the mature fraction of 
both cSP4 and SP8 populations (Fig 4.18.C-F.). Therefore this data suggests there is 
an essential role of LTβR expressing thymic endothelial cells in regulating thymocyte 
egress. Additionally, the phenotype seen within the Flk-1creLtbrflox mice may be more 
severe than the germline Ltbr-/- mice as there is a significant increase in the total 
number and percentage of cSP4 and SP8 thymocytes that was not present in Ltbr-/- 
mice (Fig 4.2.B.; Fig 4.18.B.). 
 
A recent study identified a population of thymic endothelial cells, termed thymic portal 
endothelial cells (TPEC), whose development is dependent on LTβR signaling (24). 
This population of P-selectin+ (CD62p) Ly6C- thymic endothelium are absent in Ltbr-/- 
and have been proposed to be essential for LTβR-dependent ETP entry into the 
thymus (24). Interestingly this population is also reduced in the FlkcreLtbrflox mice and 
LTβR is absent on all three sub-populations of endothelium (CD62p+Ly6C-, 
CD62p+Ly6C+ and CD62p-Ly6C+) (Fig 4.19.A-E). Consistent with Ltbr-/- mice, the 
total number of CD31+ endothelium is not altered in FlkcreLtbrflox mice (Fig 4.19.D). 
This loss of portal endothelial cells that regulate T-cell progenitor entry correlates 
nicely with the increased intrathymic accumulation of mature thymocytes and 
therefore could suggest a potential mechanism by which LTβR is regulating 
thymocyte egress.  
 
Ltbr-/- and Flk-1creLtbrflox mice both displayed an intrathymic accumulation of mature 








Figure 4.18. Deletion of LTβR On Thymic Endothelial Cells Results In A 
Significant Intrathymic Accumulation Of Mature SP4 Thymocytes 
Thymic lobes were harvested from control (Flk-1cre/+) and mesenchyme specific 
LTβR-deficient (Flk-1cre/+Ltbrfl/fl) mice and enzymatically digested for FACS analysis 
of the thymocyte populations. 
(A) Expression pattern of CD4 and CD8 within Flk-1cre (left) and Flk-1creLtbrflox (right) 
thymi to identify CD4+CD8- SP4, CD4+CD8+ DP and CD4-CD8+ SP8 thymocytes.  
(B) Cell number of the thymus, cSP4, SP8 and DP thymocytes and percentages of 
CD4+CD8- and CD4-CD8+ were calculated for Flk-1cre (blue, n=6) and Flk-1creLtbrflox 
(red, n=4) mice.  
(C) Expression pattern of CD69 and CD62L within cSP4 thymocytes of Flk-1cre (left) 
and Flk-1creLtbrflox  (right) mice. 
(D) Cell numbers and percentages of immature and mature cSP4 thymocytes were 
calculated for Flk-1cre (blue, n=6) and Flk-1creLtbrflox (red, n=4) mice. 
(E) Expression pattern of CD69 and CD62L within SP8 thymocytes of Flk-1cre (left) 
and Flk-1creLtbrflox (right) mice. 
(F) Cell numbers and percentages of immature and mature SP8 thymocytes were 
calculated for Flk-1cre (blue, n=6) and Flk-1creLtbrflox (red, n=4) mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where * denotes a significant difference as p<0.05 and ** denotes p<0.01. All data is 
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Figure 4.19. Targeted Deletion Of LTβR On Flk-1cre Expressing Endothelial 
Cells Causes Specific Loss Of Thymic Portal Endothelial Cells 
Thymic lobes were harvested from adult mice and enzymatically digested for FACS 
analysis of stromal populations. 
(A) Expression pattern of CD62p and Ly6C on TER119-Viability-CD45-EpCAM-1-
PDPN-CD31+ thymic endothelium of Ltbr+/+, Ltbr-/-, Flk-1cre and FlkcreLtbrflox mice.  
(B) Expression of LTβR on CD62p+Ly6C-, CD62p+Ly6C+ and CD62p-Ly6C+ thymic 
endothelium of Flk-1cre and FlkcreLtbrflox mice alongside Ltbr-/- control mice. 
(C) LTβR MFI on CD62p+Ly6C-, CD62p+Ly6C+ and CD62p-Ly6C+ thymic 
endothelium of Flk-1cre (blue, n=6) and FlkcreLtbrflox (red, n=5) mice alongside Ltbr-/- 
control (grey, n=2) mice. 
(D) The cell number and percentage of CD31+ thymic endothelium within TER119-
Viability-CD45-EpCAM-1- non-epithelial stroma (NES) was calculated for Flk-1cre 
(blue, n=6) and FlkcreLtbrflox (red, n=5) mice. 
(E) The percentage of CD62p+Ly6C-, CD62p+Ly6C+ and CD62p-Ly6C+ populations 
with CD31+ thymic endothelium was calculated for Flk-1cre (blue, n=6) and 
FlkcreLtbrflox (red, n=5) mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where ** denotes a significant difference as p<0.01. All data is typical of 2 






































































































































sought to identify where within the thymus the mature thymocytes are being held. 
Mice with a thymocyte egress defect/block are often associated with a build up of 
cells within the perivascular space (PVS), a location within the thymus that exists 
between perivascular cells and the endothelium of the blood vessels that the 
perivascular cells surround (111). In instances of PVS accumulation, thymocytes are 
stuck at the last checkpoint of exit and are not able to enter the blood stream (111). 
Unlike mice with an intrathymic accumulation of mature thymocytes and an 
accompanying PVS accumulation as reported in Il4ra-/- mice, Ltbr/- do not show any 
signs of a PVS accumulation (Fig 4.20.A.B.). Perivascular TR7+ mesenchyme tightly 
surround CD31+ thymic endothelial cells, with no obvious accumulation of 
thymocytes in the space between the two basement membranes (Fig 4.20.A.B.). 
Consistent with this, the same phenotype was observed in Flk-1creLtbrflox mice 
suggesting that accumulating thymocytes are not located in the PVS (Fig 21.A.B.).  
 
Another method of measuring cells within the PVS that are in the process of 
egressing the thymus is through the use of I.V. injecting an anti-CD4 antibody to label 
SP4 thymocytes in contact with the blood (111). This technique has been previously 
used to identify PVS accumulations by showing an increase in the percentage of 
cells labeled with the I.V. administered anti-CD4 antibody (IV CD4+ cells) (111). Anti-
CD4 injection labels a very small fraction of cells within WT mice, which is reduced in 
WT mice treated with FTY720 to block entry into the PVS (Fig 4.22.A.). Ltbr+/+ and 
Ltbr-/- mice were injected with the anti-CD4 antibody and, consistent with the 
immunofluorescence microscopy, there was no increase of IV CD4+ cells within Ltbr-/- 
mice (Fig 4.22.B.). Surprisingly there was actually a decrease in the percentage of IV 
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CD4+ labeled cells and potentially a reduction in number within Ltbr-/- mice 
suggesting that mature cells are struggling to enter the PVS highlighting a potential 
role of LTβR in thymocyte entry to the PVS (Fig 4.22.B.). The same experiment and 
analysis were carried out on Flk-1creLtbrflox mice and consistent with Ltbr-/- thymic, 
endothelial specific deletion of Ltbr resulted in a similar reduction in the percentage 
and a significant reduction in the number of IV CD4+ cells (Fig 4.22.C.). These data 
highlight a role for LTβR in controlling thymocyte entry into the PVS and suggests 
this could be linked to the thymocyte egress defect found within these mice. 
Additionally it suggests that this role is carried out by thymic endothelium.  
 
After identifying endothelial cells as the essential population for regulating LTβR-
dependent thymocyte egress what remained to investigate was the mechanism 
through which LTβR is regulating thymocyte egress. The sphingosine-1-phosphate 
(S1P) pathway is regarded as the primary mechanism of thymocyte egress and is 
regulated by multiple cell types through the action of enzymes that are required for 
S1P production or reduction to maintain an S1P gradient that directs thymocyte 
egress (111,112,114). It has yet to be investigated whether LTβR signaling plays a 
role in regulating the S1P pathway. To investigate this, stromal cells were isolated 
from 2-dGuo-treated FTOC lobes stimulated with agonistic anti-LTβR antibody. PCR 
analysis was carried out for genes associated with the S1P pathway including S1P 
degrading enzyme Sgpl1 and dephosphorylating enzyme Ppap2b, which reduce the 
amount of S1P. Spns2 and Sphk1, which are required for the production of S1P, 
were also included in the analysis. This analysis revealed that Sgpl1, Sphk1 and 









Figure 4.20. Ltbr-/- Mice Do Not Have Perivascular Accumulations 
Thymic lobes were harvested from control (Ltbr+/+) and LTβR-deficient (Ltbr-/-) mice 
and snap-frozen on dry ice. Lobes were then cut 7µm thick and stained for 
immunofluorescence microscopy. 
(A) Thymic sections of Ltbr+/+ thymi were stained with CD8 (blue), TR7 (red), CD31 
(green) and DAPI (grey). Scale bars indicated a scale of 10µm. Single color images 
are shown as well as composite images of all colors with (bottom right) or without 
(top right) DAPI. 
(B) Thymi sections of Ltbr-/- thymi were stained with CD8 (blue), TR7 (red), CD31 
(green) and DAPI (grey). Scale bars indicated a scale of 10µm. Single color images 
are shown as well as composite images of all colors with (bottom right) or without 
(top right) DAPI. 
 
Data is representative of 2 mice. 
  
A) Ltbr+/+ 










Figure 4.21. Flk-1creLtbRflox Mice Do Not Have Perivascular Accumulations 
Thymic lobes were harvested from control (Flk-1cre/+) and endothelial specific LTβR-
deficient (Flk-1cre/+Ltbrfl/fl) mice and snap-frozen on dry ice. Lobes were then cut 7µm 
thick and stained for immunofluorescence microscopy. 
(A) Thymic sections of Flk-1cre thymi were stained with CD8 (blue), TR7 (red), CD31 
(green) and DAPI (grey). Scale bars indicated a scale of 20µm. Single color images 
are shown as well as composite images of all colors with (bottom right) or without 
(top right) DAPI. 
(B) Thymi sections of Flk-1creLtbrflox thymi were stained with CD8 (blue), TR7 (red), 
CD31 (green) and DAPI (grey). Scale bars indicated a scale of 20µm. Single color 
images are shown as well as composite images of all colors with (bottom right) or 
without (top right) DAPI. 
 
Data is representative of 2 mice. 
  
A) Flk-1cre 







Figure 4.22. LTβR Is Required For Cells To Enter The Perivascular Space 
During T-cell Egress 
Adult control (Ltbr+/+) and LTβR deficient (Ltbr-/-) mice were injected I.V. with anti-
CD4 PE-conjugated antibody at a concentration of 5µg/ml. Mice were sacrificed three 
minutes after injection and the thymi were immediately harvested and mechanically 
disrupted for thymocyte analysis. 
(A) Expression of anti-CD4 PE (IV CD4) and CD8 on thymocytes of WT mice of the 
following conditions: an uninjected control, a mouse injected with FTY720 I.P. the 
day before anti-CD4 I.V. injections and a mouse just receiving anti-CD4 I.V. 
injections.  
(B) Expression of IV CD4 and CD8 on thymocytes of Ltbr+/+ (left) and Ltbr-/- (right) 
injected with anti-CD4 I.V. Cell numbers of thymus and IV CD4+ labeled cells and 
percentages of IV CD4+ labeled cells from Ltbr+/+ (blue, n=7) and Ltbr-/- (red, n=7) 
injected with anti-CD4 I.V. 
(C) Expression of IV CD4 and CD8 on thymocytes of Flk-1cre/+ (left) and Flk-
1cre/+Ltbrfl/fl (right) injected with anti-CD4 I.V. Cell numbers of thymus and IV CD4+ 
labeled cells and percentages of IV CD4+ labeled cells from Flk-1cre/+ (blue, n=6) and 
Flk-1cre/+Ltbrfl/fl (red, n=6) injected with anti-CD4 I.V. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where * denotes a significant difference as p<0.05 and ** p<0.01. All data is typical of 






























































































































stimulation (Fig 4.23.A.), suggesting LTβR may play a role in regulating S1P. CCL21 
and CCL19 are known targets of LTβR and were included to control for successful 
LTβR stimulation. To ensure the thymocytes within Ltbr-/- mice do not have a cell 
intrinsic defect in S1P-related machinery, PCR analysis was carried out on sorted 
immature and mature SP4 thymocytes from Ltbr+/+ and Ltbr-/- mice. Mature SP4 
thymocytes from Ltbr-/- expressed similar levels of S1pr1, which is the gene encoding 
S1PR1 as well Foxo1 and Klf2 which are regulators of S1PR1 (Fig 4.23.B.) (99,101). 
Additionally Ltbr+/+ and Ltbr-/- mature SP4 thymocytes expressed similar levels of 
Coro1a, which is associated with regulating thymocyte egress (Fig 4.23.B.). 
Therefore S1P associated thymic machinery is not altered within Ltbr-/- thymocytes. 
 
Levels of S1P can be measured indirectly by the expression of S1PR1 on mature 
thymocytes within the thymus. This can be a useful way to measure whether S1P 
levels are altered, as the level of S1PR1 expression on the thymocyte surface is 
inversely correlated with ligand exposure and therefore a reduction of S1P will result 
in increased surface expression of S1PR1. Therefore measuring S1PR1 on mature 
thymocytes can be used to explore whether Ltbr-/- mice have altered S1P levels 
within the thymus. Thymocytes were stained with an anti-S1PR1 antibody and its 
expression is restricted to mature, egress competent, SP4 thymocytes, consistent 
with previous reports (Fig 4.24.A.B.) (262). Interestingly, the expression of S1PR1 is 
significantly higher on mature SP4 thymocytes of Ltbr-/- mice compared to Ltbr+/+ 
controls (Fig 4.24.C.D). To ensure that higher levels of S1PR1 are not being 
measured due to the increased number of older mature SP4 thymocytes within Ltbr-/- 
mice, RAGgfp+ mature SP4 thymocytes from Ltbr+/+RAGgfp and Ltbr-/-RAGgfp mice 
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were split into five different populations of differing RAGgfp levels to target cells of 
different ages and ensure comparison of S1PR1 between thymocytes of an 
equivalent age within each strain (Fig 4.24.E.). Consistent with S1PR1 levels on total 
mature SP4 thymocytes, S1PR1 is significantly increased on Ltbr-/- mature 
thymocytes at all ages groups created (Fig 4.24.E.F.). This indicates a reduction of 
S1P within the thymus of Ltbr-/- mice suggesting that either the S1P gradient is 
altered or exposure of the mature thymocytes to S1P is altered, resulting in the 
intrathymic accumulation and egress defects seen within these mice. Additionally the 
same analysis was carried out on Flk-1creLtbrflox mice, which show a similar increase 
in S1PR1 is present on mature SP4 thymocytes within Flk-1creLtbrflox mice (Fig 
4.24.G.). Interestingly S1PR1 is not altered on mature thymocytes within Foxn-
1creLtbrflox thymus consistent with no intrathymic accumulation (Fig 4.24.H.). This 
suggests that LTβR regulates the S1P gradient through LTβR expressing 
endothelium, which may be restricted to CD62P+Ly6C- portal endothelial cells that 
have been proposed to regulate ETP entry. 
 
Together these analyses support a role for LTβR signaling in regulating thymocyte 
egress. The expression of LTβR was found to be stromal and our analysis revealed 
that deletion of Ltbr specifically on thymic endothelial cells is sufficient to recapitulate 
the thymocyte egress defect of Ltbr-/- mice. Additionally we have shown that S1P 
levels appear reduced in the germ line and endothelial specific LTβR deletion models 
and suggest a role for LTβR in regulating thymocyte entry into the perivascular space 
during thymocyte egress. Therefore we propose a novel role for thymic endothelium 









Figure 4.23. PCR Analysis Of S1P-S1PR1 Pathway Related Genes 
(A) Quantitative real time PCR was performed on stroma isolated from E15 
embryonic thymic lobes cultured with dGuo for 7 days, which was then cultured with 
or without an agonistic anti-LTβR antibody. 
 (B) Quantitative real time PCR was performed on the following populations sorted 
from adult Ltbr+/+ (blue) and Ltbr-/- (red) mice: 
  CD4+CD8-TCRbhiCD25-RAG+CD69+CD62L- Im SP4 
  CD4+CD8-TCRbhiCD25-RAG+CD69-CD62L+ Ma SP4 
 
Error bars indicate the SEM and mRNA levels were normalized to housekeeping 
gene β-actin. Data is from at least two independently sorted biological samples; with 
each gene analyzed a minimum of two times and each PCR ran in triplicates to 
obtain a SEM.  
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Figure 4.24. Mature SP4 Thymocytes Of Ltbr-/- And Flk-1creLtbrflox Mice Have 
Altered S1PR1 Expression 
Thymic lobes were harvested from control (Ltbr+/+) and LTβR-deficient (Ltbr-/-) mice 
and mechanically disrupted for FACS analysis of thymocytes. 
(A) Expression pattern of S1PR1 on CD4+CD8-TCRβhiCD25-CD69+CD62L- immature 
(blue) and CD4+CD8-TCRβhiCD25-CD69loCD62L+ mature (red) SP4 thymocytes 
alongside a staining control (grey).  
(B) S1PR1 MFI for immature (blue) and mature (red) CD25- SP4 thymocytes of 
Ltbr+/+ (n=7) mice.  
(C) Expression pattern of S1PR1 on mature CD25- SP4 thymocytes of Ltbr+/+ (blue, 
n=7) and Ltbr-/- (red, n=7) mice alongside a staining control (grey). 
(D) S1PR1 MFI for mature CD25- SP4 thymocytes of Ltbr+/+ (blue, n=7) and Ltbr-/- 
(red, n=7) mice.  
(E) Expression pattern of CD4 and RAGgfp within RAG+ mature CD25- SP4 
thymocytes of Ltbr+/+ (left) and Ltbr-/- (right) mice. The RAGgfp population is separated 
into five slices (1-5) to create five populations of different ages and the S1PR1 MFI is 
plotted for each population for Ltbr+/+ (blue, n=7) and Ltbr-/- (red, n=7) mice. 
(F) Expression of S1PR1 on the five populations of RAG+ mature CD25- SP4 
thymocytes identified in (E) of Ltbr+/+ (blue, n=7) and Ltbr-/- (red, n=7) mice alongside 
a staining control. 
(G) Expression of S1PR1 on CD25- mature SP4 thymocytes from Flk-1 (blue, n=3) 
and Flk-1creLtbrflox mice (red, n=3) alongside a staining control and the S1PR1 MFI is 
plotted. 
(H) S1PR1 MFI plotted for CD25- mature Sp4 thymocytes from Foxn-1 (blue, n=6) 
and Foxn-1creLtbrflox mice (red, n=5). 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where * denotes a significant difference as p<0.05 and ** p<0.001. All data is typical 
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Whilst previous studies have investigated the role of LTβR in regulating thymocyte 
egress, the precise mechanism whereby LTβR regulates this process remains 
unknown. This chapter sought to identify the cellular and molecular regulators of 
thymocyte egress and explore the role that LTβR plays in this process. 
 
LTβR was first identified to be important for thymocyte egress in initial studies by 
Boehm et al., which investigated the thymic phenotype of Ltbr-/- adult mice. The 
thymus from these mice had an intrathymic accumulation of mature SP4 and SP8 
thymocytes, as well as altered medullary organization and mTEC numbers (151). 
The accumulation of mature thymocytes within these mice was assumed to be due to 
a block in thymocyte egress as the increase in the number of mature cells was not 
the result of increased proliferation, a finding we have also observed (not shown). 
Whilst an intrathymic accumulation may correlate with an egress problem, this was 
not directly explored in the Boehm et. al study. Alternative explanations for increased 
mature thymocytes could include an increased intrathymic dwell time or reduced rate 
of T-cell export. In order to directly investigate the impact of LTβR-deficiency on 
thymocyte egress we used the RAGgfp mouse model to track recent thymic emigrants 
(RTE) in the periphery of Ltbr-/- mice and showed that the proportion of RTE in the T-
cell pool was significantly reduced. However, this reduction was not seen at a 
quantitative level, which is most likely due to the absence of pLN in Ltbr-/- which 
results in an increase in splenocyte cellularity, with the bulk of the peripheral T-cell 
pool to residing within the spleen. Therefore our data is the first instance where an 
egress problem has been directly observed within Ltbr-/- mice. Interestingly, in 
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addition to the intrathymic accumulation of mature thymocytes and corresponding 
reduction in peripheral RTE, our data demonstrates that LTβR directly regulates the 
kinetics of medullary residency as reflected by increased intrathymic dwell time.  
 
The lack of lymph nodes in Ltbr-/- could potentially be a contributing factor to the 
egress defect within these mice as a lack of periphery lymphoid tissues available for 
T-cells to migrate to in the periphery may feedback to reduce T-cell output of the 
thymus. However the kidney capsule grafting experiment showed an intrathymic 
accumulation within grafted Ltbr-/- thymic lobes and in this context the host mouse 
has normal peripheral lymph nodes. Therefore the presence of peripheral lymph 
nodes does not rescue the defective egress phenotype of the Ltbr-/- thymus.   
 
Because LTβR-deficient mice have a disrupted medullary phenotype, exhibiting both 
gross medullary disorganization and reduced mTEC populations, as well as a 
significant intrathymic accumulation of mature thymocytes it was proposed that 
mTEC and/or the medullary organization could be essential for LTβR-dependent 
thymocyte egress (151). Our bone marrow chimera (BMC) and kidney capsule 
transfer experiments, where LTβR-deficiency is limited to thymic stroma or 
hematopoietic cells, respectively, supported a role for thymic stroma and not 
hematopoietic cells in regulating thymocyte egress through LTβR signaling. The 
finding that hematopoietic cells are not required for thymocyte egress was 
interesting; a recent study found that deleting sphingosine-1-phosphate lyase (SPL) 
in bone marrow derived cells, thymocytes or dendritic cells (DCs) was sufficient to 
prevent thymocyte egress and cause an intrathymic accumulation of mature single-
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positive (SP) thymocytes (114). The study of Zamora-Pineda et. al revealed that 
deleting SPL in thymic epithelial cells (TEC) or endothelial cells did not impact 
egress, therefore it seems from our own analysis that LTβR is dispensable for SPL-
mediated thymocyte egress.  
 
Thymic epithelial, mesenchymal and endothelial cells all express LTβR (Fig 4.4.B.) 
and through the use of stromal cell-specific Cre mice crossed with Ltbrflox mice we 
were able to specifically delete Ltbr on each of the stromal populations in order to 
explore the cell-specific role of LTβR in thymic stromal compartments. 
 
There have been previous studies that support a role for TEC regulating thymocyte 
egress; however there has not been any study to date that directly links LTβR’s 
regulation of TEC and thymocyte egress (112,115). TEC express the CCR7-ligands 
CCL21 and CCL19, which have been shown to regulate neonatal thymocyte egress 
(69,116). Additionally TEC have been shown to be essential in maintaining the S1P 
gradient required for normal thymocyte egress through the production of LPP3 (112). 
CCR7-ligands are known targets of LTβR signaling however it is not known whether 
LPP3 is as well (194). However despite these factors there was no observable 
intrathymic accumulation of mature thymocytes within the epithelial-specific deletion 
of LTβR mice (Foxn-1creLtbrflox). This was a surprising finding because the 
disorganization of the medulla and loss of mTEC and CCL21+ mTEClo are such 
drastic phenotypes within both the constitutive Ltbr-/- mouse and the epithelial-
specific Foxn-1creLtbrflox mouse. The impact of a disorganized medulla on thymocyte 
egress has been ruled out through the use of plt/plt mice as well as Ccr7-/- mice, 
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which both have disorganized medullary architecture, complete inhibition of the 
CCR7-CCR7-L pathway and impaired cortex-medulla migration (69,71,249). 
Although we have not directly investigated this, Zhu et. al proposed that the cortex-
medulla migration of SP8 thymocytes was impaired in Ltbr-/- mice (155). Because the 
Foxn-1creLtbrflox mice have a very similar medullary phenotype, these mice may also 
have the same cortex-medulla migration defect. As there is no accumulation of 
mature thymocytes within plt/plt or Foxn-1creLtbrflox mice, this would suggest that the 
potential mispositioning of the SP thymocytes does not impact thymocyte egress. 
Together this suggests that a disrupted medullary environment does not impact the 
ability of thymocytes to egress and therefore is not the source of the thymocyte 
egress defect present within the Ltbr-/- mouse thymus.  
 
The loss of mTEC within both Ltbr-/- and Foxn-1creLtbrflox mice would suggest that 
there may be reduced thymocyte:mTEC interactions due to the reduced frequency of 
mTEC within the medullas. Consistent with this, Ltbr-/- mice do show signs of reduced 
interactions between SP4 thymocytes and mTEC by measuring reduced MHC Class 
II on the surface of SP4 thymocytes which indicates cell contact between SP4 and 
mTEC (153). This would suggest that interactions with mTEC are not essential for 
thymocyte egress, which is consistent with the normal programme of SP thymocyte 
development within Relb-/- mice, which have an absence of RelB-dependent mTEC, 
however experiments directly investigating thymocyte egress within Relb-/- mice 




Previously thymic pericytes have been implicated in regulating thymocyte egress 
through the production of the enzymes sphingosine-1-phosphate kinase (SPHK) 1 
and SPHK2 which catalyze the ATP-dependent phosphorylation of sphingosine to 
produce S1P (111). Our own research has shown that PDPN+ thymic mesenchyme 
have a somewhat pericyte-like phenotype as they have a perivascular positioning 
and express PDGFRβ (Chapter 3). Interestingly we have also shown that the 
population of ICAM-1hiVCAM-1hi PDPN+ thymic mesenchyme expresses CCL19 and 
SPHK1, both of which have been implicated in the regulation of thymocyte egress 
(110,111,116). Additionally, the development of this population of ICAM-1hiVCAM-1hi 
PDPN+ thymic mesenchyme is dependent on LTβR signaling, suggesting that this 
mesenchyme population may be a candidate for the stromal regulator of LTβR-
dependent thymocyte egress. 
 
Using Wnt-1creLtbrflox we were able to specifically target Ltbr deletion to PDPN+ 
thymic mesenchyme and this recapitulated the loss of ICAM-1hiVCAM-1hi PDPN+ 
thymic mesenchyme seen in the constitutive Ltbr-/- mouse (Fig 4.7. & Fig 4.8.). 
Additionally Wnt-1creLtbrflox mice have a thymic dendritic cell (DC) defect that mirrors 
that of Ltbr-/- mice, revealing a functional defect in the Wnt-1creLtbrflox mouse model 
consistent with successful Ltbr deletion (157). However despite these positive 
identifiers of specific and efficient Cre-mediated deletion of floxed Ltbr in thymic 
mesenchyme, there was no observable intrathymic accumulation of mature 
thymocytes (Fig 4.9.). Therefore despite the clear role for LTβR in regulating the 
development of thymic mesenchyme and thymic DC, LTβR signaling is not essential 
for regulation of thymocyte egress via thymic mesenchyme.  
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This would suggest that previously identified regulators of thymocyte egress that are 
expressed by thymic mesenchyme such as SPHK1 and SPHK2 are not dependent 
on LTβR signaling (111). Staining for S1PR1 on mature thymocytes within the Wnt-
1creLtbrflox thymus could further test this hypothesis, however the lack of an 
intrathymic accumulation would predict that intrathymic S1P levels are normal.  
 
It was surprising that LTβR expression by PDPN+ thymic mesenchyme is not 
essential for thymocyte egress given their perivascular location around thymic 
endothelial cells (Chapter 3). Indeed we have not been able to directly identify the 
location of ICAM-1hiVCAM-1hi mesenchyme within the thymus and therefore one 
possible explanation as to why this population is not required for thymocyte egress is 
that these cells may be the non-perivascular thymic mesenchymal cells identified in 
Chapter 3. However the PCR analysis of gene expression of Sphk1 within ICAM-1hi 
PDPN+ mesenchyme compared to ICAM-1lo is consistent with a pericyte-like 
phenotype, which would support a perivascular positioning of the ICAM-1hiVCAM-1hi 
PDPN+ mesenchyme cells.  
 
In addition to the deletion of Ltbr within thymic mesenchymal cells resulting in the 
loss of the ICAM-1hiVCAM-1hi PDPN+ population, Wnt-1creLtbrflox mice have reduced 
DC populations, which is consistent with the constitutive Ltbr-/- mice shown in our 
recently published study (157). This is an interesting observation as thymic DC have 
been shown to regulate thymocyte egress through their production of S1P lyase 
which helps to maintain the S1P gradient by degrading interstitial S1P (114). Our 
BMC results revealed that LTβR operates to regulate egress in a non-hematopoietic 
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manner and therefore there is no role for LTβR expressed by DCs to regulated 
thymocyte egress, however the above data also rules out an indirect role of LTβR-
expression thymic mesenchyme regulating thymocyte egress via regulation of DC 
populations within the thymus.  
 
Thymic endothelial cells remained the final stromal cell candidate for LTβR-
dependent thymocyte egress. Using Flk-1creLtbrflox mice we were able to specifically 
and efficiently target Ltbr deletion to CD31+ thymic endothelial cells. A caveat of 
using some endothelial-specific Cre lines, including the Flk-1cre model, is that Cre 
activity does target hematopoietic cells due to an upstream precursor population 
shared by hematopoietic cells and endothelial cells (245). However in the context of 
LTβR-dependent thymocyte egress, our BMC experiments reveal no impact on 
thymocyte egress when LTβR is absent on hematopoietic cells and therefor the Cre 
activity within hematopoietic cells should not interfere with this analysis. These mice 
exhibited an intrathymic accumulation that was similar to Ltbr-/- mice suggesting they 
have a thymocyte egress defect, however the impact on RTE has yet to be directly 
confirmed through the use of Flk-1creLtbrfloxRAGgfp mice, which due to time 
constraints of breeding have yet to investigated. Therefore our data highlights a novel 
role of thymic endothelium regulating LTβR-dependent thymocyte egress. Thymic 
endothelial cells have been shown to regulate thymocyte egress before. Deletion of 
Ppa2b (gene encoding LPP3) on thymic endothelial cells resulted in an intrathymic 
accumulation of mature thymocytes (112). However our PCR analysis of 2-dGuo 
treated fetal thymic organ cultures (FTOC) stimulated with anti-LTβR revealed that 
expression of Ppa2b was not increased upon stimulation of anti-LTβR. To directly 
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investigate this, cell sorting of thymic endothelial cells from Ltbr+/+, Ltbr-/- as well as 
from Flk-1cre and Flk-1creLtbrflox mice is currently underway to identify potential 
regulators of S1P, including Ppa2b. Vascular endothelium has been previously 
reported to be a major source of plasma S1P in addition to the hematopoietic system 
(267). Findings from Venkataraman et. al have shown that cultured endothelial cells 
express Sphk1 and Sphk2 which are required for the production of S1P, but also 
express Sgpp2 and Sgpl which degrade S1P (267). Whilst the production of S1P by 
endothelial cells may be counterintuitive due to their expression of Sgpp2 and Sgpl 
which degrade S1P, in vitro analysis appeared to show that under conditions of 
laminar shear stress there was a down regulation of Sgpp2 and Sgpl and a 
concomitant release of S1P. Whilst these findings are from in vitro endothelial cell 
cultures there may be scope for thymic endothelial cells to contribute to the S1P 
gradient beyond as a negative regulator of S1P, which we hope our PCR analysis will 
reveal. Additionally, expression of the S1P transporter spinster homolog 2 (Spns2) on 
thymic endothelial cells is essential for thymocyte egress, suggesting another 
possible mechanism for LTβR regulation of thymocyte egress via thymic endothelium 
(113).  
 
We believe the S1P pathway is involved in LTβR-dependent thymocyte egress due to 
the altered expression of the S1P receptor 1 (S1PR1) on mature thymocytes, which 
is significantly higher on mature thymocytes within Ltbr-/- and Flk-1creLtbrflox mice. 
Importantly using Ltbr-/-RAGgfp mice we were able to gate mature SP4 thymocyte 
populations of a comparable age between Ltbr+/+ and Ltbr-/- mice and showed that 
mature cells of a comparable age from Ltbr-/- mice have significantly higher 
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expression of S1PR1. Therefore the increase of S1PR1 is likely due to altered 
interstitial free S1P and not due to the increased maturity of mature SP4 thymocytes 
within Ltbr-/- mice. Another important result was that Foxn-1creLtbrflox mature SP4 
thymocytes have normal levels of S1PR1, which suggests that disorganization and 
potential mispositioning within the Ltbr-/- thymus does not cause an increase of 
S1PR1 on mature SP4 thymocytes. However this finding does not rule out that 
increased S1PR1 is due to altered exposure of the mature cells to S1P rather than 
altered levels of S1P within the thymus. 
  
Therefore our analysis highlights a novel role of LTβR regulating the S1P-S1PR1 
pathway to regulate thymocyte egress, however the exact mechanism through which 
this occurs requires further research. 
 
It was recently revealed in a study of the role of LTβR in T-cell progenitor entry into 
the thymus that the total CD31+ thymic endothelial population could be further 
subdivided into distinct populations (24). The findings of Shi et al. revealed that Ltbr-/- 
mice have a specific loss of CD62p+ (P-selectin) Ly6C- endothelial cells that they 
termed thymic portal endothelial cells (TPECs) due to their localization with 
perivascular spaces and thymic seeding progenitor cells, and these TPECs are 
crucial to the entry of T-cell progenitors into the thymus (24). Therefore Ltbr-/- mice 
have a mature thymocyte egress defect as well as an ETP entry defect both 
correlating with altered thymic endothelial cells at the CMJ which is the proposed site 
of entry and exit (22,24,268). Our analysis revealed that Flk-1creLtbrflox mice have a 
significant loss of TPECs and that TPECs express LTβR in control mice but have a 
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loss of LTβR expression in Flk-1creLtbrflox mice. Therefore our analysis suggests that 
LTβR is regulating thymocyte egress through its control of thymic endothelial cells 
and this may map to a specific population of portal endothelial cells, whose 
development is dependent on LTβR. Furthermore, stromal cells that regulate 
thymocyte egress may also regulate ETP entry into the thymus raising an interesting 
hypothesis that LTβR-dependent ETP entry and thymocyte egress could be linked. 
 
An interesting observation to come out of our immunofluorescence microscopy 
analysis was the lack of accumulating cells within the PVS of Ltbr-/- and Flk-1creLtbrflox 
mice. In previous studies of mice within an intrathymic accumulation of mature 
thymocyte and/or a thymocyte egress defect there can be an associated 
accumulation of cells in the PVS (111). It was previously shown that S1PR1-
transgenic mice which had premature expression of S1PR1 on DP thymocytes 
showed an accumulation of cells within the PVS (111). Additionally a recent study 
showed that in the absence of IL-4Rα there is reduced RTE as well as an intrathymic 
accumulation of mature cells within the PVS (115). Both studies used a technique of 
labeling cells in the process of thymocyte egress within the PVS space, which 
involves injecting anti-CD4 PE antibody intravenously (I.V) for a short period of time. 
Both studies revealed an increase in the proportion of labeled cells and consistent 
with our microscopy we did not see an increase. Rather there was a decrease in the 
percentage and number of cells entering the PVS, suggesting that a potential reason 
as to why thymocytes might not be leaving the thymus efficiently is that they have a 
reduced capacity to access the PVS. Whilst this does suggest that entry into the PVS 
is faulty, it does not rule out a potentially compounding effect of defective egress from 
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the PVS into the periphery. As previously discussed, the regulation of the S1P 
gradient by endothelial cells through both the negative and positive regulators of S1P 
levels (degrading S1P via S1P lyase or increased release/production of S1P via 
Spns2 or SPHK) may compound the egress defect. Future experiments exploring the 
differential expression of genes within endothelial cells of Ltbr-/- and Flk-1creLtbrflox 
mice will attempt to address this. 
 
As the intrathymic accumulation of mature thymocytes does not appear to be 
occurring within the PVS, current experiments are underway to directly investigate 
where the intrathymic accumulation of mature thymocytes is occurring which we 
hypothesis may be found within the medulla due to it being the final site of maturation 
prior to thymocyte egress. Preliminary analysis is indicating that this may be the case 
in both the Ltbr-/- and the Flk-1creLtbrflox thymus. An interesting hypothesis as to why 
this may occur comes from observations of the balance of the CCR7 and S1P-
S1PR1 pathway in lymph nodes. For cells to enter the lymph nodes they must 
express CCR7 and due to the high levels of S1P in the blood these cells do not 
express S1PR1 (269). Subsequent exit of the LN is dependent on downregulation of 
CCR7 and expression of S1PR1 to overcome CCR7-CCR7-L mediated retention 
within the LN (270). The observation that cells within Ltbr-/- and Flk-1creLtbrflox have 
increased S1PR1 (suggesting reduced S1P) and still have presence of CCR7-ligands 
within the medulla (although reduced in the Ltbr-/-) may suggest a similar mechanism 
is in place within the thymus. The hypothesis being that in these mice, intrathymic 
S1P is reduced; preventing the cells to efficiently leave the medulla via overcoming 
CCR7-CCR7-L signals. This would also be consistent with Foxn-1creLtbrflox mice, 
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which have reduced CCL21+ mTEC, but normal S1P levels which is sufficient for 
normal thymocyte egress. To investigate this hypothesis directly we have begun 
preliminary analysis of Ltbr-/-plt/plt “double KO (dKO)” mice, which will have the 
proposed S1P-reduction of the Ltbr-/- but a complete loss of CCL21. Therefore if our 
hypothesis is correct the complete absence of CCR7-ligands should rescue the 
egress defect of the Ltbr-/- mice. Our preliminary analysis of these mice may suggest 
that dKO mice do not have an intrathymic accumulation defect and intrathymic dwell 
time appears normal. If these findings are consistent this would provide evidence that 
CCR7-L and S1P-S1PR1 pathways are opposing each other within the thymus to 
regulate thymocyte egress. This would highlight a novel role within the thymus for 
LTβR, S1P-S1PR1 and CCR7-CCR7-L signals regulating thymocyte egress through 
a mechanism where fine balance of retention and egress signals determines 
thymocyte egress.   
 
As well as the S1P-S1PR1 pathway, alternative pathways have been proposed to 
regulate thymocyte egress. CXCR4 has previously been suggested to regulate 
thymocyte egress however if or how CXCR4 regulates thymocyte egress was unclear 
due to the embryonic lethality of CXCR4-deficient mouse models (118–120). 
However a recent study using a more refined model of CXCR4 deletion, where 
Cd4creCxcr4flox mice were used to avoid the embryonic lethality and deleted Cxcr4 
specifically in DP thymocytes and their downstream progeny, revealed no role for 
CXCR4 in thymocyte egress (122). As previously discussed, IL-4Rα was recently 
identified as a novel regulator of thymocyte egress, however a distinct phenotype of 
the Il4ra-/- thymus was large accumulations of cells within the PVS (115). As Ltbr-/- 
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mice lack PVS accumulation it is unlikely that this type 2 cytokine axis is being 
regulated via LTβR. Moreover Il4ra-/- mice show no impact on S1P-mediated 
signaling, further suggesting LTβR is not regulating IL-4Rα-dependent egress.   
 
Based on these findings, summarized in Figure 4.25, our analysis does not rule out 
the role of multiple stromal cell types regulating thymocyte egress, on the contrary 
there are many different mechanisms and cell types regulating thymocyte egress. We 
propose that thymic endothelial cells are essential for the regulation of LTβR-
dependent thymocyte egress and this may be occurring specifically at the stage of T-
cell entry into the perivascular space. Therefore our analysis highlights this as a 








Figure 4.25. LTβR Regulation Of Thymic Endothelium Is A Critical Regulatory 
Pathway Of T-Cell Egress  
(A) Under normal steady-state conditions, T-cell egress within the adult thymus 
occurs following maturation of immature SP thymocytes from a CD69+CD62L- 
RAGgfp+++ population into a CD69loCD62L+S1PR1+RAGgfp++ population. This 
expression of S1PR1 signifies the mature SP thymocytes ability to egress the 
thymus, which it undergoes via blood vessels at the corticomedullary junction (CMJ). 
(B) Adult LTβR-deficient mice have a significant T-cell egress defect. S1PR1-
expressing mature SP thymocytes do not exit the thymus properly and instead 
accumulate within the thymus. These cells have significantly higher expression of 
S1PR1, which indicates that intrathymic levels of S1P are reduced, which may be the 
cause of the altered T-cell egress. These cells also have lower RAGgfp expression 
indicative of their increased time within the thymus due to their inability to exit the 
thymus properly. 
(C) We generated Flk-1creLtbrflox mice within which Ltbr is specifically deleted on 
endothelial cells, including all the endothelial cells within the thymus. These mice 
phenotypically mirrored LTβR-deficient mice, exhibiting the same intrathymic 
accumulation defect and increased S1PR1 expression on the mature thymocytes. 
Interestingly deleting LTβR on thymic mesenchyme or epithelial cells did not result in 
an egress defect despite the essential role for LTβR regulation of medullary thymic 
epithelial cell development. Thus our data indicated that LTβR regulation of thymic 





























































CHAPTER FIVE: UNDERSTANDING THE TIMING OF 




Once thymocytes have undergone positive and negative selection the final stage in 
their development is maturation to an egress competent mature cell that expresses 
molecules essential for their exit, such as the S1P-receptor 1 (S1PR1) (98,262). 
Whilst regulators of thymus egress, including mediators of the S1P-S1PR1 pathway, 
have been identified through many studies including our own, the finer details of 
egress remain in debate (115,271). There are two main hypotheses regarding 
thymocyte egress; the stochastic model and the conveyor-belt model (272). The 
former suggests that thymocyte egress is a random process; once thymocytes have 
reached maturation and are egress competence e.g. express S1PR1, they are able 
to leave the thymus at random. However the latter suggests that only the cells that 
have reached maturation first leave the thymus before the newer mature cells in a 
strictly ordered linear manner. 
 
There is supporting evidence for both models and which of these models are correct 
still remains in contention. In 1995 Scollay and Godfrey reviewed the evidence that 
supported these models, highlighting how much of the studies up until that point 
supported either model and definitive evidence for one over the other was lacking 
(272–276). Since then studies that attempt to definitively investigate the timing and 
order of thymocyte egress have been lacking and even the recent studies of this 
topic are still not clear.  
 
Supporting the conveyor-belt model, McCaughtry et. al separated SP thymocytes into 
subsets based on the expression of RAGgfp (277). The GFPlo cells were identified as 
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the most mature, expressing the lowest levels of CD69 and HSA and were egress 
competent as evidenced by their expression of S1pr1 (277). Using a method of 
intrathymically labeling thymocytes with biotin, McCaughtry et. al were able to identify 
the newest RTE and show that these cells expressed similar levels of HSA as the 
GFPlo fraction and concluded that the most mature SP thymocytes are exiting the 
thymus first and therefore proposed the conveyor-belt model to be the mode of 
thymocyte egress.  
 
Around a similar time Jin et. al published a study investigating the dynamics of 
medullary thymocyte development and separated the SP4 population into 4 fractions 
of different maturational status based on their expression of the T-cell activation 
marker CD69 and markers of T-cell maturation 6C10 and QA2 (278–281). Using an 
adoptive transfer technique, Jin et. al reintroduced sorted populations of the 4 SP4 
fractions, Sp1 (youngest), Sp2, Sp3 and Sp4 (oldest) into the thymus and monitored 
their development (278). This approach revealed that these fractions displayed 
ordered maturational progression within the medulla with Sp1 giving rise to Sp2, Sp2 
giving rise to Sp3 and Sp3 giving rise to Sp4 (278). Whilst their analyses revealed 
that, consistent with their expression of S1PR1, the older Sp3 and Sp4 fractions were 
detected in the periphery before the younger Sp1 and Sp2 fractions, Sp3 thymocytes 
were detectable in the peripheral before all of the Sp4 thymocyte had left, suggesting 
that once SP thymocytes reach egress-competence their egress from the thymus is 
stochastic (278). 
 
Both of these studies, as well as others published prior to these, provide well-
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reasoned arguments, backed up with clear data, to support either of the thymocyte 
egress models (263,272–278). Therefore this chapter aims to adopt a more accurate 
and detailed approach to identify SP thymocytes of differing maturational stages and 
to investigate whether the egress of these mature SP thymocytes follow a random or 
ordered program of egress. 
 
5.2 RESULTS 
5.2.1 Is Thymic Egress A Random Or Ordered Process 
 
The kinetics and timing of thymocyte egress remains a point of contention. The two 
main schools of thought are the stochastic (random) model and the conveyor-belt 
(ordered) model. The former suggests that once a cell has become egress 
competent it can exit the thymus at any time, regardless of that cells age relative to 
the other egress-competent SP thymocytes amongst that cell, whereas the latter 
suggests that the oldest egress-competent mature cells will leave before the newer 
mature cells in a strictly linear manner.  
 
To investigate whether cells leave in an ordered or random process, the 
CD69loCD62L+ mature fraction of conventional SP4 (cSP4) thymocytes needed to be 
separated into subsets of different ages. To do this, the CD69loCD62L+ fraction was 
separated into four distinct populations (M1-M4) based on their expression of CD69 
(M1 has highest CD69 expression, M4 has the lowest) (Fig 5.1.A.). This was carried 
out in RAGgfp mice to determine the sequential maturation of these different M1-M4 
subpopulations. The analysis of RAGgfp MFI on each population revealed significant 
reduction of RAGgfp between M1-M4 populations of mature SP4 thymocytes, 
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revealing a positive correlation of CD69 and RAGgfp expression and identifying M1 
cells as the youngest population whilst M4 cells are the oldest (Fig 5.1.B.). A defining 
characteristic of the most mature cells is their expression of molecular regulators of 
thymic exit, including the sphingosine-1-phosphate receptor 1 (S1PR1), expression 
of which correlates with egress competency (97). Expression of S1PR1 was found to 
be present on all four M1-M4 subsets and expression levels of S1PR1 increase, 
correlating with reduced RAGgfp indicating higher levels of S1PR1 on older mature 
SP thymocytes (Fig 5.1.C.) Plotting MFI for both RAGgfp and S1PR1 on a dual axis 
plot clearly demonstrates this positive relationship between the age of the mature cell 
and its expression of S1PR1 (Fig 5.1.D.). These analyses support both stochastic 
and conveyor-belt models of thymocytes egress; the mature population as a whole 
possesses the ability to egress the thymus via S1PR1 expression, however older 
mature SP4 fractions do express higher levels of S1PR1 and therefore may have a 
greater propensity to egress the thymocyte compared to the younger mature SP4 
fractions and thus may egress the thymus first. 
 
As this analysis provided data to support stochastic and conveyor-belt egress models 
we sought to investigate the timing of thymocyte egress using additional fine-grain 
experimental analysis. The method of injecting anti-CD4 antibody intravenously (IV 
CD4) is often used to identify cells within the perivascular space (PVS) and therefore 
is a robust method of labeling cells in the act of egress (111,115). Therefore the 
stochastic model would suggest that PVS resident IV CD4+ labeled cells will be a mix 
of SP thymocytes at differing stages of maturation, whereas the conveyor-belt model 








Figure 5.1. Mature SP4 Thymocytes Can Be Separated Into Four Distinct 
Fractions 
Thymic lobes were harvested from WT RAGgfp reporter mice and mechanically 
disrupted for FACS analysis of the thymocyte populations. 
(A) Conventional single positive CD4 (cSP4) thymocytes were identified as 
CD4+CD8-TCRβhiCD25-Foxp3-. Immature and mature thymocytes were identified as 
CD69+CD62L- and CD69loCD62L+, respectively and the CD69loCD62L+ mature 
fraction was further separated based on levels of CD69 in to M1 (red), M2 (blue), M3 
(green) and M4 (orange) populations. 
(B) RAGgfp expression for each of M1-M4 population and the RAGgfp MFI was 
calculated for each population; M1 (red), M2 (blue), M3 (green) and M4 (orange). 
(C) S1PR1 expression for each M1-M4 population and the S1PR1 MFI was 
calculated for each population; M1 (red), M2 (blue), M3 (green) and M4 (orange). 
(D) Graph plotting RAGgfp (blue circle) and S1PR1 (red square) MFI for each M1-M4 
population as previously calculated for (B) and (C). 
 
The standard error bars display the SEM and an one-way ANOVA test was 
performed, where ** denotes a significant difference as p<0.01, *** as p<0.001 and 
**** as p<0.0001. All data is typical of 3 independent repeats where total n=5.  















































































































IV CD4+ labeled cells were identifiable in adult wild type mice that have been I.V. 
injected with the anti-CD4 PE antibody (Fig 5.2.A.) by flow cytometric analysis. 
Surprisingly more than half of the IV CD4+ cells were RAGgfp- which may indicate that 
these cells are recirculating cells and are entering the thymus rather than exiting the 
thymus, therefore only RAGgfp+ cells were gated on to ensure the analysis was 
accurately investigating newly generated thymocytes exiting the thymus (Fig 5.2.A.). 
RAG+ IV CD4+ cells expressed high levels of TCRβ and were CD25- suggesting 
these cells were conventional SP4 thymocytes (Fig 5.2.A.). Within the CD25- SP4 
thymocytes the majority of the labeled cells were CD69loCD62L+ mature thymocytes 
consistent with egressing cells and S1PR1 expression (Fig 5.2.B.). Using the gating 
method to split the mature population into four subsets based on CD69 expression 
revealed that all subsets were labeled with the anti-CD4 antibody (Fig 5.2.C.). This 
suggests that all mature SP4 cells, regardless of their age, can enter the PVS and 
therefore are able to exit the thymus.  
 
The observation that over half of IV CD4+ cells are RAGgfp- is an interesting finding 
and required further analysis. Previous studies have used I.V. anti-CD4 antibody 
injections to label cells in the PVS and suggested these cells are exiting the thymus, 
yet no studies have used this technique in combination with RAGgfp (111). Separating 
the IV CD4+ thymocyte population based on RAGgfp revealed that over 50% of IV 
CD4+ cells are RAGgfp- (Fig 5.3.A.). Within the RAGgfp+ fraction the majority of cells 
were CD25- and these cells fell within the CD69loCD62L+ gate consistent with mature 
cells leaving the thymus (Fig 5.3.B.). The RAGgfp- cells may represent recirculating 
cells and Tregs are well known to recirculate to the thymus (282). However within the 
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RAGgfp- fraction of IV CD4+ cells there was no skewing towards CD25+ cells or 
obvious bias towards mature cells (Fig 5.3.C.). This suggests that IV CD4+ cells may 
be labeling cells that are not only exiting the thymus but also entering the thymus and 
therefore analysis using this technique requires the inclusion of RAGgfp to more 
accurately measure cells with the PVS that are recirculating. 
  
If mature thymocytes are leaving in an ordered manner then the conveyor-belt model 
predicts that mice with egress defects and an intrathymic accumulation of mature 
thymocytes such as Ltbr-/- mice would have a selective increase in the number of the 
most mature fraction of these cells, defined here as M4. CD69loCD62L+ mature cSP4 
thymocytes from Ltbr+/+and Ltbr-/- mice were separated into the M1-M4 fractions as 
before (Fig 5.4.A.). There was no specific increase in the oldest fraction of mature 
cSP4 thymocytes (M4), instead there was a significant increase in the number of M2 
and M3 fractions and M1 and M4 followed the same trend, consistent with the 
stochastic model of thymocyte egress and our IV CD4 analysis (Fig 5.4.B.). Uptake 
of BrdU reveals cells that are proliferating and the mature subset of cSP4 thymocytes 
have reduced proliferation consistent with previous reports (Fig 5.4.C.) (151). To 
exclude the possibility that the increase in the M2 and M3 fractions was not simply 
due to increased proliferation, the percentage of BrdU+ cells within each M1-M4 
fraction was calculated. Fractions M2-M4 all had significantly lower BrdU+ cells 
consistent with the mature population as a whole, whereas M1 had normal 
proportions of BrdU+ cells (Fig 5.4.C.). This data suggests that in the context of 
altered egress and an intrathymic accumulation of mature thymocytes the stochastic 








Figure 5.2. Each M1-M4 Subpopulation of Mature SP4 Thymocytes Can Enter 
The Perivascular Space 
Adult WT RAGgfp reporter mice were injected I.V. with anti-CD4 PE-conjugated 
antibody at a concentration of 5µg/ml. Mice were sacrificed three minutes after 
injection and the thymi were immediately harvested and mechanically disrupted for 
thymocyte analysis. 
(A) Gating strategy to identify RAGgfp+ CD25- IV CD4+ labeled cells within the 
perivascular space (PVS). 
(B) Gating for immature (CD69+CD62L-) and mature (CD69loCD62L+) cells within IV 
CD4+ RAGgfp+ CD25- SP4 thymocytes. The proportions of immature (blue circle) and 
mature (red square) cells with CD4+ RAGgfp+ CD25- SP4 thymocytes reveal mature 
cells as the dominant population within the PVS. 
(C) The mature IV CD4+ labeled cells as identified in (B) separated into M1-M4 to 
identify each population within the PVS; M1 (red), M2 (blue), M3 (green) and M4 
(orange). 
 
The standard error bars display the SEM. A mann-whitney test was performed in (B), 
where ** denotes a significant difference as p<0.01. An one-way ANOVA as 
performed in (C), where ** denotes a significant difference as p<0.01, *** denotes 
p<0.001 and **** denotes p<0.0001. All data is typical of 3 independent repeats 















































































































Figure 5.3. IV CD4 Labeled Cells Contain Both RAGgfp- And RAGgfp+ Cells Within 
The Perivascular Space 
Adult WT RAGgfp reporter mice were injected I.V. with anti-CD4 PE-conjugated 
antibody at a concentration of 5µg/ml. Mice were sacrificed three minutes after 
injection and the thymi were immediately harvested and mechanically disrupted for 
thymocyte analysis. 
(A) Expression of anti-CD4 PE (IV CD4) and CD8 on thymocytes of WT RAGgfp mice. 
Expression of RAGgfp expression within the IV CD4+ population (middle) and the 
proportions of RAGgfp- (blue circle) and RAGgfp+ (red square) IV CD4+ cells were 
calculated (right).  
(B) RAGgfp+ IV CD4+ cells were separated based on expression of CD25 and the 
expression of pattern CD69 and CD62L was plotted for CD25+ (middle) and CD25- 
(right) RAGgfp+ IV CD4+. 
(C) RAGgfp- IV CD4+ cells were separated based on expression of CD25 and the 
expression of pattern CD69 and CD62L was plotted for CD25+ (middle) and CD25- 
(right) RAGgfp- IV CD4+. 
 
The standard error bars display the SEM and a mann-whitney test was performed. All 






































































































Figure 5.4. Each Of The M1-M4 Subpopulations Of Mature SP4 Thymocytes 
Accumulate Within The Adult LTβR-deficient Mouse Thymus 
Thymic lobes were harvested from control (Ltbr+/+) and LTβR-deficient (Ltbr-/-) mice 
and mechanically disrupted for FACS analysis of thymocytes. 
(A) Expression pattern of CD69 and CD62L on mature conventional single positive 
CD4 (cSP4) thymocytes, identified as CD4+CD8-TCRβhiCD25-Foxp3-CD69loCD62L. 
The CD69loCD62L+ mature fraction was further separated based on levels of CD69 in 
to M1, M2, M3 and M4. 
(B) Cell numbers for each M1-M4 fraction were calculated for Ltbr+/+ (blue, n=12) and 
Ltbr-/- (red, n=11). 
(C) Ltbr+/+ and Ltbr-/- adult mice were administered BrdU to measure proliferation 
within mature cSP4 thymocytes and the M1-M4 subpopulations within the mature 
cSP4 population. The percentage of BrdU+ cells was calculated for each population 
within Ltbr+/+ (blue, n=5) and Ltbr-/- (red, n=6) mice. 
 
The standard error bars display the SEM and a mann-whitney test was performed, 
where ** denotes a significant difference as p<0.01, *** denotes p<0.001 and **** 
denotes p<0.0001. (A-B) is typical of 3 independent repeats and (C) is typical of 2 
















































































































This supports our previous data suggesting that once mature thymocytes reach 
egress competence they can leave the cell in a random timing and are not restricted 
to an ordered program of egress where the oldest cells must leave first.   
 
Data from the Ltbr-/-RAGgfp mouse model revealed how mature thymocytes within the 
Ltbr-/- thymus have a much longer intrathymic dwell time compared to the control 
counterparts (Chapter 4). This model could also help provide insight into the dwell 
time of each of the M1-M4 fractions and if the dwell time of each of the fractions were 
similarly increased it would support the stochastic egress model. To investigate this a 
similar approach was applied to data acquired from Ltbr-/-RAGgfp data. The RAGgfp+ 
mature subset of SP4 thymocytes was separated into the M1-M4 fractions based on 
CD69 expression (Fig 5.5.A.). For each fraction the RAGgfp expression was plotted 
comparing Ltbr+/+RAGgfp and Ltbr-/-RAGgfp mice (Fig 5.5.B.). Analysis of the MFI of 
RAGgfp on each fraction revealed RAGgfp is significantly lower on each of the M2-M4 
fractions of Ltbr-/-RAGgfp mature thymocytes (Fig 5.5.C.). Therefore this suggests that 
all fractions within the mature subset of SP4 thymocytes are accumulating rather 
than accumulation of just the most mature M4 fraction, further supporting the 
stochastic model.  
 
Finally, the method of splitting the mature fraction into M1-M4 was used for the IV 
CD4+ cells within Ltbr-/- mice. Gating was consistent with previous experiments where 
RAGgfp+ IV CD4+ CD25- cells were gated on and split into immature and mature cells 
based on CD69 and CD62L expression (Fig 5.6.A.). CD69loCD62L+ mature cells 
were gated on and separated into the M1-M4 fraction. Importantly, there was no 
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specific skewing of IV CD4+ cells within any of the M1-4 fractions within the 
perivascular space (Fig 5.6.B.). This indicates that accumulating thymocytes in the 
process of active emigration consisted of all stages of mature thymocytes, further 
supporting the stochastic model of thymocyte egress. 
 
These results reveal that the CD69loCD62L+ mature fraction can be split based on 
CD69 expression into subsets that exhibit sequential maturation. All of these subset 
can be found within the PVS indicating that they are actively undergoing thymic 
egress and each of these fractions were found among accumulating mature 
thymocytes within a model of disrupted thymocyte egress (Ltbr-/- mice). Together 
these analyses provide novel evidence to support the stochastic model of thymocyte 











Figure 5.5. RAGgfp And S1PR1 Are Increased On Each Of The M1-M4 
Subpopulations Of Mature SP4 Thymocytes Within Adult LTβR-deficient Mice 
Thymic lobes were harvested from control (Ltbr+/+RAGgfp) and LTβR-deficient (Ltbr-/-
RAGgfp) mice and mechanically disrupted for FACS analysis. 
(A) Expression pattern of CD69 and CD62L on mature conventional single positive 
CD4 (cSP4) thymocytes, identified as CD4+CD8-TCRβhiCD25-Foxp3-
RAGgfp+CD69loCD62L. The CD69loCD62L+ mature fraction was further separated 
based on levels of CD69 in to M1 (red), M2 (blue), M3 (green) and M4 (orange). 
(B) The expression of RAGgfp on M1-M4 fraction of CD69loCD62L+ mature SP4 
thymocytes within Ltbr+/+RAGgfp (blue) and Ltbr-/-RAGgfp (red) mice. Expression of 
RAGgfp is also compared to a non-fluorescent control (grey) for each population. 
(C) RAGgfp MFI for each M1-M4 population of mature SP4 thymocytes was 
calculated. Left: RAGgfp MFI is compared between Ltbr+/+RAGgfp (left bar) and Ltbr-/-
RAGgfp (right bar) for M1 (red), M2 (blue), M3 (green) and M4 (orange). Right: 
RAGgfp MFI is compared between Ltbr+/+RAGgfp (blue) and Ltbr-/-RAGgfp (red) for M1-
M4. 
 
The standard error bars display the SEM and an one-way ANOVA test was 
performed, where * denotes a significant difference as p<0.05. All data is typical of 3 
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Figure 5.6. Each Of The M1-M4 Subpopulations Of Mature SP4 Thymocytes 
Within The Adult LTβR-deficient Mouse Thymus Are Present Within The PVS 
Adult LTβR deficient (Ltbr-/-RAGgfp) mice were injected I.V. with anti-CD4 PE-
conjugated antibody at a concentration of 5µg/ml. Mice were sacrificed three minutes 
after injection and the thymi were immediately harvested and mechanically disrupted 
for thymocyte analysis. 
(A) Gating strategy to reveal immature (CD69+CD62L-) and mature (CD69loCD62L+) 
cells within IV CD4+ RAGgfp+ CD25- SP4 thymocytes.  
(B) Mature (CD69loCD62L+) IV CD4+ RAGgfp+ CD25- SP4 thymocytes were separated 
into M1-M4 fractions based on CD69 expression and the proportions of M1 (red), M2 
(blue), M3 (green) and M4 (orange) were calculated. 
 
The standard error bars display the SEM and an one-way ANOVA test was 




































































































































Thymocyte development is a highly regulated, multi-step programme, which ensures 
that T-cells generated by the thymus express a functional T-cell receptor and are 
self-tolerant. The final step in this process is thymocyte egress and the timing and 
regulation of this is highly important in ensuring that only functionally mature 
thymocytes that have undergone a full developmental programme leave the thymus 
to generate and maintain the peripheral T-cell pool. Although multiple cellular and 
molecular regulators of thymocyte egress have been identified, specific details of 
egress timing, such as the order of cells leaving the thymus, remain contentious 
topics. The aim of this chapter was to develop an approach to enable a more 
accurate investigation of the timing and order of thymocyte egress, which may be 
important for further studies of the regulators of thymocyte egress or approaches to 
manipulate the T-cell immune system via thymocyte egress. 
 
Different models have been proposed for how maturation and timing of thymocyte 
egress occurs with studies supporting two models in particular, the conveyor-belt 
model and the stochastic model. The conveyor-belt model proposes that thymocytes 
follow a linear, strictly ordered pattern of egress, where only the most mature cells 
can exit following a specified period of medullary residency. Alternatively the 
stochastic, or random, thymocyte egress model proposes that once a thymocyte has 
matured and has become egress competent it can leave the thymus, regardless if 
there are cells that are older than itself that have not yet undergone egress.  
 
Previous studies have separated the SP4 population as a whole to investigate which 
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of the two models of egress is occurring. The study by McCaughtry et al. took an 
approach where the SP4 thymocyte population was separated into three subsets 
based on their expression of RAGgfp: GFPhi, GFPmid and GFPlo (94). Their analysis 
revealed that GFPlo cells had the most mature phenotype, expressing high levels of 
maturation associated molecules such as CD62L and Qa2 and low levels of CD69, 
consistent with our own gating of mature SP4 thymocytes, which are CD69loCD62L+ 
and express lower levels of RAGgfp compared to CD69+CD62L- immature SP4 
thymocytes. The findings of McCaughtry et al. revealed that GFPmid and GFPlo cells 
both express S1pr1, whereas GFPhi cells do not and that GFPlo SP4 thymocytes had 
the highest expression of S1pr1. Additionally intrathymic (I.T.) injection of biotin was 
used to directly track RTE which revealed that RTE have a phenotype resembling the 
most mature GFPlo SP4 fraction. Because GFPlo SP4 thymocytes were more mature 
than GFPmid and RTE resembled only the GFPlo it was concluded that this data 
supported the conveyor belt method.  
 
Because this gating strategy using RAGgfp levels was used to separate the SP4 
population as a whole it will include both egress incompetent immature SP4 
thymocytes and egress competent mature SP4 thymocytes. Therefore it is most likely 
that the GFPhi population is the CD69+CD62L- immature population, which our own 
analysis reveals have higher levels of RAGgfp compared to the CD69loCD62L+ 
population. GFPmid and GFPlo express S1PR1 and CD62L and our analysis reveals 
that S1PR1 expression is restricted to the CD69loCD62L+ population and although 
the McCaughtry et al. study suggests that the more mature, GFPlo, SP4 thymocytes 
have higher levels of S1pr1 gene expression, there is only a modest increase in 
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S1PR1 expression between our M1-M4 SP4 populations (M1<M2<M2<M4). 
Therefore it appears that the populations identified in the McCaughtry et al. study 
most likely reveal differences between the CD69+CD62L- immature and 
CD69loCD62L+ mature population. Thus the approach utilized by McCaughtry et. al 
fails to separate the mature population in order to definitively measure the order of 
thymocyte egress whereas our strategy of separating the mature SP4 fraction into 
subsets of differing maturational statuses allows for a more fine-grain analysis of 
thymocyte maturation.  
 
Another study used a similar approach to separate the SP4 thymocyte population as 
a whole into four different maturation fractions based on CD69, Qa2 and 6C10 
expression to create Sp1 CD69+6C10+, Sp2 CD69+6C10-, Sp3 CD69-6C10-QA2- and 
Sp4 CD69-6C10-QA2+ populations (278). The findings of Jin et al. revealed that the 
Sp3 and Sp4 fractions, which are CD69-, expressed higher levels of S1pr1 compared 
to Sp1 and Sp2, which are both CD69+ (278). This difference in S1pr1 gene 
expression is perhaps not surprising due to the antagonistic nature of CD69 and 
S1PR1 expression (102,103,106). The Jin et al. study nicely showed a precursor-
product relationship between the Sp1, Sp2, Sp3 and Sp4 populations (developing in 
that order) and adoptive transfer of these four populations revealed that Sp3 and Sp4 
fractions were found in the periphery sooner than Sp1 and Sp2. However Sp3 cells 
were found in the periphery when some Sp4 thymocytes were still within the thymus 
suggesting that egress may not be occurring in an ordered manner.  The Jin et al. 
study faces the same caveat as the McCaughtry et al study which is that the SP4 
thymocyte population as a whole is being separated into different maturational 
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subsets. Thus many of the differences identified between the different SP4 fractions 
are key differences previously identified between immature and mature SP4 
thymocytes, such as the expression of S1PR1 and thus do not offer enough depth to 
accurately investigate the order of mature thymocyte egress. Together the results of 
both studies do not clearly conclude whether thymocyte egress is a random or 
ordered process. 
 
An additional caveat of the study by Jin et al. is the use of Qa2 to distinguish 
between the Sp3 and Sp4 populations. Xing et al. showed that the expression of Qa2 
is dependent on type 1 interferon signaling in SP thymocytes and is not associated 
with the maturation status of the thymocyte itself (262). Therefore the use of Qa2 to 
define different maturation subsets with the SP4 thymocyte population is inherently 
flawed. Instead Xing et al. proposed the use of CD69 and MHC Class I to separate 
SP4 thymocytes into three distinct populations, CD69+Class I- SM, CD69+Class I+ M1 
and CD69-Class I+ M2 and showed that the Sp3 and Sp4 populations shown in the 
study by Jin et al. can be identified as CD69-Class I+ M2. Interestingly the M2 
population of SP4 thymocytes express CD62L, S1PR1 and are CD69- which would 
make them the equivalent population to the CD69loCD62L+ mature SP4 population 
we have used for our own analysis. 
 
Our approach to understand which of the two models operates to regulate thymocyte 
egress was similar but, in contrast to previous studies, we separated the 
CD69loCD62L+ mature SP4 cells into sub fractions. This allowed us to focus on SP4 
thymocytes that are egress competent and possess the potential to exit the thymus, 
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a point that extends the findings of the previous studies discussed above. We used 
the expression levels of CD69 to split the CD69loCD62L+ SP4 population into four 
populations termed M1-M4 and analysis of RAGgfp expression across the four 
populations revealed sequential populations of different ages, with M1>M2>M3>M4 
for RAGgfp. Additionally all four M1-4 populations expressed S1PR1 suggesting that 
all cells are egress competent allowing us to directly compare cells capable of 
thymus exit and investigate whether the more mature M4 cells leave before the 
relatively less mature M1 cells. Interestingly the use of I.V. injection of an anti-CD4 
antibody, to label cells in the thymic PVS as previously reported, revealed that all four 
populations are present in the perivascular space (PVS) and therefore likely to be in 
the process of egress (111,115). Therefore this revealed that younger (higher 
RAGgfp) mature cells possess the capacity to undergo the first step of egress via 
entry to the PVS at the same time as the older (lower RAGgfp) mature cells, providing 
evidence for a stochastic model of thymocyte egress at the level of PVS entry. 
Additionally our analysis revealed that in the context of an intrathymic accumulation 
of mature SP4 thymocytes, as observed in Ltbr-/- mice, there was an increase in each 
of the M1-M4 mature subpopulations and thus no specific build up of the most 
mature, M4, subset of SP4 thymocytes. There was also an increase in the 
intrathymic dwell time for each M1-M4 fraction not just the more mature M4 fraction. 
These are also indicative of a stochastic model of egress, as it could be predicted 
that ordered egress would result in the most mature M4 cells preferentially 




Our data therefore support the stochastic model of thymocyte egress, revealing that 
PVS entry occurs randomly within the mature, egress-competent SP thymocyte 
population. However, whether the whole process of thymocyte egress is stochastic 
remains to be determined as PVS entry is only one step of the egress process and 
cells within the PVS must then undergo reverse transendothelial migration into the 
blood.  To determine whether reverse transendothelial migration from the PVS into 
the blood subsequently occurs in a stochastic manner requires further experiments to 
analyze RTE in the periphery and compare their phenotype to the M1-M4 mature 
populations. Using our approach to identify M1-M4 populations of mature thymocytes 
in conjunction with the biotin intrathymic labeling technique used in the McCaughtry 
et al. study would allow us to specifically show whether younger mature cells can 
leave before older mature cells and experiments are currently underway to address 
this. 
 
Our analysis to identify different mature populations within the PVS through I.V. 
injections of anti-CD4 revealed an interesting observation. Over half of the IV CD4+ 
cells were RAGgfp- suggesting that I.V. anti-CD4 labels cells in the PVS that are 
exiting but also entering the thymus. Preliminary analysis of the RAGgfp- population 
interestingly did not suggest a skewing to CD25+ cells. CD25+ cells will include 
activated T-cells but could also potentially include CD25+ regulatory T-cells (Treg) 
and previous studies have shown that a large portion of thymic Treg are recirculating 
and would therefore be RAGgfp- (282,283). This RAGgfp- IV CD4+ population may also 
include the long-term thymic resident population of iNKT cells which have recently 
been implicated in the regulation of thymocyte egress via type 2 cytokines (115,284). 
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Thus the potential localization of iNKT cells to points of conventional T-cell egress 
may have interesting implications for how these cells are capable of contributing to 
the regulation of T-cell egress. These observations highlight an important 
requirement for the inclusion of RAGgfp when interpreting IV CD4+ cells. Further 
experiments are currently underway to identify these RAGgfp- cells through the use of 
a more diverse staining panel to include DC, iNKT and Treg markers. Once the 
RAGgfp- population(s) within PVS have been identified it would be interesting to 
investigate whether this population is interacting with the egressing cells also within 
the PVS and whether there is a requirement for these cells for normal egress or PVS 
entry. 
 
An additional interesting observation came from the analysis of the M1-M4 fractions 
of mature SP4 thymocytes in Ltbr-/-RAGgfp mice. Our analysis revealed that not only 
is RAGgfp expression lower on each fraction compared to Ltbr+/+RAGgfp control mice, 
but that the RAGgfp expression of Ltbr-/- M1 cells is lower than the RAGgfp expression 
of Ltbr+/+ M1. This would suggest that the length of time spent by all mature SP4 
thymocytes in Ltbr-/- thymus exceeds the time spent by even the most mature SP4 
thymocytes within the control mice. As described in Chapter 4, RAGgfp reduction 
does not occur in immature SP thymocytes, thus only egress-competent SP 
thymocytes accumulate and this occurs at all mature stages within CD69loCD62L+ 
mature SP thymocytes supporting the stochastic model of egress.  
 
Together this chapter uses an alternative approach of identifying populations of 
different ages within the mature fraction of SP4 thymocytes to show that, beyond the 
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acquisition of egress capability, egress of these cells does not depend on the age of 
the cell. Our data show that once a SP4 thymocyte has reached the CD69loCD62L+ 
mature stage it expresses S1PR1 and can enter the PVS and potentially egress the 
thymus regardless of the mature cells around it, supporting the stochastic model of 
thymocyte egress. Thus thymocyte egress as a whole process may actually be 
thought of as a mixture of both the stochastic and conveyor belt models. Conveyor 
belt, because immature SP thymocytes must undergo maturation before becoming 
egress-competent and thus there is a specific timing and order to when cells have 
the ability to exit. However once this maturation occurs entry into the PVS can occur 
randomly, independent of the residency within the thymus of the mature cell, 
supporting the stochastic model. As discussed above, whether the final step of 
thymocyte egress from the PVS into the blood remains to be determined. 
 
An implication of the stochastic model is that the mature SP thymocytes can leave 
once they reach egress-competence and therefore must undergo sufficient 
maturation prior to this point. It has been shown that HSAhi immature SP thymocytes 
are sensitive to negative selection upon TCR stimulation but once these cells mature 
into HSAlo SP thymocytes they are resistant to this and instead have a proliferative 
capacity following TCR stimulation which is vital to the T-cell response to their 
cognate Ag (96). Thus the ability to egress the thymus is limited to the mature 
thymocytes to ensure that this functional transition has occurred. Development into 
the mature phenotype is also associated with cytokine licensing of the SP thymocyte, 
i.e. the ability to produce cytokines, which a recent study by Xing et. al shows is 
restricted to M2 mature fraction (97). Both studies restrict these functional abilities to 
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the mature SP population as a whole, therefore our approach of separating the 
mature population into different fractions based on their maturation may provide 
further insight into these functional abilities in relation to the maturational status of the 
mature cell.  
 
An interesting extension of this would be that if functional capacity differed between 
the M1-M4 populations, which all have the capacity to exit the thymus, it would imply 
that T-cells entering the peripheral pool may potentially have different functional 
capacities. There has been evidence that may support this which reveals medullary 
residency time is important in the acquisition of functional phenotype for mature SP 
thymocytes. Jin et. al intrathymically injected the most mature, Sp4, SP thymocyte 
population and studied their phenotypic and functional changes following either 1 day 
or 4 days within the thymus (278).  Their analysis revealed increased frequencies of 
IL-4 and interferon (IFN)-γ producing cells when cells were in the thymus for 4 days 
suggesting functional changes increased with increased medullary residency (278). 
Thus this may support the hypothesis that T-cells of the M1 fraction may not undergo 
full medullary residency-dependent acquisition of functional capacities. Investigation 
of this hypothesis would require functional analysis of each of the M1-M4 fractions of 
the CD69loCD62L+ mature SP population to show that the older fractions have a 
greater functional capacity compared to the younger fractions. An alternative to this 
could be that functional maturation has already occurred within the M1 fraction of 
CD69loCD62L+ thymocytes, thus whether the M1 fraction exits the thymus prior to 
their maturation to the older M2-M4 fractions has no consequence on their function. 
 
216 
Alternatively mature thymocytes may leave the thymus at different maturation states 
and then undergo further maturation within the periphery. Boursalian et. al provide 
evidence that such continued maturation of T-cells can occur in the periphery through 
the use of RAGgfp mice (263). RTE continued phenotypic maturation within the 
periphery, such as reduced HSA expression, as well as continued functional 
maturation as evidenced by RAGgfp+ RTE secreting less IL-2 and have lower 
expression of the high-affinity IL-2 receptor resulting in reduced antibody-induced 
proliferation compared to RAGgfp- T-cells (263). Thus current evidence may suggest 
that if T-cells leave the thymus at the earliest M1 stage they may undergo further 
maturation within the periphery, however directly investigating this using our new 
approach would be required to confirm this. 
 
Together our analysis, summarized in Figure 5.7, not only provides evidence that 
thymocyte entry into the PVS, a key step in the egress of mature thymocytes, occurs 
stochastically but also provides a novel approach of identifying different maturation 
subsets of SP thymocytes within the CD69loCD62L+ mature population which will 











Figure 5.7. T-cell Egress Is Not An Exclusively Stochastic Or Linear Process 
(A) The initial stage of T-cell egress requires the maturation of CD69+CD62L- 
immature cells to become egress-competent S1PR1+CD69loCD62L+ mature SP 
thymocytes. This indicates that the initial stage of T-cell egress is linear and ordered. 
(B) We have identified four populations within mature SP thymocytes that differ by 
RAGgfp and S1PR1 expression, where the most immature CD69loCD62L+ cells (M1) 
have high RAGgfp and lower S1PR1 compared to the most mature CD69loCD62L+ 
cells (M4). 
(C) Each of the M1, M2, M3 and M4 subpopulations can enter the perivascular 
space; an essential stage of T-cell egress, thus supporting that egress at this stage is 
stochastic. 
(D) The final stage of T-cell egress requires the reverse transendothelial migration of 
mature cells within the perivascular space to enter the blood. It has yet to be 
determined whether this process is linear or stochastic and is area of research that 
demands further testing as it may have implications on the function of the T-cells 
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CHAPTER SIX: GENERAL DISCUSSION  
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6.1 BACKGROUND AND OVERALL AIMS 
The thymus is a complex organ made up of a heterogeneous mix of hematopoietic 
and stromal cells, where the stromal cells can be separated into epithelium, 
endothelium and mesenchyme populations. The current literature surrounding thymic 
mesenchymal cells, including their function and developmental regulation, is lacking. 
Although the phenotype and function of the thymic mesenchyme within the 
embryonic thymus has in part been revealed, thymic mesenchyme within the adult 
thymus has lacked significant investigation. This is not to say that thymic 
mesenchyme in the adult is completely unknown; thymic mesenchyme has 
previously been shown to contribute to the structure of the adult thymus including the 
capsule and may also regulate thymocyte migration through the production of 
chemokines such as CXCL12 (214,251). A particularly important role of thymic 
mesenchyme was recently identified in pericytes regulating thymocyte egress via 
expression of SPHK1 and 2, which regulate S1P-mediated thymocyte egress through 
catalyzing the phosphorylation of sphingosine to generate S1P (111). The cellular 
and molecular regulators of thymic mesenchyme also represent an area of research 
that requires further investigation, as it is unknown how the development and 
maintenance of thymic mesenchyme occurs. 
 
Through our review of the literature we found that lymph node (LN) and thymic 
microenvironments may share some cellular and molecular similarities that could 
inform our own study of the thymic mesenchymal compartment. For example, stromal 
cells within LNs and the thymus express CCR7-ligands which attract CCR7+ T-cells 
and dendritic cells (DC) (21,69–71,220,222,223). One particular similarity of note was 
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the essential requirement for signaling through the TNFRSF member lymphotoxin 
beta receptor (LTβR) for the development of LN mesenchyme as well as thymic 
stromal microenvironments (22,24,149,151,153,194,231,232). However this also 
revealed that whilst LTβR was important for mTEC and thymic endothelial cell 
development and function, it’s role in regulating thymic mesenchyme had not been 
investigated (22,24,151,153,194). In addition to regulating the thymic stromal 
microenvironment, studies of LTβR-deficient mouse thymi revealed a role for LTβR in 
regulating thymocyte egress, however it remained unknown precisely how LTβR was 
regulating this process (151). 
 
Therefore the general aims of this study were to address the following questions: 
• What are the phenotypic and functional characteristics of adult thymic 
mesenchyme? 
• How is adult thymic mesenchyme regulated at both the cellular and molecular 
levels? 
• What are the cellular and molecular regulators of LTβR-dependent thymocyte 
egress? 
6.2 DEFINING THE ROLE OF LTβR IN REGULATING THYMIC MESENCHYME 
Using flow cytometric analysis we sought to define the phenotype and potential 
heterogeneity of thymic mesenchyme within the adult murine thymus. Within the 
adult thymus we were able to identify thymic mesenchyme as PDPN+CD31- non-
epithelial stroma using a gating strategy similar to that used to identify stromal 
populations within LNs (220). This PDPN+CD31- population expressed a number of 
markers previously associated with thymic mesenchyme such as PDGFRα, also 
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expressed by embryonic mesenchyme and PDGFRβ, reported to identify thymic 
pericytes, as well as the adhesion molecules ICAM-1 and VCAM-1 (111,202). Our 
analysis revealed that the development of the ICAM-1hiVCAM-1hi mesenchyme 
population was critically dependent on LTβR signaling mediated via αβ T-cell 
interactions with thymic mesenchyme and ICAM-1hiVCAM-1hi are a significant 
population as they expressed Sphk1, Ccl19 and Autotaxin linking their potential 
function to regulating thymocyte migration and egress. This dependency on 
interactions between mesenchyme and T-cells reflects a similar mechanism of 
crosstalk that operates for thymocyte-TEC development, which are both dependent 
on signaling to each other for their development. The initial discovery of the thymic 
phenotype of LTβR-deficient mice by Boehm et. al revealed a potential role for LTβR 
in thymocyte egress (151). Thus together with a reported role for thymic 
mesenchyme for regulation of thymic egress and our own results indicating an 
essential requirement for LTβR for mesenchyme development, we hypothesized that 
LTβR regulation of thymic mesenchyme is a critical regulatory pathway of T-cell 
egress (151). What made this hypothesis attractive was that, if correct, it would 
suggest that developing T-cells signal LTβR-dependent development of thymic 
mesenchyme. The mesenchyme, acting as gatekeepers of T-cell exit, would in turn 
produce mediators enabling T-cell egress, thus suggesting that T-cells enable their 
own egress through their regulation of thymic mesenchyme.  
 
To directly investigate this hypothesis we generated a mouse model to specifically 
delete Ltbr on thymic mesenchyme. We crossed the previously reported neural-crest 
derived mesenchyme specific Cre mouse model, Wnt-1cre, to an mT/mG fate mapper, 
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wherein all cells express mT but switch to mG following Cre excision, which can be 
identified by flow cytometry (111,241). The Wnt-1cremT/mG mice revealed efficient 
and specific activity of Cre within PDPN+ thymic mesenchyme. We crossed the Wnt-
1cre strain to the Ltbrflox strain to specifically delete Ltbr on Wnt-1cre thymic 
mesenchyme to investigate the role of LTβR regulation of thymic mesenchyme in 
regulating T-cell egress. Analysis of the thymus of these mice revealed that despite a 
loss of ICAM-1hiVCAM-1hi thymic mesenchyme, thymocyte egress was unperturbed 
disproving our hypothesis that LTβR regulation of thymic mesenchyme acts to control 
thymic T cell exit. Therefore despite the essential role of LTβR in the development of 
ICAM-1hiVCAM-1hi thymic mesenchyme, this regulatory pathway is not essential for 
thymocyte egress. Importantly our analysis is focusing on LTβR regulation of thymic 
mesenchyme controlling egress and therefore does not rule out a role for thymic 
mesenchyme to regulate LTβR-independent thymocyte egress. The study of thymic 
pericytes, which are thymic mesenchymal cells, clearly supports thymic mesenchyme 
regulating thymocyte egress via SPHK production and therefore our analysis shows 
that LTβR is not regulating this process (111). Our preliminary gene-expression 
analysis of thymic stroma from WT and Ltbr-/- mice appears to support this, with Ltbr-/- 
thymic mesenchyme having no major reduction in Sphk.  Our analysis centered on a 
role for LTβR regulation of thymic mesenchyme in regulating thymocyte egress 
however an alternative function of these cells could be regulating the entry of 
progenitor cells which is also dysfunctional in LTβR-deficient mice (22,24). The case 
for thymic mesenchyme regulating T-cell progenitor entry is similar to that for 
regulating T-cell egress, in that thymic mesenchymal cells are situated around blood 
vessels which are the site of T-cell progenitor entry and mature T-cell egress, making 
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them well positioned to regulate these processes. Although endothelial cells have 
currently been identified in recent studies to regulate the process of T-cell progenitor 
entry into the thymus, these studies have not investigated a role for thymic 
mesenchyme in this LTβR-dependent process (22,24). This may be of interest as 
thymus colonization is regulated by CCR7-CCR7-ligands and our own analysis 
shows that thymic mesenchyme express Ccl19 and therefore thymic mesenchyme 
may have a role in this process. Analysis of the ETP population within the Wnt-
1creLtbrflox mice would allow us to investigate this potential function of thymic 
mesenchyme. Our recently published study revealed that Wnt-1creLtbrflox mice had a 
significant reduction of a subpopulation of dendritic cells termed cDC1 and this 
reduction of cDC1 in Wnt-1creLtbrflox mice mirrored the reduction found in Ltbr-/- mice 
(157). cDC1 cells arise from a progenitor that migrate into the thymus, suggesting 
that the reduction of cDC1 in the Wnt-1creLtbrflox could be due to reduced colonization 
of the thymus by cDC1 progenitors or impaired development of the cDC1 from the 
progenitors. Therefore this highlights a potential role for thymic mesenchyme in 
regulating the intrathymic DC populations, which have essential roles in negative 
selection to prevent autoimmunity.  
 
The other main defect within LTβR-deficient thymi is the drastic medullary 
disorganization and reduced mTEC, particularly CCL21+ mTEClo. Our analysis of 
Foxn-1creLtbrflox mice reveal that this defect is primarily cell intrinsic, however early 
studies of thymocyte function within the embryonic thymus found that thymic 
mesenchyme regulate TEC proliferation through the production of growth factors 
such as FGF10, which our own gene analysis shows is expressed in adult thymic 
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mesenchymal cells (201,202). Therefore an experiment to analyze the TEC 
populations within Wnt-1creLtbrflox would be interesting to investigate whether LTβR 
regulation of thymic mesenchyme is indirectly regulating TEC. 
 
Alternatively thymic mesenchyme express Ccl19 which may suggest a role in 
regulating thymocyte egress in the neonatal thymus rather than the adult. The CCR7 
pathway has been shown to regulate the cortical to medullary migration of T-cells 
however this is regulated through CCL21 and not CCL19 (220,249). However The 
CCR7-dependent control of T-cell egress in neonates was shown to be regulated by 
CCL19 (69,116). Therefore the CCR7 pathway of neonatal T-cell egress may be 
controlled by LTβR regulation of thymic mesenchyme. Therefore investigation of Ltbr-
/- and Wnt-1creLtbrflox neonates could be a very interesting avenue to pursue in the 
future. Alternatively transwell migration assays could be carried out to explore a role 
for thymic mesenchyme in regulating intrathymic migration of thymocytes as well as 
other lymphocytes such as thymic B-cells in the context of mesenchyme expression 
of Cxcl13. This potential regulation of intrathymic B-cells is interesting as thymic B-
cells have recently been identified to contribute to negative selection (260). 
Furthermore, as our analysis indicates a potential role of thymic mesenchyme in 
regulating DC migration into the thymus, this could indicate a common mechanism 
for hematopoietic entry of cells associated with negative selection. Our preliminary 
analysis found that sorted PDPN+ thymic mesenchyme could successfully be sorted 




It would be very interesting to investigate whether our strategy of identifying thymic 
mesenchyme is possible within human thymic tissues and whether the ICAM-
1hiVCAM-1hi population is present similarly to the mouse thymus. A recent study 
which engineered a human thymic microenvironment isolated and cultured thymic 
mesenchyme and briefly phenotyped them using mesenchyme markers including 
PDGFRα (285). Interestingly Chung et. al found that they were able to reaggregate 
cultured human TEC and thymic mesenchyme to form a functional thymus which 
supported thymopoiesis (285). Therefore thymic mesenchyme within the human 
thymus may play a similar role to embryonic mice for the development of the thymus 
however additional functions of human thymic mesenchyme could also be 
investigated. We were fortunate to be able to carry out pilot experiments to 
investigate the mesenchyme population within human neonatal thymus tissue from 
patients undergoing cardiac surgery. In these experiments we were able to identify 
PDPN+CD31- thymic mesenchyme, however due to the size of the thymus tissue 
itself and the accompanying large number of thymocytes it was difficult to enrich for 
the thymic mesenchyme population for further in-depth analysis. We are aiming to 
repeat these pilot analyses using different techniques to deplete the thymocyte 
population in order to enrich the stromal populations, however lack of availability of 
human tissue has currently prevented this. 
 
During age-related thymic involution there is a loss of TEC with a concomitant 
increase in adipocytes, with thymic involution ultimately resulting in reduced 
thymopoiesis (286,287). The increased adiposity of the thymus is believed to occur 
through epithelial-mesenchymal transition (EMT) where epithelial cells lose their 
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epithelial phenotype and differentiate into mesenchyme cells, followed by 
transdifferentiation of EMT-derived thymic mesenchyme cells into adipocytes (288). 
This EMT process was observed using Foxn-1creROSA26RstoplacZ fate mapper 
mice which showed LacZ+ cells (therefore cells that expressed Foxn-1cre) expressing 
Fibroblast Specific Protein-1 (FSP1), an EMT specific marker therefore indicating that 
these cells were previously epithelial cells that have undergone EMT (289). EMT is 
an important process that is not restricted to the thymus and is involved in many 
aspects of development and is characterized by reduced expression of epithelial 
markers and increased expression of mesenchymal markers (290,291). Thus a 
population within the total thymic mesenchyme pool identified, as PDPN+CD31- in our 
analysis may have previously been TEC that have undergone EMT and may also be 
a population that will transition to pre-adipocytes within the aging thymus. Within 
peripheral LNs LTβR operates to direct adipocyte precursors into lymphoid stroma 
(231). Thus LTβR may have a similar role within the thymus to inhibit adipogenesis 
and maintain mesenchyme phenotype of the cells. Therefore an interesting study 
would be to investigate the adiposity of LTβR-deficient thymus, which may be 
increased due to absent LTβR-mediated inhibition of adipogenesis.  
 
Together our study of thymic mesenchyme has revealed a novel role of αβ T-cell 
mediated conditioning of ICAM-1hiVCAM-1hi thymic mesenchyme and these 
interactions occur through LTβR. Although thymic mesenchyme express genes 
associated with T-cell exit, LTβR regulation of thymic mesenchyme is not involved in 
the control of T-cell egress. Therefore further investigations are required to identify 
the functional role of ICAM-1hiVCAM-1hi thymic mesenchyme within the adult thymus. 
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6.3 IDENTIFYING THE MECHANISM OF LTβR-REGULATED T-CELL EGRESS 
Our data indicated that the initial hypothesis that LTβR regulation of thymic 
mesenchyme is an essential pathway involved in thymocyte egress was incorrect. 
However LTβR-deficient mice have a clear thymocyte egress defect, which led us to 
identify the cellular regulator of LTβR-dependent egress. Through in vivo models to 
separate hematopoietic and stromal sources of LTβR we were able to show that 
LTβR expression by stromal cells is required for T-cell egress. As our analysis had 
already ruled out an essential role for thymic mesenchyme, the other stromal 
populations to explore were TEC and endothelium. Boehm et. al proposed that the 
strong medullary phenotype and T-cell egress defect of the LTβR-deficient thymus 
may be linked, we therefore hypothesized that LTβR regulation of TEC may be an 
essential pathway regulating T-cell egress (151). Using a Foxn-1creLtbrflox model to 
delete Ltbr on TEC we were able to show that, despite medullary disorganization and 
reduced mTEC populations, Foxn-1creLtbrflox mice had no intrathymic accumulation 
and therefore LTβR regulation of TEC is not an essential regulator of T-cell egress. 
Our finding of normal intrathymic mature T-cells is important as Zhu et. al proposed 
that LTβR controls CCR7-ligands and absence of this pathway results in SP 
thymocytes in the cortex as a result of defective CCR7-mediate cortex-medulla 
migration (155). Therefore not only do our results reveal that thymic medullary 
disorganization does not impact T-cell egress, it shows that reduced mTEC 
populations, including CCL21+ mTEClo which are the primary source of CCL21 in the 
thymus, are not the source of the T-cell egress defect within LTβR-deficient mice. 
Therefore the proposed role for LTβR regulating cortex-medulla migration via CCR7 
is not the mechanism regulating T-cell egress. The last stromal candidate for 
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regulation of LTβR-dependent T-cell egress was the thymic endothelium. Endothelial 
cells have been shown to regulated LTβR-dependent T-cell progenitor entry and 
have previously been implicated in regulating S1P-dependent T-cell egress 
(22,24,112,113). Using the same approach as to delete Ltbr in mesenchyme and 
TEC, we crossed the endothelial-specific Flk-1cre mouse strain to the Ltbrflox strain to 
generate Flk-1creLtbrflox. Interestingly these mice appeared to have an intrathymic 
accumulation of mature thymocytes of a similar magnitude found within Ltbr-/- mice, 
suggesting that LTβR regulation of thymic endothelial cells is critical for LTβR-
dependent T-cell egress. Additionally our analysis found that both Ltbr-/- and Flk-
1creLtbrflox mice had a significant loss of TEPC which are thought to regulated T-cell 
progenitor entry (24). Thus our data reveal a novel role for LTβR regulation of thymic 
endothelial cells as a critical pathway to control T-cell egress and suggests that 
TEPCs may have an additional role of regulating T-cell egress as well as their 
previously identified role of regulating T-cell progenitor entry. If this secondary 
hypothesis of a dual role of endothelial cells regulating entry and exit is correct it 
could have potential implications for attempts to manipulate one of these processes 
as it may result in affecting both pathways simultaneously.  
 
Examples of this can be seen in the recent studies of the role of the LTβR pathway in 
T-cell progenitor entry. Lucas et. al found that in vivo stimulation of LTβR following 
bone marrow reconstitution of lethally irradiated mice enhanced the reconstitution of 
the thymus, as revealed by increased donor cells within the thymus (22). Interestingly 
this study by Lucas et. al found increased frequencies of T-cell populations within the 
periphery of mice receiving agonistic anti-LTβR (22). Whilst this increase is likely 
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due, in part, to increased T-cell production downstream of increased thymus 
reconstitution, it may also indicate that T-cell egress is increased upon anti-LTβR 
stimulation. Additionally it was shown that this agonistic anti-LTβR treatment 
increased the frequency of the thymic portal endothelial cells (TPEC) which are 
thought to regulate T-cell progenitor entry (24). We saw a similar reduction of TPEC 
in the Flk-1creLtbrflox accompanying the T-cell egress defect and therefore the effects 
of anti-LTβR stimulation observed by Lucas et. al are likely via stimulation of TPEC.  
 
Whilst in this context manipulating T-cell progenitor entry to boost thymic 
reconstitution and boost egress for thymic output sound like attractive outcomes for 
therapies, affecting both of these pathways simultaneously may actually be 
disadvantageous. As our analysis has shown, T-cell egress, or at least the first stage 
of entry into the PVS, occurs randomly once the cell has acquired egress 
competence. However we do not fully know whether there is a requirement for 
different mature T-cells to spend longer in the medulla prior to exit. If a therapy aimed 
to boost thymus reconstitution by stimulating increased progenitor entry into the 
thymus, it may also directly increase T-cell egress which could potentially reduce the 
intramedullary dwell time of the mature thymocytes prior to exit. Further studies 
would be required to investigate whether this could have any negative impact on the 
function of these T-cells, which would clearly be counterproductive to the therapy.  
 
An important point to consider regarding our findings of LTβR-dependent T-cell 
egress is that the altered egress of LTβR-deficient mice does not result in peripheral 
T-cell lymphopenia. Therefore even though T-cell egress is defective it does not 
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appear to impact peripheral T-cell-mediated immunity at the quantitative level, 
however it remains to be determined whether the reduced T-cell egress influences 
the quality of the T-cells and the repertoire of the peripheral T-cell pool. A 
consequence of reduced T-cell egress in these mice could be more evident and 
significant in neonates during the initial establishment of the peripheral T-cell pool 
and may even cause reduced T-cell diversity within the T-cell pool. As discussed in 
the previous section, Ccr7-/- and plt/plt neonates have reduced T-cell egress and this 
results in a severe T-cell lymphopenia that is present for the first two weeks neonates 
(69,116). Therefore the role of LTβR in T-cell egress may have more significance 
during early stages if further experiments revealed a similar phenotype within Ltbr-/- 
neonates. An additional experiment investigating the TCR Vβ repertoire would be 
very interesting both at the neonatal and adult stages to explore the long term 
consequences of reduced T-cell egress in these mice. 
 
It is important to note that another major phenotype of Ltbr-/- mice is the loss of 
peripheral lymph nodes due to the essential role of LTβR in their development 
(149,232). This lack of peripheral LNs may complicate the interpretation of the results 
from LTβR-deficient mice, however there is no intrathymic accumulation of mature 
thymocytes in LTα-deficient mice (data not shown), which lack peripheral lymph 
nodes (237). In addition to this, an intrathymic accumulation is present in WT mice 
grafted with LTβR-deficient thymic lobes as well as Flk-1creLtbrflox mice, which also 
have peripheral LNs (although it has yet to be determined whether there is any 
consequence on LN development within these mice). Therefore the absence of 




During our experiments investigating the role LTβR in T-cell egress and upon 
reviewing the current literature surrounding T-cell egress, we found that the 
understanding of the timing of thymocyte egress was lacking. Therefore an additional 
aim of our study was to examine the timing and order of T-cell egress to understand 
whether this process was occurring randomly or in an ordered fashion. What our 
analysis revealed was that T-cell egress is likely occurring both stochastically and 
ordered. Previous studies of T-cell egress, particularly the studies by McCaughtry et. 
al  and Jin et. al, supported the hypothesis that the initial stage of T-cell egress is 
ordered (277,278). This first stage of T-cell egress involves the maturation of SP 
thymocytes to become egress-competent and therefore is a linear process, as this 
must first occur before T-cells have the ability to leave the thymus. However our own 
analyses suggest that the next step of T-cell egress, where egress-competent T-cells 
migrate into the PVS, occurs randomly. What currently remains unknown following 
this study is whether the final step of reverse transendothelial migration of T-cells 
from the PVS into the blood remains stochastic or is an ordered process. We aim to 
test this by using a method used by McCaughtry et. al to intrathymically label 
thymocytes with biotin to identify newly generated T-cells within the periphery (277). 
By using this technique in conjunction with IV anti-CD4 to label T-cells within the 
PVS, we aim to compare the phenotype of RTE with CD69loCD62L+ T-cells of 
different maturation within the thymus and the PVS. This will allow us to investigate 
whether RTE resemble the most mature subset (M4), or are heterogeneous and 
includes all of the mature subsets of the CD69loCD62L+ population. This experiment 
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would then allow us to understand the finer details of the timing of T-cell egress and 
would contribute to further experiments of function and phenotype of RTE. 
6.4 CONCLUDING REMARKS 
In summary, the two main arms of this thesis have furthered our understanding of the 
mesenchyme compartment of the thymus, revealing a novel mechanism of αβ T-cell 
conditioning of thymic mesenchyme via LTβR signaling. Additionally this thesis has 
also revealed a novel mechanism for LTβR regulation of thymic endothelial cells to 
control T-cell, as summarized in Figure 6.1. Our observation that thymic 
mesenchyme development is dependent on LTβR signaling provided by αβ T-cells 
highlights a potential mechanism through which to manipulate this stromal 
population, however the functional importance of LTβR-dependent regulation of 
thymic mesenchyme requires further investigation. Our analysis provides evidence 
that LTβR regulation of thymic epithelial cells is dispensable for T-cell egress, a 
hypothesis proposed following the initial discovery of LTβR-dependent T-cell egress. 
Instead our experiments revealed a previously unrecognized role for LTβR regulation 
of thymic endothelial cells impacting on T-cell egress, specifically at the stage of 
entry into the PVS. Furthermore our data demonstrates that entry into the PVS is a 
stochastic process, addressing an important, previously outstanding question 
regarding when and in what order does the process of T-cell egress occur. Further 
experiments to explore the molecular basis for this novel finding may prove an 











Figure 6.1. LTβR Regulation Of Thymic Endothelium Is A Critical Pathway In 
Controlling T-Cell Egress And T-Cell Egress Is Both A Linear And Stochastic 
Process. 
(A) LTβR regulation of thymic endothelium is essential for T-cell egress and this 
regulation is likely critical for entry of T-cells into the PVS. 
(B) Once thymocytes have matured from a CD69+CD62L- phenotype to an egress-
competent CD69loCD62L+ phenotype they have the ability to enter the PVS. This 
initial maturation is essential for T-cell egress and therefore suggests that T-cell 
egress fits a linear model. However our analysis has revealed that subsets of cells 
within the CD69loCD62L+ mature T-cell population that differ on their age and 
expression of S1PR1 are all able to enter the PVS, supporting the stochastic model 
of T-cell egress.  
(C) What remains to be tested is whether the transendothelial migration of T-cells 
within the PVS is a linear or stochastic process. If this process were linear we would 
expect only the most mature (M4) fraction of CD69loCD62L+ cells in the PVS to enter 
the periphery. Alternatively if this process were stochastic then all cells within the 
PVS would be found in the periphery and therefore can leave the PVS randomly. 
Whether or not each of these processes is occurring will require further investigation 
as it may have important implications on the function of the RTE once in the 
periphery and may determine whether these cells require further maturation once 
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